JP3481802B2 - Silver halide photographic material, developer for silver halide photographic material and processing method thereof - Google Patents
Silver halide photographic material, developer for silver halide photographic material and processing method thereofInfo
- Publication number
- JP3481802B2 JP3481802B2 JP29716996A JP29716996A JP3481802B2 JP 3481802 B2 JP3481802 B2 JP 3481802B2 JP 29716996 A JP29716996 A JP 29716996A JP 29716996 A JP29716996 A JP 29716996A JP 3481802 B2 JP3481802 B2 JP 3481802B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- silver halide
- developer
- halide photographic
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- -1 Silver halide Chemical class 0.000 title claims description 128
- 229910052709 silver Inorganic materials 0.000 title claims description 88
- 239000004332 silver Substances 0.000 title claims description 88
- 239000000463 material Substances 0.000 title claims description 69
- 238000003672 processing method Methods 0.000 title description 5
- 238000012545 processing Methods 0.000 claims description 123
- 150000001875 compounds Chemical class 0.000 claims description 89
- 239000007787 solid Substances 0.000 claims description 84
- 238000000034 method Methods 0.000 claims description 67
- 239000000839 emulsion Substances 0.000 claims description 33
- 239000000126 substance Substances 0.000 claims description 32
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 21
- 125000000217 alkyl group Chemical group 0.000 claims description 18
- 229910052783 alkali metal Inorganic materials 0.000 claims description 16
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 16
- 125000003118 aryl group Chemical group 0.000 claims description 15
- 238000011161 development Methods 0.000 claims description 15
- 150000001340 alkali metals Chemical group 0.000 claims description 14
- 150000003839 salts Chemical class 0.000 claims description 14
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 13
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 claims description 10
- 125000003277 amino group Chemical group 0.000 claims description 9
- 125000001424 substituent group Chemical group 0.000 claims description 9
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical group [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims description 8
- 239000000084 colloidal system Substances 0.000 claims description 8
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 7
- 150000005205 dihydroxybenzenes Chemical class 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 239000000243 solution Substances 0.000 description 99
- 239000003795 chemical substances by application Substances 0.000 description 98
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 86
- 229920000728 polyester Polymers 0.000 description 53
- 239000007788 liquid Substances 0.000 description 38
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 33
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 32
- 239000010410 layer Substances 0.000 description 31
- 239000000047 product Substances 0.000 description 27
- 239000000203 mixture Substances 0.000 description 25
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 24
- 230000000694 effects Effects 0.000 description 21
- 229920000139 polyethylene terephthalate Polymers 0.000 description 20
- 239000005020 polyethylene terephthalate Substances 0.000 description 20
- 108010010803 Gelatin Proteins 0.000 description 17
- 229920000159 gelatin Polymers 0.000 description 17
- 239000008273 gelatin Substances 0.000 description 17
- 235000019322 gelatine Nutrition 0.000 description 17
- 235000011852 gelatine desserts Nutrition 0.000 description 17
- 238000002360 preparation method Methods 0.000 description 17
- 238000002156 mixing Methods 0.000 description 16
- 239000002245 particle Substances 0.000 description 16
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 15
- 239000004743 Polypropylene Substances 0.000 description 15
- 238000003756 stirring Methods 0.000 description 15
- 230000018109 developmental process Effects 0.000 description 14
- 239000011248 coating agent Substances 0.000 description 13
- 238000000576 coating method Methods 0.000 description 13
- 229920001155 polypropylene Polymers 0.000 description 13
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 13
- NVXLIZQNSVLKPO-UHFFFAOYSA-N Glucosereductone Chemical compound O=CC(O)C=O NVXLIZQNSVLKPO-UHFFFAOYSA-N 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- 239000007864 aqueous solution Substances 0.000 description 12
- 239000012153 distilled water Substances 0.000 description 12
- 239000005022 packaging material Substances 0.000 description 12
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 12
- 229910052782 aluminium Inorganic materials 0.000 description 11
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 11
- 239000008187 granular material Substances 0.000 description 11
- 238000005469 granulation Methods 0.000 description 11
- 230000003179 granulation Effects 0.000 description 11
- 230000007774 longterm Effects 0.000 description 11
- 239000004677 Nylon Substances 0.000 description 10
- 239000002253 acid Substances 0.000 description 10
- 229920001778 nylon Polymers 0.000 description 10
- 238000004806 packaging method and process Methods 0.000 description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 239000004372 Polyvinyl alcohol Substances 0.000 description 9
- 239000011230 binding agent Substances 0.000 description 9
- 229920001577 copolymer Polymers 0.000 description 9
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 9
- 239000006185 dispersion Substances 0.000 description 9
- 229920002451 polyvinyl alcohol Polymers 0.000 description 9
- 239000011241 protective layer Substances 0.000 description 9
- 239000011734 sodium Substances 0.000 description 9
- 229910021612 Silver iodide Inorganic materials 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 239000000565 sealant Substances 0.000 description 8
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 8
- 239000007858 starting material Substances 0.000 description 8
- 239000004698 Polyethylene Substances 0.000 description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical group [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 7
- 229920002678 cellulose Polymers 0.000 description 7
- 235000010980 cellulose Nutrition 0.000 description 7
- 229920000573 polyethylene Polymers 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- 238000003860 storage Methods 0.000 description 7
- 229920003002 synthetic resin Polymers 0.000 description 7
- JKFYKCYQEWQPTM-UHFFFAOYSA-N 2-azaniumyl-2-(4-fluorophenyl)acetate Chemical compound OC(=O)C(N)C1=CC=C(F)C=C1 JKFYKCYQEWQPTM-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 6
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 6
- 239000003513 alkali Substances 0.000 description 6
- 239000002738 chelating agent Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000007906 compression Methods 0.000 description 6
- 230000006835 compression Effects 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 239000010419 fine particle Substances 0.000 description 6
- 229920001684 low density polyethylene Polymers 0.000 description 6
- 239000004702 low-density polyethylene Substances 0.000 description 6
- 229910017604 nitric acid Inorganic materials 0.000 description 6
- 229920003023 plastic Polymers 0.000 description 6
- 239000004033 plastic Substances 0.000 description 6
- 229920001223 polyethylene glycol Polymers 0.000 description 6
- 239000005033 polyvinylidene chloride Substances 0.000 description 6
- 229910052700 potassium Inorganic materials 0.000 description 6
- 229960003975 potassium Drugs 0.000 description 6
- 239000011591 potassium Substances 0.000 description 6
- 229940100890 silver compound Drugs 0.000 description 6
- 150000003379 silver compounds Chemical class 0.000 description 6
- 229940045105 silver iodide Drugs 0.000 description 6
- 229910001961 silver nitrate Inorganic materials 0.000 description 6
- 235000019698 starch Nutrition 0.000 description 6
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 5
- 101710134784 Agnoprotein Proteins 0.000 description 5
- 239000004375 Dextrin Substances 0.000 description 5
- 229920001353 Dextrin Polymers 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 5
- 239000000853 adhesive Substances 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 5
- 229940121375 antifungal agent Drugs 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 5
- 239000004327 boric acid Substances 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 235000019425 dextrin Nutrition 0.000 description 5
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 229910052744 lithium Inorganic materials 0.000 description 5
- 150000002772 monosaccharides Chemical class 0.000 description 5
- 239000000123 paper Substances 0.000 description 5
- 239000011087 paperboard Substances 0.000 description 5
- CMCWWLVWPDLCRM-UHFFFAOYSA-N phenidone Chemical compound N1C(=O)CCN1C1=CC=CC=C1 CMCWWLVWPDLCRM-UHFFFAOYSA-N 0.000 description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 239000004800 polyvinyl chloride Substances 0.000 description 5
- 229920000915 polyvinyl chloride Polymers 0.000 description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 description 5
- 235000011181 potassium carbonates Nutrition 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- ZUNKMNLKJXRCDM-UHFFFAOYSA-N silver bromoiodide Chemical compound [Ag].IBr ZUNKMNLKJXRCDM-UHFFFAOYSA-N 0.000 description 5
- 239000010802 sludge Substances 0.000 description 5
- 229940083542 sodium Drugs 0.000 description 5
- 235000010265 sodium sulphite Nutrition 0.000 description 5
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 5
- 235000019345 sodium thiosulphate Nutrition 0.000 description 5
- HRQDCDQDOPSGBR-UHFFFAOYSA-M sodium;octane-1-sulfonate Chemical compound [Na+].CCCCCCCCS([O-])(=O)=O HRQDCDQDOPSGBR-UHFFFAOYSA-M 0.000 description 5
- 238000007711 solidification Methods 0.000 description 5
- 230000008023 solidification Effects 0.000 description 5
- MNNBCKASUFBXCO-UHFFFAOYSA-N 2-acetamido-3-methyl-3-sulfanylbutanoic acid Chemical compound CC(=O)NC(C(O)=O)C(C)(C)S MNNBCKASUFBXCO-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 4
- 229920000858 Cyclodextrin Polymers 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 239000004793 Polystyrene Substances 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 4
- 229910021536 Zeolite Inorganic materials 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 125000003342 alkenyl group Chemical group 0.000 description 4
- 125000000304 alkynyl group Chemical group 0.000 description 4
- 150000003863 ammonium salts Chemical class 0.000 description 4
- 239000003957 anion exchange resin Substances 0.000 description 4
- 230000000843 anti-fungal effect Effects 0.000 description 4
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 4
- 239000003729 cation exchange resin Substances 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 230000001143 conditioned effect Effects 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 125000000623 heterocyclic group Chemical group 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 229920005615 natural polymer Polymers 0.000 description 4
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 4
- 229920002223 polystyrene Polymers 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 230000001235 sensitizing effect Effects 0.000 description 4
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 4
- 229940001584 sodium metabisulfite Drugs 0.000 description 4
- 235000010262 sodium metabisulphite Nutrition 0.000 description 4
- 159000000000 sodium salts Chemical class 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 239000000057 synthetic resin Substances 0.000 description 4
- 239000010457 zeolite Substances 0.000 description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- AXCGIKGRPLMUDF-UHFFFAOYSA-N 2,6-dichloro-1h-1,3,5-triazin-4-one;sodium Chemical compound [Na].OC1=NC(Cl)=NC(Cl)=N1 AXCGIKGRPLMUDF-UHFFFAOYSA-N 0.000 description 3
- DSVIHYOAKPVFEH-UHFFFAOYSA-N 4-(hydroxymethyl)-4-methyl-1-phenylpyrazolidin-3-one Chemical compound N1C(=O)C(C)(CO)CN1C1=CC=CC=C1 DSVIHYOAKPVFEH-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 3
- 229930024421 Adenine Natural products 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000004373 Pullulan Substances 0.000 description 3
- 229920001218 Pullulan Polymers 0.000 description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 229960000643 adenine Drugs 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- 235000011114 ammonium hydroxide Nutrition 0.000 description 3
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 239000008119 colloidal silica Substances 0.000 description 3
- 238000004040 coloring Methods 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 229920006238 degradable plastic Polymers 0.000 description 3
- 238000011033 desalting Methods 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 239000011888 foil Substances 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 239000003456 ion exchange resin Substances 0.000 description 3
- 229920003303 ion-exchange polymer Polymers 0.000 description 3
- 239000001630 malic acid Substances 0.000 description 3
- 235000011090 malic acid Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 125000001624 naphthyl group Chemical group 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 239000004417 polycarbonate Substances 0.000 description 3
- 229920000515 polycarbonate Polymers 0.000 description 3
- 239000011118 polyvinyl acetate Substances 0.000 description 3
- 229920002689 polyvinyl acetate Polymers 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 235000019423 pullulan Nutrition 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000006722 reduction reaction Methods 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 229910052711 selenium Inorganic materials 0.000 description 3
- 239000011669 selenium Substances 0.000 description 3
- 239000002356 single layer Substances 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 229920001059 synthetic polymer Polymers 0.000 description 3
- ZFVJLNKVUKIPPI-UHFFFAOYSA-N triphenyl(selanylidene)-$l^{5}-phosphane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=[Se])C1=CC=CC=C1 ZFVJLNKVUKIPPI-UHFFFAOYSA-N 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- WFNHDWNSTLRUOC-UHFFFAOYSA-M (2-nitrophenyl)-triphenylphosphanium;chloride Chemical compound [Cl-].[O-][N+](=O)C1=CC=CC=C1[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 WFNHDWNSTLRUOC-UHFFFAOYSA-M 0.000 description 2
- VOZKAJLKRJDJLL-UHFFFAOYSA-N 2,4-diaminotoluene Chemical compound CC1=CC=C(N)C=C1N VOZKAJLKRJDJLL-UHFFFAOYSA-N 0.000 description 2
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical class NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 2
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- PYSRRFNXTXNWCD-UHFFFAOYSA-N 3-(2-phenylethenyl)furan-2,5-dione Chemical compound O=C1OC(=O)C(C=CC=2C=CC=CC=2)=C1 PYSRRFNXTXNWCD-UHFFFAOYSA-N 0.000 description 2
- REKYPYSUBKSCAT-UHFFFAOYSA-N 3-hydroxypentanoic acid Chemical compound CCC(O)CC(O)=O REKYPYSUBKSCAT-UHFFFAOYSA-N 0.000 description 2
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 2
- JIGUICYYOYEXFS-UHFFFAOYSA-N 3-tert-butylbenzene-1,2-diol Chemical compound CC(C)(C)C1=CC=CC(O)=C1O JIGUICYYOYEXFS-UHFFFAOYSA-N 0.000 description 2
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical compound NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 description 2
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 2
- WSGURAYTCUVDQL-UHFFFAOYSA-N 5-nitro-1h-indazole Chemical compound [O-][N+](=O)C1=CC=C2NN=CC2=C1 WSGURAYTCUVDQL-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical group NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 2
- 229920000298 Cellophane Polymers 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 229910021607 Silver chloride Inorganic materials 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229920000147 Styrene maleic anhydride Polymers 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- SOIFLUNRINLCBN-UHFFFAOYSA-N ammonium thiocyanate Chemical compound [NH4+].[S-]C#N SOIFLUNRINLCBN-UHFFFAOYSA-N 0.000 description 2
- XYXNTHIYBIDHGM-UHFFFAOYSA-N ammonium thiosulfate Chemical compound [NH4+].[NH4+].[O-]S([O-])(=O)=S XYXNTHIYBIDHGM-UHFFFAOYSA-N 0.000 description 2
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 2
- 125000004104 aryloxy group Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 229940000635 beta-alanine Drugs 0.000 description 2
- 229920000704 biodegradable plastic Polymers 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- ZUIVNYGZFPOXFW-UHFFFAOYSA-N chembl1717603 Chemical compound N1=C(C)C=C(O)N2N=CN=C21 ZUIVNYGZFPOXFW-UHFFFAOYSA-N 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 150000001844 chromium Chemical class 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 239000011247 coating layer Substances 0.000 description 2
- 239000013256 coordination polymer Substances 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 229920001903 high density polyethylene Polymers 0.000 description 2
- 239000004700 high-density polyethylene Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000005001 laminate film Substances 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 239000006224 matting agent Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 2
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 150000002892 organic cations Chemical class 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 125000006678 phenoxycarbonyl group Chemical group 0.000 description 2
- 239000003279 phenylacetic acid Substances 0.000 description 2
- 229960003424 phenylacetic acid Drugs 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 239000004848 polyfunctional curative Substances 0.000 description 2
- 239000002952 polymeric resin Substances 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 239000011736 potassium bicarbonate Substances 0.000 description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 2
- KYKNRZGSIGMXFH-ZVGUSBNCSA-M potassium bitartrate Chemical compound [K+].OC(=O)[C@H](O)[C@@H](O)C([O-])=O KYKNRZGSIGMXFH-ZVGUSBNCSA-M 0.000 description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- ADZWSOLPGZMUMY-UHFFFAOYSA-M silver bromide Chemical compound [Ag]Br ADZWSOLPGZMUMY-UHFFFAOYSA-M 0.000 description 2
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 2
- KMQKYDWPAZMUDX-UHFFFAOYSA-M sodium;hydrogen sulfite;pentanedial Chemical compound [Na+].OS([O-])=O.O=CCCCC=O KMQKYDWPAZMUDX-UHFFFAOYSA-M 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000001384 succinic acid Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 150000003568 thioethers Chemical class 0.000 description 2
- DHCDFWKWKRSZHF-UHFFFAOYSA-L thiosulfate(2-) Chemical compound [O-]S([S-])(=O)=O DHCDFWKWKRSZHF-UHFFFAOYSA-L 0.000 description 2
- 238000007740 vapor deposition Methods 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 239000003232 water-soluble binding agent Substances 0.000 description 2
- YZOUYRAONFXZSI-SBHWVFSVSA-N (1S,3R,5R,6R,8R,10R,11R,13R,15R,16R,18R,20R,21R,23R,25R,26R,28R,30R,31S,33R,35R,36R,37S,38R,39S,40R,41S,42R,43S,44R,45S,46R,47S,48R,49S)-5,10,15,20,25,30,35-heptakis(hydroxymethyl)-37,39,40,41,42,43,44,45,46,47,48,49-dodecamethoxy-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,38-diol Chemical compound O([C@@H]([C@H]([C@@H]1OC)OC)O[C@H]2[C@@H](O)[C@@H]([C@@H](O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3O)OC)O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3OC)OC)O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3OC)OC)O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3OC)OC)O3)O[C@@H]2CO)OC)[C@H](CO)[C@H]1O[C@@H]1[C@@H](OC)[C@H](OC)[C@H]3[C@@H](CO)O1 YZOUYRAONFXZSI-SBHWVFSVSA-N 0.000 description 1
- BNGXYYYYKUGPPF-UHFFFAOYSA-M (3-methylphenyl)methyl-triphenylphosphanium;chloride Chemical compound [Cl-].CC1=CC=CC(C[P+](C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 BNGXYYYYKUGPPF-UHFFFAOYSA-M 0.000 description 1
- CBDMBBKKGFKNCA-UHFFFAOYSA-N 1,5-diphenylpyrazolidin-3-one Chemical compound N1C(=O)CC(C=2C=CC=CC=2)N1C1=CC=CC=C1 CBDMBBKKGFKNCA-UHFFFAOYSA-N 0.000 description 1
- HLESEOXHRZRIAG-UHFFFAOYSA-N 1-(1,3-benzothiazol-2-yl)pyrazolidin-3-one Chemical compound N1C(=O)CCN1C1=NC2=CC=CC=C2S1 HLESEOXHRZRIAG-UHFFFAOYSA-N 0.000 description 1
- JIPBZEFOQFUCIQ-UHFFFAOYSA-N 1-(4-hydroxyphenyl)-4,4-dimethylpyrazolidin-3-one Chemical compound N1C(=O)C(C)(C)CN1C1=CC=C(O)C=C1 JIPBZEFOQFUCIQ-UHFFFAOYSA-N 0.000 description 1
- SVJPLZNMCJQWPJ-UHFFFAOYSA-N 1-(4-methylphenyl)pyrazolidin-3-one Chemical compound C1=CC(C)=CC=C1N1NC(=O)CC1 SVJPLZNMCJQWPJ-UHFFFAOYSA-N 0.000 description 1
- GGZHVNZHFYCSEV-UHFFFAOYSA-N 1-Phenyl-5-mercaptotetrazole Chemical compound SC1=NN=NN1C1=CC=CC=C1 GGZHVNZHFYCSEV-UHFFFAOYSA-N 0.000 description 1
- CCKNPKNHNFDGND-UHFFFAOYSA-N 1-fluoro-3-(isothiocyanatomethyl)benzene Chemical compound FC1=CC=CC(CN=C=S)=C1 CCKNPKNHNFDGND-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- CWZRXXJJOCTIJA-UHFFFAOYSA-N 2,3-dihydro-1h-pyrazol-5-amine Chemical class NC1=CCNN1 CWZRXXJJOCTIJA-UHFFFAOYSA-N 0.000 description 1
- LKCHSNFSFPARNH-UHFFFAOYSA-N 2,3-dihydrothiophen-5-ol Chemical compound OC1=CCCS1 LKCHSNFSFPARNH-UHFFFAOYSA-N 0.000 description 1
- VYHSWZULFYFDMO-UHFFFAOYSA-N 2-(2-hydroxyethylamino)phenol Chemical compound OCCNC1=CC=CC=C1O VYHSWZULFYFDMO-UHFFFAOYSA-N 0.000 description 1
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
- XZZWGQJWQDJJBX-UHFFFAOYSA-N 2-(4-amino-3-methylphenyl)-1,3-dihydropyrazol-5-amine Chemical compound C1=C(N)C(C)=CC(N2NC(N)=CC2)=C1 XZZWGQJWQDJJBX-UHFFFAOYSA-N 0.000 description 1
- QTLHLXYADXCVCF-UHFFFAOYSA-N 2-(4-amino-n-ethyl-3-methylanilino)ethanol Chemical compound OCCN(CC)C1=CC=C(N)C(C)=C1 QTLHLXYADXCVCF-UHFFFAOYSA-N 0.000 description 1
- WFXLRLQSHRNHCE-UHFFFAOYSA-N 2-(4-amino-n-ethylanilino)ethanol Chemical compound OCCN(CC)C1=CC=C(N)C=C1 WFXLRLQSHRNHCE-UHFFFAOYSA-N 0.000 description 1
- BRNHOYYKQLTXRN-UHFFFAOYSA-N 2-(benzotriazol-2-yl)-1,3-thiazole Chemical compound C1=CSC(N2N=C3C=CC=CC3=N2)=N1 BRNHOYYKQLTXRN-UHFFFAOYSA-N 0.000 description 1
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 1
- XWKAZXKJYHZGAI-UHFFFAOYSA-N 2-acetyl-4,4-dimethyl-1-phenylpyrazolidin-3-one Chemical compound C1C(C)(C)C(=O)N(C(=O)C)N1C1=CC=CC=C1 XWKAZXKJYHZGAI-UHFFFAOYSA-N 0.000 description 1
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 1
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- KRTDQDCPEZRVGC-UHFFFAOYSA-N 2-nitro-1h-benzimidazole Chemical compound C1=CC=C2NC([N+](=O)[O-])=NC2=C1 KRTDQDCPEZRVGC-UHFFFAOYSA-N 0.000 description 1
- LTPDITOEDOAWRU-UHFFFAOYSA-N 3,4-dihydroxybenzenesulfonic acid Chemical compound OC1=CC=C(S(O)(=O)=O)C=C1O LTPDITOEDOAWRU-UHFFFAOYSA-N 0.000 description 1
- IUPHTVOTTBREAV-UHFFFAOYSA-N 3-hydroxybutanoic acid;3-hydroxypentanoic acid Chemical compound CC(O)CC(O)=O.CCC(O)CC(O)=O IUPHTVOTTBREAV-UHFFFAOYSA-N 0.000 description 1
- WHBMMWSBFZVSSR-UHFFFAOYSA-M 3-hydroxybutyrate Chemical compound CC(O)CC([O-])=O WHBMMWSBFZVSSR-UHFFFAOYSA-M 0.000 description 1
- AJKLCDRWGVLVSH-UHFFFAOYSA-N 4,4-bis(hydroxymethyl)-1-phenylpyrazolidin-3-one Chemical compound N1C(=O)C(CO)(CO)CN1C1=CC=CC=C1 AJKLCDRWGVLVSH-UHFFFAOYSA-N 0.000 description 1
- SJSJAWHHGDPBOC-UHFFFAOYSA-N 4,4-dimethyl-1-phenylpyrazolidin-3-one Chemical compound N1C(=O)C(C)(C)CN1C1=CC=CC=C1 SJSJAWHHGDPBOC-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- WSEFOZIMAJPJHW-UHFFFAOYSA-N 4-amino-2-(hydroxymethyl)phenol Chemical compound NC1=CC=C(O)C(CO)=C1 WSEFOZIMAJPJHW-UHFFFAOYSA-N 0.000 description 1
- FQQGQVUWBXURTA-UHFFFAOYSA-N 4-ethyl-1-phenylpyrazolidin-3-one Chemical compound N1C(=O)C(CC)CN1C1=CC=CC=C1 FQQGQVUWBXURTA-UHFFFAOYSA-N 0.000 description 1
- QGNGOGOOPUYKMC-UHFFFAOYSA-N 4-hydroxy-6-methylaniline Chemical compound CC1=CC(O)=CC=C1N QGNGOGOOPUYKMC-UHFFFAOYSA-N 0.000 description 1
- ZZEYCGJAYIHIAZ-UHFFFAOYSA-N 4-methyl-1-phenylpyrazolidin-3-one Chemical compound N1C(=O)C(C)CN1C1=CC=CC=C1 ZZEYCGJAYIHIAZ-UHFFFAOYSA-N 0.000 description 1
- XBTWVJKPQPQTDW-UHFFFAOYSA-N 4-n,4-n-diethyl-2-methylbenzene-1,4-diamine Chemical compound CCN(CC)C1=CC=C(N)C(C)=C1 XBTWVJKPQPQTDW-UHFFFAOYSA-N 0.000 description 1
- FFAJEKUNEVVYCW-UHFFFAOYSA-N 4-n-ethyl-4-n-(2-methoxyethyl)-2-methylbenzene-1,4-diamine Chemical compound COCCN(CC)C1=CC=C(N)C(C)=C1 FFAJEKUNEVVYCW-UHFFFAOYSA-N 0.000 description 1
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- PZBQVZFITSVHAW-UHFFFAOYSA-N 5-chloro-2h-benzotriazole Chemical compound C1=C(Cl)C=CC2=NNN=C21 PZBQVZFITSVHAW-UHFFFAOYSA-N 0.000 description 1
- FIARATPVIIDWJT-UHFFFAOYSA-N 5-methyl-1-phenylpyrazolidin-3-one Chemical compound CC1CC(=O)NN1C1=CC=CC=C1 FIARATPVIIDWJT-UHFFFAOYSA-N 0.000 description 1
- LRUDIIUSNGCQKF-UHFFFAOYSA-N 5-methyl-1H-benzotriazole Chemical compound C1=C(C)C=CC2=NNN=C21 LRUDIIUSNGCQKF-UHFFFAOYSA-N 0.000 description 1
- AOCDQWRMYHJTMY-UHFFFAOYSA-N 5-nitro-2h-benzotriazole Chemical compound C1=C([N+](=O)[O-])C=CC2=NNN=C21 AOCDQWRMYHJTMY-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical group CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 239000001715 Ammonium malate Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229920013642 Biopol™ Polymers 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- LVDKZNITIUWNER-UHFFFAOYSA-N Bronopol Chemical compound OCC(Br)(CO)[N+]([O-])=O LVDKZNITIUWNER-UHFFFAOYSA-N 0.000 description 1
- GQUZTSGWULGOLE-UHFFFAOYSA-N C(C)(=O)O[C-]1NN(CC1=O)C1=CC=CC=C1 Chemical compound C(C)(=O)O[C-]1NN(CC1=O)C1=CC=CC=C1 GQUZTSGWULGOLE-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- ODBLHEXUDAPZAU-ZAFYKAAXSA-N D-threo-isocitric acid Chemical compound OC(=O)[C@H](O)[C@@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-ZAFYKAAXSA-N 0.000 description 1
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical group CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- ODBLHEXUDAPZAU-FONMRSAGSA-N Isocitric acid Natural products OC(=O)[C@@H](O)[C@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-FONMRSAGSA-N 0.000 description 1
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- BZORFPDSXLZWJF-UHFFFAOYSA-N N,N-dimethyl-1,4-phenylenediamine Chemical compound CN(C)C1=CC=C(N)C=C1 BZORFPDSXLZWJF-UHFFFAOYSA-N 0.000 description 1
- WRUZLCLJULHLEY-UHFFFAOYSA-N N-(p-hydroxyphenyl)glycine Chemical compound OC(=O)CNC1=CC=C(O)C=C1 WRUZLCLJULHLEY-UHFFFAOYSA-N 0.000 description 1
- BRLPNQQUZFMXTQ-UHFFFAOYSA-N N1N=CC2=CC(=CC=C12)S(=O)(=O)O.SC=1NC2=C(N1)C=CC=C2 Chemical compound N1N=CC2=CC(=CC=C12)S(=O)(=O)O.SC=1NC2=C(N1)C=CC=C2 BRLPNQQUZFMXTQ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- WHBMMWSBFZVSSR-UHFFFAOYSA-N R3HBA Natural products CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 1
- 102100040160 Rabankyrin-5 Human genes 0.000 description 1
- 101710086049 Rabankyrin-5 Proteins 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- 229910004283 SiO 4 Inorganic materials 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- KSQXVLVXUFHGJQ-UHFFFAOYSA-M Sodium ortho-phenylphenate Chemical compound [Na+].[O-]C1=CC=CC=C1C1=CC=CC=C1 KSQXVLVXUFHGJQ-UHFFFAOYSA-M 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 229920002978 Vinylon Polymers 0.000 description 1
- SJOOOZPMQAWAOP-UHFFFAOYSA-N [Ag].BrCl Chemical compound [Ag].BrCl SJOOOZPMQAWAOP-UHFFFAOYSA-N 0.000 description 1
- XCFIVNQHHFZRNR-UHFFFAOYSA-N [Ag].Cl[IH]Br Chemical compound [Ag].Cl[IH]Br XCFIVNQHHFZRNR-UHFFFAOYSA-N 0.000 description 1
- JVFGXECLSQXABC-UHFFFAOYSA-N ac1l3obq Chemical compound O1C(C(C2O)O)C(COCC(C)O)OC2OC(C(C2O)O)C(COCC(C)O)OC2OC(C(C2O)O)C(COCC(C)O)OC2OC(C(C2O)O)C(COCC(C)O)OC2OC(C(C2O)O)C(COCC(C)O)OC2OC(C(O)C2O)C(COCC(O)C)OC2OC(C(C2O)O)C(COCC(C)O)OC2OC2C(O)C(O)C1OC2COCC(C)O JVFGXECLSQXABC-UHFFFAOYSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000004840 adhesive resin Substances 0.000 description 1
- 229920006223 adhesive resin Polymers 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000004931 aggregating effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 229910001508 alkali metal halide Inorganic materials 0.000 description 1
- 150000008045 alkali metal halides Chemical class 0.000 description 1
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 description 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- AMVQGJHFDJVOOB-UHFFFAOYSA-H aluminium sulfate octadecahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O AMVQGJHFDJVOOB-UHFFFAOYSA-H 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- XIWMTQIUUWJNRP-UHFFFAOYSA-N amidol Chemical compound NC1=CC=C(O)C(N)=C1 XIWMTQIUUWJNRP-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 1
- KGECWXXIGSTYSQ-UHFFFAOYSA-N ammonium malate Chemical compound [NH4+].[NH4+].[O-]C(=O)C(O)CC([O-])=O KGECWXXIGSTYSQ-UHFFFAOYSA-N 0.000 description 1
- 235000019292 ammonium malate Nutrition 0.000 description 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 125000005135 aryl sulfinyl group Chemical group 0.000 description 1
- 125000005110 aryl thio group Chemical group 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- NHJPVZLSLOHJDM-UHFFFAOYSA-N azane;butanedioic acid Chemical compound [NH4+].[NH4+].[O-]C(=O)CCC([O-])=O NHJPVZLSLOHJDM-UHFFFAOYSA-N 0.000 description 1
- JOILQYURMOSQTJ-UHFFFAOYSA-N azanium;2,4-dihydroxybenzenesulfonate Chemical compound [NH4+].OC1=CC=C(S([O-])(=O)=O)C(O)=C1 JOILQYURMOSQTJ-UHFFFAOYSA-N 0.000 description 1
- NGPGDYLVALNKEG-UHFFFAOYSA-N azanium;azane;2,3,4-trihydroxy-4-oxobutanoate Chemical compound [NH4+].[NH4+].[O-]C(=O)C(O)C(O)C([O-])=O NGPGDYLVALNKEG-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- DMSMPAJRVJJAGA-UHFFFAOYSA-N benzo[d]isothiazol-3-one Chemical compound C1=CC=C2C(=O)NSC2=C1 DMSMPAJRVJJAGA-UHFFFAOYSA-N 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 229920003064 carboxyethyl cellulose Polymers 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 229920003090 carboxymethyl hydroxyethyl cellulose Polymers 0.000 description 1
- 229940023913 cation exchange resins Drugs 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 description 1
- GTKRFUAGOKINCA-UHFFFAOYSA-M chlorosilver;silver Chemical class [Ag].[Ag]Cl GTKRFUAGOKINCA-UHFFFAOYSA-M 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000000748 compression moulding Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000002242 deionisation method Methods 0.000 description 1
- 230000032798 delamination Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- WPUMTJGUQUYPIV-JIZZDEOASA-L disodium (S)-malate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](O)CC([O-])=O WPUMTJGUQUYPIV-JIZZDEOASA-L 0.000 description 1
- WBZKQQHYRPRKNJ-UHFFFAOYSA-L disulfite Chemical compound [O-]S(=O)S([O-])(=O)=O WBZKQQHYRPRKNJ-UHFFFAOYSA-L 0.000 description 1
- TXKMVPPZCYKFAC-UHFFFAOYSA-N disulfur monoxide Inorganic materials O=S=S TXKMVPPZCYKFAC-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- NFDRPXJGHKJRLJ-UHFFFAOYSA-N edtmp Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CCN(CP(O)(O)=O)CP(O)(O)=O NFDRPXJGHKJRLJ-UHFFFAOYSA-N 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 150000002083 enediols Chemical class 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000010350 erythorbic acid Nutrition 0.000 description 1
- 239000004318 erythorbic acid Substances 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002168 ethanoic acid esters Chemical group 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- BFMKFCLXZSUVPI-UHFFFAOYSA-N ethyl but-3-enoate Chemical compound CCOC(=O)CC=C BFMKFCLXZSUVPI-UHFFFAOYSA-N 0.000 description 1
- 229920001038 ethylene copolymer Polymers 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 1
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229940050521 gelatin agent Drugs 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000011086 glassine Substances 0.000 description 1
- VOZRXNHHFUQHIL-UHFFFAOYSA-N glycidyl methacrylate Chemical compound CC(=C)C(=O)OCC1CO1 VOZRXNHHFUQHIL-UHFFFAOYSA-N 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 239000011361 granulated particle Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 238000009775 high-speed stirring Methods 0.000 description 1
- 239000012943 hotmelt Substances 0.000 description 1
- 150000002429 hydrazines Chemical class 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000011229 interlayer Substances 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 1
- 229940006461 iodide ion Drugs 0.000 description 1
- 150000004694 iodide salts Chemical class 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 229940026239 isoascorbic acid Drugs 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 239000002655 kraft paper Substances 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 229960001078 lithium Drugs 0.000 description 1
- 229940071264 lithium citrate Drugs 0.000 description 1
- WJSIUCDMWSDDCE-UHFFFAOYSA-K lithium citrate (anhydrous) Chemical compound [Li+].[Li+].[Li+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WJSIUCDMWSDDCE-UHFFFAOYSA-K 0.000 description 1
- 229910001416 lithium ion Inorganic materials 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- ZPPPLBXXTCVBNC-ZVGUSBNCSA-M lithium;(2r,3r)-2,3,4-trihydroxy-4-oxobutanoate Chemical compound [Li+].OC(=O)[C@H](O)[C@@H](O)C([O-])=O ZPPPLBXXTCVBNC-ZVGUSBNCSA-M 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000006626 methoxycarbonylamino group Chemical group 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 125000006216 methylsulfinyl group Chemical group [H]C([H])([H])S(*)=O 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 235000016337 monopotassium tartrate Nutrition 0.000 description 1
- NPKFETRYYSUTEC-UHFFFAOYSA-N n-[2-(4-amino-n-ethyl-3-methylanilino)ethyl]methanesulfonamide Chemical compound CS(=O)(=O)NCCN(CC)C1=CC=C(N)C(C)=C1 NPKFETRYYSUTEC-UHFFFAOYSA-N 0.000 description 1
- RODAXCQJQDMNSH-UHFFFAOYSA-N n-[4-(diethylamino)-6-(hydroxyamino)-1,3,5-triazin-2-yl]hydroxylamine Chemical compound CCN(CC)C1=NC(NO)=NC(NO)=N1 RODAXCQJQDMNSH-UHFFFAOYSA-N 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- QXFHPLPMTXEJPV-UHFFFAOYSA-N octane-1-sulfonic acid;sodium Chemical compound [Na].CCCCCCCCS(O)(=O)=O QXFHPLPMTXEJPV-UHFFFAOYSA-N 0.000 description 1
- JPMIIZHYYWMHDT-UHFFFAOYSA-N octhilinone Chemical compound CCCCCCCCN1SC=CC1=O JPMIIZHYYWMHDT-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000001741 organic sulfur group Chemical group 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 150000004989 p-phenylenediamines Chemical class 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229960003330 pentetic acid Drugs 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 150000004986 phenylenediamines Chemical class 0.000 description 1
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000233 poly(alkylene oxides) Chemical class 0.000 description 1
- 229920001308 poly(aminoacid) Polymers 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 239000004632 polycaprolactone Substances 0.000 description 1
- 229920001225 polyester resin Polymers 0.000 description 1
- 239000004645 polyester resin Substances 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 229940086065 potassium hydrogentartrate Drugs 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- LJCNRYVRMXRIQR-OLXYHTOASA-L potassium sodium L-tartrate Chemical compound [Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O LJCNRYVRMXRIQR-OLXYHTOASA-L 0.000 description 1
- 229940074439 potassium sodium tartrate Drugs 0.000 description 1
- BHZRJJOHZFYXTO-UHFFFAOYSA-L potassium sulfite Chemical compound [K+].[K+].[O-]S([O-])=O BHZRJJOHZFYXTO-UHFFFAOYSA-L 0.000 description 1
- 235000019252 potassium sulphite Nutrition 0.000 description 1
- 239000001472 potassium tartrate Substances 0.000 description 1
- 229940111695 potassium tartrate Drugs 0.000 description 1
- 235000011005 potassium tartrates Nutrition 0.000 description 1
- ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 1
- 229940116357 potassium thiocyanate Drugs 0.000 description 1
- SJZFFCZQDPVHQI-UHFFFAOYSA-N potassium;sulfurous acid Chemical compound [K].OS(O)=O SJZFFCZQDPVHQI-UHFFFAOYSA-N 0.000 description 1
- 238000009700 powder processing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000000075 primary alcohol group Chemical group 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- NDGRWYRVNANFNB-UHFFFAOYSA-N pyrazolidin-3-one Chemical class O=C1CCNN1 NDGRWYRVNANFNB-UHFFFAOYSA-N 0.000 description 1
- DNXIASIHZYFFRO-UHFFFAOYSA-N pyrazoline Chemical compound C1CN=NC1 DNXIASIHZYFFRO-UHFFFAOYSA-N 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000003566 sealing material Substances 0.000 description 1
- 125000003198 secondary alcohol group Chemical group 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- IZXSLAZMYLIILP-ODZAUARKSA-M silver (Z)-4-hydroxy-4-oxobut-2-enoate Chemical compound [Ag+].OC(=O)\C=C/C([O-])=O IZXSLAZMYLIILP-ODZAUARKSA-M 0.000 description 1
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 description 1
- 229940071536 silver acetate Drugs 0.000 description 1
- AQRYNYUOKMNDDV-UHFFFAOYSA-M silver behenate Chemical compound [Ag+].CCCCCCCCCCCCCCCCCCCCCC([O-])=O AQRYNYUOKMNDDV-UHFFFAOYSA-M 0.000 description 1
- XNGYKPINNDWGGF-UHFFFAOYSA-L silver oxalate Chemical compound [Ag+].[Ag+].[O-]C(=O)C([O-])=O XNGYKPINNDWGGF-UHFFFAOYSA-L 0.000 description 1
- 229910001923 silver oxide Inorganic materials 0.000 description 1
- YPNVIBVEFVRZPJ-UHFFFAOYSA-L silver sulfate Chemical compound [Ag+].[Ag+].[O-]S([O-])(=O)=O YPNVIBVEFVRZPJ-UHFFFAOYSA-L 0.000 description 1
- 229910000367 silver sulfate Inorganic materials 0.000 description 1
- 235000019265 sodium DL-malate Nutrition 0.000 description 1
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 125000004436 sodium atom Chemical group 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229960001790 sodium citrate Drugs 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000001394 sodium malate Substances 0.000 description 1
- 235000010294 sodium orthophenyl phenol Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940006186 sodium polystyrene sulfonate Drugs 0.000 description 1
- 235000011006 sodium potassium tartrate Nutrition 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 239000001433 sodium tartrate Substances 0.000 description 1
- 229960002167 sodium tartrate Drugs 0.000 description 1
- 235000011004 sodium tartrates Nutrition 0.000 description 1
- NKAAEMMYHLFEFN-ZVGUSBNCSA-M sodium;(2r,3r)-2,3,4-trihydroxy-4-oxobutanoate Chemical compound [Na+].OC(=O)[C@H](O)[C@@H](O)C([O-])=O NKAAEMMYHLFEFN-ZVGUSBNCSA-M 0.000 description 1
- AMZPPWFHMNMIEI-UHFFFAOYSA-M sodium;2-sulfanylidene-1,3-dihydrobenzimidazole-5-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)C1=CC=C2NC(=S)NC2=C1 AMZPPWFHMNMIEI-UHFFFAOYSA-M 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- 125000000565 sulfonamide group Chemical group 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 229910052714 tellurium Inorganic materials 0.000 description 1
- PORWMNRCUJJQNO-UHFFFAOYSA-N tellurium atom Chemical compound [Te] PORWMNRCUJJQNO-UHFFFAOYSA-N 0.000 description 1
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical compound CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 description 1
- 150000004685 tetrahydrates Chemical class 0.000 description 1
- QEMXHQIAXOOASZ-UHFFFAOYSA-N tetramethylammonium Chemical compound C[N+](C)(C)C QEMXHQIAXOOASZ-UHFFFAOYSA-N 0.000 description 1
- USFPINLPPFWTJW-UHFFFAOYSA-N tetraphenylphosphonium Chemical compound C1=CC=CC=C1[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 USFPINLPPFWTJW-UHFFFAOYSA-N 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- VLLMWSRANPNYQX-UHFFFAOYSA-N thiadiazole Chemical compound C1=CSN=N1.C1=CSN=N1 VLLMWSRANPNYQX-UHFFFAOYSA-N 0.000 description 1
- 150000003557 thiazoles Chemical class 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 150000003567 thiocyanates Chemical class 0.000 description 1
- 125000003396 thiol group Chemical class [H]S* 0.000 description 1
- 150000003585 thioureas Chemical class 0.000 description 1
- ODBLHEXUDAPZAU-UHFFFAOYSA-N threo-D-isocitric acid Natural products OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 description 1
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 description 1
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical group CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical group CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Landscapes
- Silver Salt Photography Or Processing Solution Therefor (AREA)
Description
【0001】[0001]
【発明の属する技術分野】本発明はハロゲン化銀写真感
光材料、ハロゲン化銀写真感光材料用の現像液及びその
処理方法に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a silver halide photographic light-sensitive material, a developer for silver halide photographic light-sensitive material and a processing method thereof.
【0002】[0002]
【従来の技術】従来より、ハロゲン化銀写真感光材料
(以下、感光材料、又は感材ということもある。)の被
覆率の向上は銀量の節約につながり重要である。一方、
環境負荷の軽減が要求される中での廃液の減量化のため
の低補充処理、迅速処理化が近年の主流となりつつあ
り、低補充処理の処理疲労、酸化疲労の影響や迅速処理
の現像活性の影響を受ける中で、益々被覆率向上技術は
重要度を増している。2. Description of the Related Art Conventionally, it has been important to improve the coverage of a silver halide photographic light-sensitive material (hereinafter also referred to as a light-sensitive material or a light-sensitive material) because it saves the amount of silver. on the other hand,
In recent years, low replenishment processing and rapid processing have become the mainstream in order to reduce the amount of waste liquid while the environmental load is required to be reduced. Under the influence of, the technology for improving the coverage rate is becoming more and more important.
【0003】しかしながら、高い銀被覆力を与えた場合
に現像銀の色調はほとんど例外なく粒子サイズや粒子厚
みに依存するが黄色味を帯びて画像観察者に不快な印象
を与える。However, when a high silver covering power is given, the color tone of developed silver almost always depends on the grain size and grain thickness, but is yellowish and gives an unpleasant impression to an image observer.
【0004】特開平5−66525号にはアスペクト比
3以上の平板粒子を含む感材で含窒素複素環メルカプト
化合物を含む現像液で処理し、感度、Dmを維持したま
ま銀色調を改善する技術を開示しているが、銀色調改善
度としては不十分であり、銀スラッジ性、長期ランニン
グ処理(酸化疲労を長期に受けた状態)時のDm、色調
の安定性については触れていない。Japanese Unexamined Patent Publication No. 5-66525 discloses a technique in which a photosensitive material containing tabular grains having an aspect ratio of 3 or more is processed with a developing solution containing a nitrogen-containing heterocyclic mercapto compound to improve the silver tone while maintaining the sensitivity and Dm. However, the degree of improvement in silver color tone is insufficient, and silver sludge property, Dm during long-term running treatment (state of being subjected to oxidation fatigue for a long time), and stability of color tone are not mentioned.
【0005】特開平7−114153号にはジヒドロキ
シベンゼンフリーで補助現像剤と炭酸カリを含む現像液
にメルカプト含有化合物を用いて銀スラッジ防止、迅速
処理の感度、γ向上する技術が開示されているが、本発
明の如く特有なメルカプト化合物の併用の構成でないば
かりか効果として銀色調、上記の長期安定性については
触れていない。Japanese Unexamined Patent Publication (Kokai) No. 7-114153 discloses a technique of using a mercapto-containing compound in a developer containing a dihydroxybenzene-free auxiliary developer and potassium carbonate to prevent silver sludge, improve sensitivity of rapid processing, and improve γ. However, as well as the constitution of the present invention in which a peculiar mercapto compound is used in combination, silver tone and the above long-term stability are not mentioned as effects.
【0006】[0006]
【発明が解決しようとする課題】本発明の課題は銀色調
を改善し、同時に酸化疲労の影響を受ける長期ランニン
グ処理、特に少量処理で水分蒸発量が多く処理液の濃縮
の影響を受ける処理状態時にDm、γ、銀色調の安定度
を向上することができるハロゲン化銀写真感光材料、ハ
ロゲン化銀写真感光材料用の現像液及びその処理方法を
提供することである。SUMMARY OF THE INVENTION An object of the present invention is to improve the silver tone and at the same time a long-term running process which is affected by oxidative fatigue, particularly a process state in which a large amount of water is evaporated in a small amount of process and the process liquid is concentrated. It is another object of the present invention to provide a silver halide photographic light-sensitive material, a developing solution for a silver halide photographic light-sensitive material, and a processing method thereof, which can improve the stability of Dm, γ, and silver tone.
【0007】[0007]
【課題を解決するための手段】上記課題を解決する本発
明は、
1.支持体上に少なくとも1層のハロゲン化銀乳剤層を
含む親水性コロイド層を設けたハロゲン化銀写真感光材
料において、前記親水性コロイド層は下記一般式(1)
で表される化合物及び一般式(2)で表される化合物を
含有することを特徴とするハロゲン化銀写真感光材料。The present invention which solves the above-mentioned problems includes: In a silver halide photographic light-sensitive material in which a hydrophilic colloid layer containing at least one silver halide emulsion layer is provided on a support, the hydrophilic colloid layer has the following general formula (1)
A silver halide photographic light-sensitive material comprising a compound represented by: and a compound represented by the general formula (2).
【0008】[0008]
【化3】
式中Y、ZはNまたはCR2(R2は水素原子及び置
換、無置換のアルキル基又はアリール基を表す。)
R1は少なくとも1個以上のスルホ基、カルボキシ基、
アミノ基、ヒドロキシ基又はその塩又はボロン残基で置
換されたアリール基を表す。またそれらの置換基が2個
以上ある時は同じであっても異なっても良い。Mは水素
原子、アルカリ金属原子、4級アンモニウム及びアルカ
リ条件下でMが水素原子又はアルカリ金属となりうる基
を表す。[Chemical 3] In the formula, Y and Z are N or CR 2 (R 2 represents a hydrogen atom and a substituted or unsubstituted alkyl group or aryl group.) R 1 is at least one or more sulfo group, carboxy group,
It represents an amino group, a hydroxy group or a salt thereof, or an aryl group substituted with a boron residue. When two or more of these substituents are present, they may be the same or different. M represents a hydrogen atom, an alkali metal atom, quaternary ammonium, and a group in which M can be a hydrogen atom or an alkali metal under alkaline conditions.
【0009】[0009]
【化4】
式中P、QはNまたはCR4(R4は水素原子及び置
換、無置換のアルキル基又はアリール基を表す。)
R3は少なくとも1個以上のスルホ基、カルボキシ基、
アミノ基、ヒドロキシ基又はその塩又はボロン残基で置
換されたアルキル基を表す。[Chemical 4] In the formula, P and Q are N or CR 4 (R 4 represents a hydrogen atom and a substituted or unsubstituted alkyl group or aryl group.) R 3 is at least one or more sulfo group, carboxy group,
It represents an alkyl group substituted with an amino group, a hydroxy group or a salt thereof, or a boron residue.
【0010】それらの置換基が2個以上ある時は同じで
あっても異なっても良い。M1は水素原子、アルカリ金
属原子、4級アンモニウム及びアルカリ条件下でMが水
素原子又はアルカリ金属となりうる基を表す。When there are two or more substituents, they may be the same or different. M 1 represents a hydrogen atom, an alkali metal atom, a quaternary ammonium, or a group in which M can be a hydrogen atom or an alkali metal under alkaline conditions.
【0011】2.前記一般式(1)で表される化合物及
び前記一般式(2)で表される化合物を含有することを
特徴とするハロゲン化銀写真感光材料用現像液、
3.支持体上にハロゲン化銀乳剤層を含む親水性コロイ
ド層を設けたハロゲン化銀写真感光材料を前記一般式
(1)で表される化合物及び前記一般式(2)で表され
る化合物の存在下、現像処理することを特徴とするハロ
ゲン化銀写真感光材料の処理方法、
4.現像液がレダクトン類を含有することを特徴とする
前記2記載のハロゲン化銀写真感光材料用現像液、
5.現像液がレダクトン類を含有することを特徴とする
前記3記載のハロゲン化銀写真感光材料の処理方法、
6.現像液が実質的にジヒドロキシベンゼン類を含まな
いことを特徴とする前記2又は4記載のハロゲン化銀写
真感光材料用現像液、
7.現像液が実質的にジヒドロキシベンゼン類を含まな
いことを特徴とする前記3又は5記載のハロゲン化銀写
真感光材料の処理方法、
8.前記一般式(1)で表される化合物及び前記一般式
(2)で表される化合物を含有するハロゲン化銀写真感
光材料用固体状現像剤、
9.現像液が請求項8記載の固体状現像剤を溶解して調
整されることを特徴とする前記2、4又は6記載のハロ
ゲン化銀写真感光材料用現像液、
10.現像液が請求項8記載の固体状現像剤を溶解して
調整されることを特徴とする前記3、5又は7記載のハ
ロゲン化銀写真感光材料の処理方法、である。2. 2. A developer for a silver halide photographic light-sensitive material, comprising a compound represented by the general formula (1) and a compound represented by the general formula (2). A silver halide photographic light-sensitive material having a hydrophilic colloid layer containing a silver halide emulsion layer on a support is used for the presence of the compound represented by the general formula (1) and the compound represented by the general formula (2). 3. A method for processing a silver halide photographic light-sensitive material, which is characterized in that development processing is performed below. 4. The developing solution for silver halide photographic light-sensitive material as described in 2 above, wherein the developing solution contains reductones. 5. The method for processing a silver halide photographic light-sensitive material as described in 3 above, wherein the developer contains a reductone. 6. The developing solution for silver halide photographic light-sensitive materials as described in 2 or 4 above, wherein the developing solution contains substantially no dihydroxybenzenes. 7. The method for processing a silver halide photographic light-sensitive material as described in 3 or 5 above, wherein the developer does not substantially contain dihydroxybenzenes. 8. A solid developer for a silver halide photographic light-sensitive material, containing a compound represented by the general formula (1) and a compound represented by the general formula (2). 10. The developer for a silver halide photographic light-sensitive material according to 2, 4, or 6, wherein the developer is prepared by dissolving the solid developer according to claim 8. 9. The method for processing a silver halide photographic light-sensitive material as described in 3, 5, or 7, wherein a developer is prepared by dissolving the solid developer according to claim 8.
【0012】[0012]
【作用】本発明者は含窒素複素環メルカプト化合物につ
いて鋭意検討した結果、本発明の一般式(1)の化合物
と一般式(2)の化合物を併用することにより驚くほど
に銀色調が改善されることを見いだすと同時に酸化疲労
の影響を受ける長期ランニングの化合物処理、特に少量
処理で水分蒸発量が多く処理液の濃縮の影響を受ける処
理状態時にDm、γ、銀色調の安定度が大きく向上する
ことは驚くべき発見であった。The present inventor has conducted extensive studies on nitrogen-containing heterocyclic mercapto compounds, and as a result, by using the compound of the general formula (1) and the compound of the general formula (2) in combination, the silver color tone was surprisingly improved. At the same time, the stability of Dm, γ, and silver tone is greatly improved in the long-running compound treatment that is affected by oxidative fatigue, especially in the treatment state where a small amount of treatment causes a large amount of water vaporization and influences the concentration of the treatment liquid. What to do was a surprising discovery.
【0013】本発明の一般式(1)の化合物単独でも、
一般式(2)の化合物単独でも本発明の効果は得られず
併用することに本発明の構成の発明性がある。The compound of the general formula (1) of the present invention alone,
The compound of the general formula (2) alone does not provide the effects of the present invention, and the combined use of the compounds has the invention of the constitution of the present invention.
【0014】また、本発明の一般式(1)の化合物に該
当する2種以上の化合物を使用しても発明の効果は伺え
ない。本発明の一般式(2)の化合物に該当する2種以
上の化合物を使用しても発明の効果は伺えない。本発明
の一般式(1)の化合物、一般式(2)の化合物を併用
していれば各々の化合物が2種以上存在してもよい。Further, even if two or more compounds corresponding to the compound of the general formula (1) of the present invention are used, the effect of the invention cannot be observed. Even if two or more compounds corresponding to the compound of the general formula (2) of the present invention are used, the effect of the invention cannot be seen. If the compound of the general formula (1) and the compound of the general formula (2) of the present invention are used in combination, two or more kinds of each compound may exist.
【0015】[0015]
【発明の実施の態様】本発明の一般式(1)の化合物の
添加量は現像液中であれば20mg〜1500mg/l
が好ましく、更に好ましくは100mg〜700mg/
lである。一方、一般式(2)の化合物の添加量は現像
液中であれば5mg〜500mg/lが好ましく、更に
好ましくは10mg〜200mg/lである。BEST MODE FOR CARRYING OUT THE INVENTION The addition amount of the compound of the general formula (1) of the present invention is 20 mg to 1500 mg / l in a developing solution.
Is preferable, and more preferably 100 mg to 700 mg /
It is l. On the other hand, the addition amount of the compound of the general formula (2) is preferably 5 mg to 500 mg / l, and more preferably 10 mg to 200 mg / l in the developer.
【0016】ハロゲン化銀写真感光材料中に含有する場
合は一般式(1)の化合物、一般式(2)の化合物共に
親水性コロイド層中であればいずれの場所でも良いが、
好ましくはハロゲン化銀写真乳剤層、保護層であり、よ
り好ましくは保護層に添加するのが良い。保護層に添加
することにより感材の保存性への影響(減感等)が少な
くなるため好ましい。感材中の添加量は一般式(1)の
化合物は5mg〜200mgが好ましく、一般式(2)
は1mg〜100mgが好ましく添加される。When it is contained in the silver halide photographic light-sensitive material, both the compound represented by the general formula (1) and the compound represented by the general formula (2) may be contained in any position in the hydrophilic colloid layer.
It is preferably a silver halide photographic emulsion layer or a protective layer, more preferably added to the protective layer. Addition to the protective layer is preferable because it has less effect on the storage stability of the light-sensitive material (desensitization, etc.). The amount of the compound of the general formula (1) added to the light-sensitive material is preferably 5 mg to 200 mg, and the compound of the general formula (2)
Is preferably added at 1 mg to 100 mg.
【0017】以下に一般式(1)の化合物と一般式
(2)の化合物の具体的な例示化合物を示すが、好まし
くは一般式(3)及び(4)化合物が良い。Specific examples of the compounds of the general formula (1) and the general formula (2) are shown below, but the compounds of the general formulas (3) and (4) are preferable.
【0018】[0018]
【化5】
R5は少なくとも1個以上のスルホ基、カルボキシ基、
アミノ基、ヒドロキシ基又はその塩又はボロン残基で置
換されたアリール基を表す。またそれらの置換基が2個
以上ある時は同じであっても異なっても良い。Mは水素
原子、アルカリ金属原子、4級アンモニウム及びアルカ
リ条件下でMが水素原子又はアルカリ金属となりうる基
を表す。[Chemical 5] R 5 is at least one or more sulfo group, carboxy group,
It represents an amino group, a hydroxy group or a salt thereof, or an aryl group substituted with a boron residue. When two or more of these substituents are present, they may be the same or different. M represents a hydrogen atom, an alkali metal atom, quaternary ammonium, and a group in which M can be a hydrogen atom or an alkali metal under alkaline conditions.
【0019】[0019]
【化6】
R6は少なくとも1個以上のスルホ基、カルボキシ基、
アミノ基、ヒドロキシ基又はその塩又はボロン残基で置
換されたアルキル基を表す。[Chemical 6] R 6 is at least one or more sulfo group, carboxy group,
It represents an alkyl group substituted with an amino group, a hydroxy group or a salt thereof, or a boron residue.
【0020】それらの置換基が2個以上ある時は同じで
あっても異なっても良い。M1は水素原子、アルカリ金
属原子、4級アンモニウム及びアルカリ条件下でMが水
素原子又はアルカリ金属となりうる基を表す。When there are two or more substituents, they may be the same or different. M 1 represents a hydrogen atom, an alkali metal atom, a quaternary ammonium, or a group in which M can be a hydrogen atom or an alkali metal under alkaline conditions.
【0021】詳細に説明すると、R3は1個以上のスル
ホ基、カルボキシ基又はヒドロキシ基、ボロン残基で置
換された炭素数1〜20の直鎖もしくは分岐アルキル基
(例えばメチル基、エチル基、プロピル基、ヘキシル
基、ドデシル基、イソプロピル基など)、炭素数1〜2
0のシクロアルキル基(例えばシクロプロピル基、シク
ロヘキシル基など)、R1はスルホ基、カルボキシ基、
ヒドロキシ基、ボロン残基で置換された炭素数6〜20
のアリール基(例えばフェニル基、ナフチル基など)を
表す。More specifically, R 3 is one or more sulfo group, carboxy group or hydroxy group, a linear or branched alkyl group having 1 to 20 carbon atoms substituted with a boron residue (eg, methyl group, ethyl group). , Propyl group, hexyl group, dodecyl group, isopropyl group, etc.), C 1-2
A cycloalkyl group of 0 (eg cyclopropyl group, cyclohexyl group, etc.), R 1 is a sulfo group, a carboxy group,
6 to 20 carbon atoms substituted with a hydroxy group or a boron residue
Represents an aryl group (eg, phenyl group, naphthyl group, etc.).
【0022】またアルキル基(直鎖、分岐のアルキル
基、シクロアルキル基)、アリール基は更に置換されて
もよく、具体的にはハロゲン原子(F、Cl、Brな
ど)、アルキル基(メチル基、エチル基など)、アリー
ル基(フェニル基など)、アルコキシ基(メトキシ基、
エトキシ基など)、アリールオキシ基(フェノキシ基な
ど)、スルホニル基(メタンスルホニル基、p−トルエ
ンスルホニル基など)、カルバモイル基(無置換カルバ
モイル基、ジエチルカルバモイル基など)、アミド基
(アセトアミド基、ベンズアミド基など)、アルコキシ
カルボニルアミノ基(メトキシカルボニルアミノ基な
ど)、アリロキシカルボニルアミノ基(フェノキシカル
ボニルアミノ基など)、アルコキシカルボニル基(メト
キシカルボニル基など)、アリールオキシカルボニル基
(フェノキシカルボニル基など)、シアノ基、ニロト
基、アミノ基(無置換アミノ基、ジメチルアミノ基な
ど)、アルキルスルフィニル基(メチルスルフィニル基
など)、アリールスルフィニル基(フェニルスルフィニ
ル基など)、アルキルチオ基(メチルチオ基など)、及
びアリールチオ基(フェニルチオ基等)を挙げることが
できる。R2、R4で表されるアルキル基、アリール基
はR3、R1と同義であり、置換基もR3、R1と同じ
ものを挙げることができる。R1として特に好ましいも
のは1個以上のスルホ基、カルボキシ基又はヒドロキシ
基の置換したフェニル基であり、R3として特に好まし
いのは、スルホ基、ヒドロキシ基、カルボキシ基で置換
したメチル基、エチル基、プロピル基である。R2、R
4として特に好ましいのは水素原子であり、Mは水素原
子、アルカリ金属原子(例えばナトリウム原子、カリウ
ム原子など)、4級アンモニウム基(例えばトリメチル
アンモニウム基、ジメチルアンモニウム基、トリブチル
アンモニウム基など)及びアルカリ条件下でMが水素原
子又はアルカリ金属となりうる基(例えばアセチル基、
シアノエチル基、メタンスルホニル基など)を表す。The alkyl group (straight chain, branched alkyl group, cycloalkyl group) and aryl group may be further substituted, and specifically, a halogen atom (F, Cl, Br, etc.), an alkyl group (methyl group). , Ethyl groups, etc.), aryl groups (phenyl groups, etc.), alkoxy groups (methoxy groups,
Ethoxy group), aryloxy group (phenoxy group, etc.), sulfonyl group (methanesulfonyl group, p-toluenesulfonyl group, etc.), carbamoyl group (unsubstituted carbamoyl group, diethylcarbamoyl group, etc.), amide group (acetamide group, benzamide group) Groups), alkoxycarbonylamino groups (methoxycarbonylamino groups, etc.), allyloxycarbonylamino groups (phenoxycarbonylamino groups, etc.), alkoxycarbonyl groups (methoxycarbonyl groups, etc.), aryloxycarbonyl groups (phenoxycarbonyl groups, etc.), Cyano group, niloto group, amino group (unsubstituted amino group, dimethylamino group, etc.), alkylsulfinyl group (methylsulfinyl group, etc.), arylsulfinyl group (phenylsulfinyl group, etc.), alkylthio (Such as methylthio group), an arylthio group (phenylthio group) can be exemplified. The alkyl group and aryl group represented by R 2 and R 4 have the same meanings as R 3 and R 1 , and the substituents can also be the same as those of R 3 and R 1 . Particularly preferred as R 1 is a phenyl group substituted with at least one sulfo group, a carboxy group or a hydroxy group, and particularly preferred as R 3 is a methyl group substituted with a sulfo group, a hydroxy group or a carboxy group, and ethyl. Group, a propyl group. R 2 , R
Particularly preferred as 4 is a hydrogen atom, M is a hydrogen atom, an alkali metal atom (eg, sodium atom, potassium atom, etc.), a quaternary ammonium group (eg, trimethylammonium group, dimethylammonium group, tributylammonium group, etc.) and an alkali. A group in which M can be a hydrogen atom or an alkali metal under certain conditions (eg, acetyl group,
Cyanoethyl group, methanesulfonyl group, etc.).
【0023】以下に本発明に用いられる一般式(1)で
表される化合物の具体例を示すが、本発明はこれらの化
合物に限定されるものではない。Specific examples of the compound represented by the general formula (1) used in the present invention are shown below, but the present invention is not limited to these compounds.
【0024】[0024]
【化7】 [Chemical 7]
【0025】[0025]
【化8】 [Chemical 8]
【0026】[0026]
【化9】 [Chemical 9]
【0027】[0027]
【化10】 [Chemical 10]
【0028】[0028]
【化11】 [Chemical 11]
【0029】[0029]
【化12】 [Chemical 12]
【0030】次に本発明に用いられる一般式(2)で表
される化合物の具体例を示すが、本発明はこれらの化合
物に限定されるものではない。Specific examples of the compound represented by formula (2) used in the present invention are shown below, but the present invention is not limited to these compounds.
【0031】[0031]
【化13】 [Chemical 13]
【0032】(感光材料について)ハロゲン化銀写真感
光材料については、本発明の構成要件を満足すれば、公
知公用のあらゆるものを用いることができる。(Regarding Light-Sensitive Material) As the silver halide photographic light-sensitive material, any publicly-known and publicly-known materials can be used as long as they satisfy the constitutional requirements of the present invention.
【0033】ハロゲン化銀乳剤層中のハロゲン化銀粒子
は、アスペクト比3以上の平板状粒子であることが好ま
しく、より好ましくは5以上10以下である。本発明に
おける銀色調改善や被覆率(CP)向上の効果がより顕
著に発現する。ハロゲン化銀粒子は、セレン又はテルル
増感した粒子であることが好ましい。ハロゲン化銀組成
は、塩沃臭化銀、臭化銀、沃臭化銀、塩化銀、塩臭化銀
のいずれでもよい。沃素含有量は、好ましくは1mol
%以下であり、より好ましくは0.5mol%以下であ
る。この範囲にすることにより迅速処理(dty to
sry30秒処理)性に適するようになる。又、ハロ
ゲン化銀乳剤層中及び/又は保護層、クロスオーバーカ
ット層を含む親水性コロイド層中にデキストラン、デキ
ストリン等の天然ポリマー及び/又はポリアクリルアミ
ドなどの合成ポリマーを含有することが好ましい。The silver halide grains in the silver halide emulsion layer are preferably tabular grains having an aspect ratio of 3 or more, more preferably 5 or more and 10 or less. The effects of improving the silver color tone and the coverage (CP) in the present invention are more remarkably exhibited. The silver halide grains are preferably selenium or tellurium sensitized grains. The silver halide composition may be any of silver chloroiodobromide, silver bromide, silver iodobromide, silver chloride and silver chlorobromide. Iodine content is preferably 1 mol
% Or less, and more preferably 0.5 mol% or less. Within this range, rapid processing (dty to
sry 30 seconds treatment). Further, it is preferable to contain a natural polymer such as dextran and dextrin and / or a synthetic polymer such as polyacrylamide in the silver halide emulsion layer and / or the hydrophilic colloid layer including the protective layer and the crossover cut layer.
【0034】(レダクトン類について)本発明のハロゲ
ン化銀写真感光材料及び/又はその処理方法で使用され
るレダクトン類について述べる。本発明の現像処理に用
いられるレダクトン類としては、エンジオール型、エナ
ミノール型、エンジアミン型、チオールエノール型及び
エナミンチオール型が挙げられる。好ましくは、下記一
般式(A)及び(B−1)〜(B−4)で示される化合
物が具体的に挙げられる。(Regarding Reductones) The reductones used in the silver halide photographic light-sensitive material of the present invention and / or the processing method thereof will be described. Examples of the reductones used in the development treatment of the present invention include enediol type, enaminol type, enediamine type, thiolenol type and enaminethiol type. Preferable examples include compounds represented by the following general formulas (A) and (B-1) to (B-4).
【0035】[0035]
【化14】 [Chemical 14]
【0036】式中、R4は水素原子又は水酸基を表し、
R5は水酸基又は水素原子を表し、aは1〜4の整数を
表す。In the formula, R 4 represents a hydrogen atom or a hydroxyl group,
R 5 represents a hydroxyl group or a hydrogen atom, and a represents an integer of 1 to 4.
【0037】[0037]
【化15】 [Chemical 15]
【0038】[0038]
【化14】 [Chemical 14]
【0039】本発明で用いられるレダクトン類は、リチ
ウム塩、ナトリウム塩、カリウム塩等のアルカリ金属塩
の形でも使用できる。本発明で最も好ましいレダクトン
類としては、上記A−1で示されるアスコルビン酸、エ
リソルビン酸が挙げられる。The reductones used in the present invention can also be used in the form of alkali metal salts such as lithium salt, sodium salt and potassium salt. The most preferable reductones in the present invention include ascorbic acid and erythorbic acid represented by A-1 above.
【0040】レダクトン類の含有量は、3〜80g/l
がよい。主薬として用いる場合は、好ましくは25〜5
0gである。The content of reductones is 3 to 80 g / l.
Is good. When used as a main drug, it is preferably 25 to 5
It is 0 g.
【0041】(現像液について)本発明の現像液は、p
Hが9.0〜11.0であるが、好ましくはpH9.5
〜10.5である。レダクトン類を含有する現像液の場
合は、特に好ましくは10.0〜9.5であり、ランニ
ング安定性向上に有効である。(Regarding Developer) The developer of the present invention contains p
H is 9.0 to 11.0, preferably pH 9.5
˜10.5. In the case of a developer containing a reductone, it is particularly preferably 10.0 to 9.5, which is effective in improving running stability.
【0042】本発明の現像液は、ジヒドロキシベンゼン
類を実質的に含有しないことが好ましい。実質的に含有
しないとは、例えば、5×10−4mol/l以下のよ
うな微量を限度とし、ジヒドロキシベンゼンを全く含ま
ないことが好ましい。ジヒドロキシベンゼン類、特に現
像液で用いられるハイドロキノンは環境上有害化合物で
あることから望まれると同時に効果の程度に差が生じ
る。The developer of the present invention preferably contains substantially no dihydroxybenzenes. The term "substantially free from" means, for example, that a trace amount such as 5 × 10 −4 mol / l or less is limited, and dihydroxybenzene is not contained at all. Since dihydroxybenzenes, especially hydroquinone used in a developing solution, are environmentally harmful compounds, they are desired, and at the same time, the degree of effect varies.
【0043】現像液が現像硬膜剤としてグルタルアルデ
ヒドやその重亜硫酸付加物を添加することが好ましい。
これにより本発明の銀色調改善が大きく発揮される。It is preferable that glutaraldehyde or a bisulfite adduct thereof is added to the developer as a development hardening agent.
As a result, the improvement of the silver color tone of the present invention is greatly exhibited.
【0044】本発明の現像液は、補充液としても沃化物
イオンを含有することが好ましく、2×10−4〜2×
10−3mol/lを含有することが特に好ましい。沃
化物イオンを含有することにより、CP向上の効果が高
く発揮される。特にレダクトン類を含有する本発明の現
像液においてはこの効果が大きい。現像液の補充量は、
感材1m2当たり200ml以下で補充することが好ま
しい。廃液減量化に繋がることは勿論のこと、補充量2
00ml以下での本発明の改善効果が大きい。定着液に
関しても補充量200ml/m2以下が好ましい。The developer of the present invention preferably contains iodide ions as a replenisher as well, and it is 2 × 10 −4 to 2 ×.
It is particularly preferred to contain 10 −3 mol / l. By containing the iodide ion, the effect of improving CP is highly exerted. This effect is particularly great in the developer of the present invention containing reductones. The amount of developer replenishment is
Replenishment is preferably 200 ml or less per 1 m 2 of the light-sensitive material. Replenishment amount 2 as well as reduction of waste liquid
The improvement effect of the present invention is great when the amount is 00 ml or less. The replenishing amount of the fixing solution is preferably 200 ml / m 2 or less.
【0045】本発明の現像液は、バッファー剤としてホ
ウ酸、安息香酸塩類、アルカノールアミン、リン酸塩、
重炭酸塩、炭酸塩を用いることができるが、炭酸塩を含
有することが好ましい。含有濃度として0.35mol
/l以上であることが好ましく、より好ましくは0.5
0〜1.00mol/lであり、レダクトンを含有する
本発明の現像液には長期安定性を向上するのに有効であ
る。炭酸塩、重炭酸塩としては炭酸カリウム、重炭酸カ
リウムが好ましい。これはNa、Liの塩よりDm、γ
の安定性という面で有効である。The developing solution of the present invention contains boric acid, benzoates, alkanolamines, phosphates as buffer agents,
Bicarbonates and carbonates can be used, but it is preferable to contain carbonates. 0.35 mol as the content concentration
/ L or more, more preferably 0.5
It is 0 to 1.00 mol / l, and is effective for improving long-term stability in the developer of the present invention containing reductone. As the carbonate and bicarbonate, potassium carbonate and potassium bicarbonate are preferred. This is Dm, γ from the salts of Na and Li.
It is effective in terms of stability.
【0046】本発明の現像液に関しては、特願平4−5
86232号(20項)記載のキレート剤や生分解性キ
レート剤を用いることができる。Regarding the developing solution of the present invention, Japanese Patent Application No. 4-5
The chelating agent and biodegradable chelating agent described in 86232 (paragraph 20) can be used.
【0047】さらに銀スラッジ防止剤として、特開平7
−13303号(一般式[1]、[2])記載の化合物
を用いることが好ましい。Further, as a silver sludge-preventing agent, Japanese Unexamined Patent Publication No.
It is preferable to use the compounds described in No. 13303 (general formulas [1] and [2]).
【0048】本発明の現像液は、亜硫酸ナトリウム又は
カリウム、メタ重亜硫酸塩等の亜硫酸塩を含有すること
ができる。亜硫酸塩は保恒剤として用いられるが、量が
多すぎる場合に銀スラッジが発生する等の欠点を有する
ため現像液種類によって適量がある。上記理由から本発
明の如く、レダクトンを含有する現像液の場合、0.0
1〜0.30mol/lが好ましく、特に0.05〜
0.20mol/lが好ましい。The developer of the present invention may contain a sulfite such as sodium or potassium sulfite and metabisulfite. Sulfite is used as a preservative, but it has an appropriate amount depending on the type of developer because it has a defect that silver sludge is generated when the amount is too large. For the above reason, in the case of the developer containing reductone as in the present invention, 0.0
1 to 0.30 mol / l is preferable, and especially 0.05 to
0.20 mol / l is preferred.
【0049】本発明の現像液には、現像促進剤として、
例えば、チオエーテル化合物、p−フェニレンジアミン
系化合物、4級アンモニウム塩類、アミン系化合物、ポ
リアルキレンオキサイド化合物、ヒドラジン類を用いる
ことができる。In the developer of the present invention, as a development accelerator,
For example, thioether compounds, p-phenylenediamine compounds, quaternary ammonium salts, amine compounds, polyalkylene oxide compounds, hydrazines can be used.
【0050】また抑制剤として、KBrや有機抑制剤を
用いることができる。例えば、ベンゾトリアゾール、6
−ニトロベンゾイミダゾール、5−ニトロインダゾー
ル、5−メチルベンゾトリアゾール、5−ニトロベンゾ
トリアゾール、5−クロロベンゾトリアゾール、2−チ
アゾリル−ベンゾトリアゾール、アザインデン類、アデ
ニン、チアジアゾール系の如き含窒素ヘテロ環化合物が
挙げられる。Further, KBr or an organic inhibitor can be used as the inhibitor. For example, benzotriazole, 6
-Nitrogen-containing heterocyclic compounds such as nitrobenzimidazole, 5-nitroindazole, 5-methylbenzotriazole, 5-nitrobenzotriazole, 5-chlorobenzotriazole, 2-thiazolyl-benzotriazole, azaindenes, adenine and thiadiazole Can be mentioned.
【0051】また、本発明の現像液には、シクロデキス
トリン類を添加することが好ましい。特にレダクトン類
含有の現像液の場合には、耐酸化性を向上したり、色調
に寄与が大きく、本発明の効果に大きく寄与する。Cyclodextrins are preferably added to the developer of the present invention. In particular, in the case of a reductone-containing developer, the oxidation resistance is improved and the color tone is greatly contributed, which greatly contributes to the effect of the present invention.
【0052】本発明の現像液、及び定着液は固形剤キッ
トから水に溶解して調製された液であることが好まし
い。固形剤キットにすることにより、キット状態の保存
性(長期保存での成分量・組成変化)が著しく向上する
と同時にキット形態でのスペースが縮小される面で有効
である。本発明は、長期安定性を解決すべき課題として
挙げているが、固形化キットとすることで効果をさらに
顕著にすることができる。The developing solution and fixing solution of the present invention are preferably solutions prepared by dissolving in water from a solid agent kit. The solid agent kit is effective in that the storage stability of the kit state (change in the amount of components and composition during long-term storage) is significantly improved and the space in the kit form is reduced. In the present invention, long-term stability is mentioned as a problem to be solved, but the effect can be made more remarkable by using a solidification kit.
【0053】本発明の現像液、及び定着液には、長期処
理安定化のために処理液の蒸発による濃縮化を避けるよ
うに水補充をすることが好ましい。水補充については蒸
発による液面低下をセンサーで検出し、元の液面に戻る
まで、水を加える方式、蒸発分ではなく、ある一定量を
毎日加える方式、一日当たりの処理枚数を検出してその
枚数に応じて水補充量を決める方式などを採用すること
ができる。The developer and fixer of the present invention are preferably supplemented with water so as to avoid concentration due to evaporation of the processing solution in order to stabilize long-term processing. For water replenishment, a sensor detects the drop in the liquid level due to evaporation, and a method of adding water until the original liquid level is returned, a method of adding a certain amount daily instead of the amount of evaporation, and detecting the number of processed sheets per day. A method of determining the amount of water replenishment depending on the number of sheets can be adopted.
【0054】現像液の処理温度は25〜50℃であり、
好ましくは30〜40℃である。現像時間は5〜25秒
であるが、より好ましくは5〜15秒である。定着液の
処理温度は25〜50℃であり、好ましくは30〜40
℃である。定着時間は5〜25秒であるが、好ましくは
5〜15秒である。The processing temperature of the developing solution is 25 to 50 ° C.,
It is preferably 30 to 40 ° C. The developing time is 5 to 25 seconds, more preferably 5 to 15 seconds. The processing temperature of the fixing solution is 25 to 50 ° C., preferably 30 to 40
℃. The fixing time is 5 to 25 seconds, preferably 5 to 15 seconds.
【0055】本発明における全処理時間は、現像、定
着、水洗、乾燥工程を経るDry to Dryが12
0〜30秒であることが好ましい。特に40秒〜15秒
が好ましい。The total processing time in the present invention is Dry to Dry which is 12 after development, fixing, washing with water and drying.
It is preferably 0 to 30 seconds. Particularly, 40 seconds to 15 seconds is preferable.
【0056】処理に先立ち、スターターを添加すること
が好ましく、スターターを固形化して添加することが好
ましい。スターターとしては、ポリカルボン酸化合物の
如き有機酸の他にKBrの如きアルカリ金属のハロゲン
化物や有機抑制剤、現像促進剤を用いることができる。
現像液補充量については300ml/m2〜50ml/
m2が好ましいが特に200ml/m2〜80ml/m
2が好ましい。この好ましい範囲に限定するほどより顕
著に本発明の効果が発揮される。Prior to the treatment, it is preferable to add a starter, and it is preferable to solidify and add the starter. As the starter, in addition to an organic acid such as a polycarboxylic acid compound, an alkali metal halide such as KBr, an organic inhibitor, or a development accelerator can be used.
The developer replenishment rate is 300 ml / m 2 to 50 ml /
m 2 is preferable, but especially 200 ml / m 2 to 80 ml / m
2 is preferred. As the content is limited to this preferred range, the effect of the present invention is more remarkably exhibited.
【0057】(補助現像剤について)本発明の現像剤に
は上記レダクトン類の他に補助現像剤として3−ピラゾ
リドン類(例えば、1−フェニル−3−ピラゾリドン、
1−フェニル−4−メチル−3−ピラゾリドン、1−フ
ェニル−5−メチル−3−ピラゾリドン、1−フェニル
−4−エチル−3−ピラゾリドン、1−フェニル−4,
4−ジメチル−3−ピラゾリドン、1−フェニル−4−
メチル−4−ヒドロキシメチル−3−ピラゾリドン、1
−フェニル−4,4−ジヒドロキシメチル−3−ピラゾ
リドン、1,5−ジフェニル−3−ピラゾリドン、1−
p−トリル−3−ピラゾリドン、1−フェニル−2−ア
セチル−4,4−ジメチル−3−ピラゾリドン、1−p
−ヒドロキシフェニル−4,4−ジメチル−3−ピラゾ
リドン、1−(2−ベンゾチアゾリル)−3−ピラゾリ
ドン、3−アセトキシ−1−フェニル−3−ピラゾリド
ン等)、3−アミノピラゾリン類(例えば、1−(p−
ヒドロキシフェニル)−3−アミノピラゾリン、1−
(p−メチルアミノフェニル)−3−アミノピラゾリ
ン、1−(p−アミノ−m−メチルフェニル)−3−ア
ミノピラゾリン等)及びフェニレンジアミン類(例え
ば、4−アミノ−N,N−ジエチルアニリン、3−メチ
ル−4−アミノ−N,N−ジエチルアニリン、4−アミ
ノ−N−エチル−N−β−ヒドロキシエチルアニリン、
3−メチル−4−アミノ−N−エチル−N−β−ヒドロ
キシエチルアニリン、3−メチル−4−アミノ−N−エ
チル−N−β−メタンスルホンアミドエチルアニリン、
3−メチル−4−アミノ−N−エチル−N−β−メトキ
シエチルアニリン等)等を添加することができる。好ま
しくは、1−フェニル−3−ピラゾリドン類である。(Regarding Auxiliary Developer) In the developer of the present invention, in addition to the above reductones, 3-pyrazolidones (for example, 1-phenyl-3-pyrazolidone, as an auxiliary developer,
1-phenyl-4-methyl-3-pyrazolidone, 1-phenyl-5-methyl-3-pyrazolidone, 1-phenyl-4-ethyl-3-pyrazolidone, 1-phenyl-4,
4-dimethyl-3-pyrazolidone, 1-phenyl-4-
Methyl-4-hydroxymethyl-3-pyrazolidone, 1
-Phenyl-4,4-dihydroxymethyl-3-pyrazolidone, 1,5-diphenyl-3-pyrazolidone, 1-
p-tolyl-3-pyrazolidone, 1-phenyl-2-acetyl-4,4-dimethyl-3-pyrazolidone, 1-p
-Hydroxyphenyl-4,4-dimethyl-3-pyrazolidone, 1- (2-benzothiazolyl) -3-pyrazolidone, 3-acetoxy-1-phenyl-3-pyrazolidone, etc., 3-aminopyrazolines (for example, 1 -(P-
Hydroxyphenyl) -3-aminopyrazoline, 1-
(P-Methylaminophenyl) -3-aminopyrazoline, 1- (p-amino-m-methylphenyl) -3-aminopyrazoline, etc.) and phenylenediamines (for example, 4-amino-N, N-diethyl). Aniline, 3-methyl-4-amino-N, N-diethylaniline, 4-amino-N-ethyl-N-β-hydroxyethylaniline,
3-methyl-4-amino-N-ethyl-N-β-hydroxyethylaniline, 3-methyl-4-amino-N-ethyl-N-β-methanesulfonamidoethylaniline,
3-Methyl-4-amino-N-ethyl-N-β-methoxyethylaniline etc.) and the like can be added. Preferred are 1-phenyl-3-pyrazolidones.
【0058】また更に、補助現像主薬としてアミノフェ
ノール類を用いても硬調な画像を得ることができる。ア
ミノフェノール類現像主薬としては4−アミノフェノー
ル、4−アミノ−3−メチルフェノール、4−(N−メ
チル)アミノフェノール、2,4−ジアミノフェノー
ル、N−(4−ヒドロキシフェニル)グリシン、N−
(2′−ヒドロキシエチル)−2−アミノフェノール、
2−ヒドロキシメチル−4−アミノフェノール、2−ヒ
ドロキシメチル−4−(N−メチル)アミノフェノール
やこれらの化合物の塩酸塩や硫酸塩等を挙げることがで
きる。Furthermore, even when aminophenols are used as an auxiliary developing agent, a high contrast image can be obtained. As aminophenol developing agents, 4-aminophenol, 4-amino-3-methylphenol, 4- (N-methyl) aminophenol, 2,4-diaminophenol, N- (4-hydroxyphenyl) glycine, N-
(2'-hydroxyethyl) -2-aminophenol,
Examples thereof include 2-hydroxymethyl-4-aminophenol, 2-hydroxymethyl-4- (N-methyl) aminophenol, and hydrochlorides and sulfates of these compounds.
【0059】これらの化合物添加量は現像液1リットル
当たり0.2gから40g、好ましくは0.5gから2
5gである。The amount of these compounds added is 0.2 g to 40 g, preferably 0.5 g to 2 per liter of the developing solution.
It is 5 g.
【0060】(定着剤について)次に本発明に用いられ
る定着液について述べる。本発明に用いられる定着液
は、固体処理剤を調製し、溶解して調液することが好ま
しい。定着剤としては、チオ硫酸塩を含有することが好
ましい。チオ硫酸塩は、具体的には、リチウム、カリウ
ム、ナトリウム、アンモニウムの塩として用いられる
が、好ましくは、チオ硫酸アンモニウム及びチオ硫酸ナ
トリウム塩として用いられることにより、定着速度の速
い定着液が得られる。(Regarding Fixing Agent) Next, the fixing solution used in the present invention will be described. The fixing solution used in the present invention is preferably prepared by preparing a solid processing agent, dissolving it, and preparing a solution. The fixing agent preferably contains thiosulfate. The thiosulfate is specifically used as a salt of lithium, potassium, sodium or ammonium, but preferably used as ammonium thiosulfate or sodium thiosulfate to obtain a fixing solution having a high fixing rate.
【0061】その他、定着主薬として沃化物塩やチオシ
アン酸塩等も用いることができる。本発明に用いられる
定着液は、亜硫酸塩を含有する。亜硫酸塩としては、固
体リチウム、カリウム、ナトリウム、アンモニウム塩等
が用いられる。種類としては亜硫酸ナトリウム、メタ重
亜硫酸ナトリウム等を用いることができる。In addition, iodide salts, thiocyanates and the like can be used as fixing agents. The fixer used in the present invention contains sulfite. As the sulfite, solid lithium, potassium, sodium, ammonium salt or the like is used. As the type, sodium sulfite, sodium metabisulfite, or the like can be used.
【0062】本発明に用いられる定着液は、水溶性クロ
ム塩又は水溶性アルミニウム塩等を含有しても良い。水
溶性クロム塩としてはクロム明ばんなどが挙げられ、水
溶性アルミニウム塩としては硫酸アルミニウム、塩化ア
ルミニウムカリウム、塩化アルミニウム、硝酸アルミニ
ウムなどを挙げることができる。The fixing solution used in the present invention may contain a water-soluble chromium salt or a water-soluble aluminum salt. Examples of the water-soluble chromium salt include chromium alum, and examples of the water-soluble aluminum salt include aluminum sulfate, potassium aluminum chloride, aluminum chloride, aluminum nitrate and the like.
【0063】固形状(粉末状)水溶性アルミニウム塩は
一般に結晶水を複数有しており例えば18水塩、14水
塩などが挙げられるが固形状処理剤の成分として使用す
るときにはこの結晶水の移動により固まったり、着色
(酸とハイポの反応による硫黄着色等)等の悪影響を与
えるため、あらかじめアルミニウム塩を低温((60
℃):実用保存条件を想定した時のMAX温度)処理
し、結晶水の量が平衡状態となるまで一部の結晶水を除
去したアルミニウム塩を使用することが好ましい。例え
ば18〜14水塩のアルミニウムは上記処理により6〜
4水塩にしたものを用いることが好ましい。又、脱水化
しすぎたり、完全に脱結晶水化すると溶解性が落ちた
り、逆に水を吸収するなどの悪影響があるため好ましく
ない。The solid (powdered) water-soluble aluminum salt generally has a plurality of crystal waters, and examples thereof include 18-hydrate and 14-hydrate. When used as a component of a solid treating agent, the crystal water is used. The aluminum salt may be hardened by migration or may have a bad effect on coloring (such as sulfur coloring due to the reaction between acid and hypo).
(° C.): MAX temperature when assuming practical storage conditions), and it is preferable to use an aluminum salt from which a part of the water of crystallization has been removed until the amount of water of crystallization reaches an equilibrium state. For example, aluminum of 18 to 14 hydrate is 6 to 6 by the above treatment.
It is preferable to use a tetrahydrate. In addition, it is not preferable because it is adversely affected by excessive dehydration or complete decrystallization by water, which lowers the solubility and, on the contrary, absorbs water.
【0064】本発明に用いられる定着液は酢酸イオンを
含有する。酢酸イオンの種類は任意で、定着液中での酢
酸イオンを解離する任意の化合物に対して本発明は適用
できるが、酢酸や酢酸のリチウム、カリウム、ナトリウ
ム、アンモニウム塩などが好ましく用いられ、特にナト
リウム塩、アンモニウム塩が好ましい。The fixing solution used in the present invention contains acetate ions. The type of the acetate ion is arbitrary, and the present invention can be applied to any compound that dissociates the acetate ion in the fixing solution, but acetic acid and lithium, potassium, sodium, ammonium salts of acetic acid are preferably used, and particularly, Sodium salt and ammonium salt are preferable.
【0065】また、バッファー剤として、β−アラニ
ン、琥珀酸を用いることができる。更に、クエン酸、酒
石酸、りんご酸、フェニル酢酸及びこれらの光学異性体
などが含まれてもよい。Further, β-alanine and succinic acid can be used as the buffer agent. Further, citric acid, tartaric acid, malic acid, phenylacetic acid and optical isomers thereof may be contained.
【0066】これらの塩としては(例えばクエン酸カリ
ウム、クエン酸リチウム、クエン酸ナトリウム、クエン
酸アンモニウム、酒石酸水素リチウム、酒石酸水素カリ
ウム、酒石酸カリウム、酒石酸水素ナトリウム、酒石酸
ナトリウム、酒石酸水素アンモニウム、酒石酸アンモニ
ウムカリウム、酒石酸ナトリウムカリウム、りんご酸ナ
トリウム、りんご酸アンモニウム、琥珀酸ナトリウム、
琥珀酸アンモニウムなどに代表されるリチウム、カリウ
ム、ナトリウム、アンモニウム塩などが好ましいものと
して挙げられる。Examples of these salts include potassium citrate, lithium citrate, sodium citrate, ammonium citrate, lithium hydrogen tartrate, potassium hydrogen tartrate, potassium tartrate, sodium hydrogen tartrate, sodium tartrate, ammonium hydrogen tartrate, ammonium tartrate. Potassium, potassium sodium tartrate, sodium malate, ammonium malate, sodium succinate,
Lithium, potassium, sodium, ammonium salts represented by ammonium succinate and the like are preferable.
【0067】前記化合物の中でより好ましいものとして
は、クエン酸、イソクエン酸、りんご酸、フェニル酢酸
及びこれらの塩である。その他の酸としては、例えば硫
酸、塩酸、硝酸、硼酸のような無機酸の塩や、儀酸、プ
ロピオン酸、シュウ酸、りんご酸などの有機酸類などが
挙げられるが、好ましくは硼酸、アミノポリカルボン酸
類などの酸及び塩である。Of the above compounds, more preferred are citric acid, isocitric acid, malic acid, phenylacetic acid and salts thereof. Examples of other acids include salts of inorganic acids such as sulfuric acid, hydrochloric acid, nitric acid and boric acid, and organic acids such as formic acid, propionic acid, oxalic acid and malic acid, with boric acid and aminopolyacid being preferred. Acids and salts such as carboxylic acids.
【0068】キレート剤としては、例えばニトリロ三酢
酸、エチレンジアミン四酢酸などのアミノポリカルボン
酸類及びこれらの塩などが挙げられる。Examples of the chelating agent include aminopolycarboxylic acids such as nitrilotriacetic acid and ethylenediaminetetraacetic acid, and salts thereof.
【0069】界面活性剤としては、例えば硫酸エステル
化物、スルホン化物などのアニオン活性剤、ポリエチレ
ングリコール系、エステル系等のノニオン界面活性剤、
両性活性剤などが挙げられる。Examples of the surfactant include anionic surfactants such as sulfuric acid esterified products and sulfonated compounds, nonionic surfactants such as polyethylene glycol-based and ester-based surfactants,
Examples include amphoteric activators.
【0070】潤滑剤としては、例えばアルカノールアミ
ン、アルキレングリコールなどが挙げられる。Examples of the lubricant include alkanolamine and alkylene glycol.
【0071】定着促進剤としては、チオ尿素誘導体、分
子内に三重結合を有するアルコール、チオエーテルなど
が挙げられる。Examples of fixing accelerators include thiourea derivatives, alcohols having a triple bond in the molecule, and thioethers.
【0072】定着液はpH3.8以上、好ましくは4.
2〜5.5を有する。定着液の補充量については300
ml/m2〜50ml/m2が好ましいが特に200m
l/m2〜80ml/m2が好ましい。The fixing solution has a pH of 3.8 or more, preferably 4.
2 to 5.5. 300 for fixer replenisher
ml / m 2 ~50ml / m 2 are preferred, especially 200m
1 / m 2 to 80 ml / m 2 is preferable.
【0073】(固形化について)次に写真処理剤の固体
化(固形化)について説明する。(Solidification) Next, solidification (solidification) of the photographic processing agent will be described.
【0074】写真処理剤を固体化するには、濃厚液また
は微粉ないし粒状写真処理剤と水溶性結着剤を混練し成
型化するか、仮成型した写真処理剤の表面に水溶性結着
剤を噴霧したりすることで被覆層を形成する等、任意の
手段が採用できる(特開平4−29136号、同4−8
5535号、同4−85536号、同4−85533
号、同4−85534号、同4−172341号参
照)。To solidify the photographic processing agent, a concentrated liquid or fine powder or granular photographic processing agent and a water-soluble binder are kneaded and molded, or a water-soluble binder is preliminarily formed on the surface of the photographic processing agent. Arbitrary means such as forming a coating layer by spraying (see JP-A-4-29136 and 4-8)
No. 5535, No. 4-85536, No. 4-85533
Nos. 4-85534 and 4-172341).
【0075】好ましい錠剤の製造法としては粉末状の固
体処理剤を造粒した後、打錠工程を行い形成する方法で
ある。単に固体処理剤成分を混合し打錠工程により形成
された固形処理剤より溶解性や保存性が改良され結果と
して写真性能も安定になるという利点がある。A preferable tablet manufacturing method is a method in which a powdery solid processing agent is granulated and then a tableting step is performed. There is an advantage that the solubility and storability are improved and the photographic performance becomes stable as compared with the solid processing agent formed by the tableting process by simply mixing the solid processing agent components.
【0076】錠剤形成のための造粒方法は転動造粒、押
し出し造粒、圧縮造粒、解砕造粒、攪拌造粒、流動層造
粒、噴霧乾燥造粒等公知の方法を用いることができる。
錠剤形成のためには、得られた造粒物の平均粒径は造粒
物を混合し、加圧圧縮する際、成分の不均一化、いわゆ
る偏析が起こりにくいという点で、100〜800μm
のものを用いることが好ましく、より好ましくは200
〜750μmである。さらに粒度分布は造粒物粒子の6
0%以上が±100〜150μmの偏差内にあるものが
好ましい。次に得られた造粒物を加圧圧縮する際には公
知の圧縮機、例えば油圧プレス機、単発式打錠機、ロー
タリー式打錠機、プリケッテングマシンを用いることが
できる。加圧圧縮されて得られる固体処理剤は任意の形
状を取ることが可能であるが、生産性、取扱い性の観点
から又はユーザーサイドで使用する場合の粉塵の問題か
らは円筒型、いわゆる錠剤が好ましい。As the granulation method for tablet formation, known methods such as rolling granulation, extrusion granulation, compression granulation, crushing granulation, stirring granulation, fluidized bed granulation and spray drying granulation are used. You can
In order to form tablets, the average particle size of the obtained granules is 100 to 800 μm in that when the granules are mixed and compressed under pressure, nonuniformity of the components, so-called segregation does not easily occur.
It is preferable to use the above-mentioned one, and more preferably 200
˜750 μm. Furthermore, the particle size distribution is 6 for granulated particles.
It is preferable that 0% or more is within a deviation of ± 100 to 150 μm. A known compressor, for example, a hydraulic press, a single-shot tableting machine, a rotary tableting machine, or a pre-ketching machine can be used for compressing the obtained granulated product under pressure. The solid processing agent obtained by compression under pressure can have any shape, but from the viewpoint of productivity and handleability, or from the problem of dust when used on the user side, a cylindrical type, a so-called tablet is used. preferable.
【0077】さらに好ましくは造粒時、各成分毎例えば
アルカリ剤、還元剤、保恒剤等を分別造粒する。More preferably, at the time of granulation, each component, for example, an alkali agent, a reducing agent, a preservative and the like is separately granulated.
【0078】錠剤処理剤の製造方法は、例えば、特開昭
51−61837号、同54−155038号、同52
−88025号、英国特許1,213,808号等の明
細書に記載される方法で製造でき、更に顆粒処理剤は、
例えば、特開平2−109042号、同2−10904
3号、同3−39735号及び同3−39739号等の
明細書に記載される方法で製造できる。更にまた粉末処
理剤は、例えば、特開昭54−133332号、英国特
許725,892号、同729,862号及びドイツ特
許3,733,861号等の明細書に記載されるが如き
方法で製造できる。The method for producing the tablet treating agent is described in, for example, JP-A Nos. 51-61837, 54-155038 and 52-52.
-88025, British Patent No. 1,213,808 and the like can be produced by the method described in the specification, and the granule treating agent is
For example, JP-A Nos. 2-109042 and 2-10904.
No. 3, No. 3-39735, and No. 3-39739 can be produced by the method described in the specification. Further, the powder processing agent can be prepared by a method described in, for example, JP-A-54-133332, British Patents 725,892 and 729,862, and German Patent 3,733,861. Can be manufactured.
【0079】上記の固体処理剤の嵩密度は、その溶解性
の観点と、本発明の目的の効果の点から錠剤である場合
1.0g/cm3〜2.5g/cm3が好ましく1.0
g/cm3より大きいと得られる固形物の強度の点で、
2.5g/cm3より小さいと得られる固形物の溶解性
の点でより好ましい。固体処理剤が顆粒又は粉末である
場合、嵩密度は0.40〜0.95g/cm3のものが
好ましい。[0079] The bulk density of the solid processing agent, and in view of its solubility, if a tablet from the viewpoint of the effect of the object of the present invention 1.0g / cm 3 ~2.5g / cm 3 is preferably 1. 0
In terms of the strength of the solid obtained when it is larger than g / cm 3 ,
It is more preferable that the solid content is less than 2.5 g / cm 3 in terms of solubility of the obtained solid. When the solid processing agent is granules or powder, the bulk density is preferably 0.40 to 0.95 g / cm 3 .
【0080】本発明に用いられる固体処理剤はある処理
剤の1部の成分のみ固形化することも本発明の範囲に入
るが、好ましくは該処理剤の全成分が固形化されている
ことである。各成分は別々の固体処理剤として成型さ
れ、同一個装されていることが望ましい。又別々の成分
が定期的に包装でくり返し投入される順番に包装されて
いることも望ましい。It is within the scope of the present invention to solidify only one part of a certain treating agent in the solid treating agent used in the present invention, but preferably all components of the treating agent are solidified. is there. It is desirable that each component be molded as a separate solid processing agent and packaged in the same manner. It is also desirable that the individual components are packaged in the order in which they are periodically added repeatedly in a package.
【0081】処理量情報に応じて各処理槽に補充する処
理剤全てを固体処理剤として投入することが好ましい。
補充水が必要な場合には、処理量情報又は別の補充水制
御情報に基づき補充水が補充される。この場合処理槽に
補充する液体は補充水のみとすることができる。つま
り、補充が必要な処理槽が2種類以上の複数であった場
合に、補充水を共有することによって補充用液体を貯留
するタンクは1つで済み、自動現像機のコンパクト化が
図れる。補充水タンクは外部に外置きでも、自動現像機
に内蔵してもよく、内蔵するのは省スペース等の点から
も好ましい。It is preferable to add all the processing agents to be replenished to the respective processing tanks as solid processing agents according to the processing amount information.
When replenishment water is required, it is replenished based on the throughput information or other replenishment water control information. In this case, the liquid to be replenished in the treatment tank can be only replenishing water. That is, when there are two or more types of processing tanks that need to be replenished, only one tank is required to store the replenishing liquid by sharing the replenishing water, and the automatic developing machine can be made compact. The replenishing water tank may be placed outside or may be built in the automatic developing machine, and it is preferable to install the replenishing water tank from the viewpoint of space saving.
【0082】現像剤を固形化する場合、アルカリ剤、還
元剤等、全てを固体処理剤化し、かつ錠剤の場合には少
なくとも3剤以内、即ち1剤にすることができ、又2剤
以上に分けて固体処理剤化した場合は、これら複数の錠
剤や顆粒が同一包装されていることが好ましい。When the developer is solidified, all of the alkali agent, reducing agent and the like are solidified, and in the case of the tablet, at least 3 agents, that is, 1 agent, or 2 or more agents can be used. When divided into solid processing agents, it is preferable that the plurality of tablets and granules be packed in the same package.
【0083】本発明に用いられる固体処理剤の包装体と
しては下記のような素材を用いて実施できる。合成樹脂
材質としては、ポリエチレン(高圧法、低圧法どちらで
もよい)、ポリプロピレン(無延伸、延伸どちらでもよ
い)、ポリ塩化ビニル、ポリ酢酸ビニル、ナイロン(延
伸、無延伸)、ポリ塩化ビニリデン、ポリスチレン、ポ
リカーボネート、ビニロン、エバール、ポリエチレンテ
レフタレート(PET)、その他のポリエステル、アク
リロニトリルブタジエン共重合体、エポキシ−リン酸系
樹脂(特開昭63−63037号に記載のポリマー、特
開昭57−32952号に記載のポリマー)の何れであ
ってもよい。又はパルプでもよい。The following materials can be used for the package of the solid processing agent used in the present invention. Synthetic resin materials include polyethylene (either high pressure method or low pressure method), polypropylene (either unstretched or stretched), polyvinyl chloride, polyvinyl acetate, nylon (stretched or unstretched), polyvinylidene chloride, polystyrene , Polycarbonate, vinylon, eval, polyethylene terephthalate (PET), other polyesters, acrylonitrile butadiene copolymer, epoxy-phosphoric acid resin (polymers described in JP-A-63-63037, JP-A-57-32952). Any of the listed polymers). Alternatively, it may be pulp.
【0084】これらは単一素材のものが好ましいが、フ
ィルムとして用いる際には、そのフィルムを積層接着す
るが、塗布層としてもよく、また単一層のものでもよ
い。Although these are preferably made of a single material, when they are used as a film, the films are laminated and adhered, but may be a coating layer or a single layer.
【0085】さらには、例えば上記の合成樹脂フィルム
の間にアルミニウム箔又はアルミニウム蒸着合成樹脂を
使用するなど、各種ガスバリアー膜を用いると、より好
ましい。Further, it is more preferable to use various gas barrier films such as using aluminum foil or aluminum vapor deposition synthetic resin between the above synthetic resin films.
【0086】また、固体処理剤の保存性やステイン発生
防止のためにこれらの包装材料の酸素透過率は50ml
/m224hr・atm以下(20℃、65%RH
で)、より好ましくは30ml/m224hr・atm
以下であることが好ましい。The oxygen permeability of these packaging materials is 50 ml in order to preserve the solid processing agent and prevent stains from being generated.
/ M 2 24hr · atm or less (20 ° C, 65% RH
), More preferably 30 ml / m 2 24 hr · atm
The following is preferable.
【0087】これらの積層膜又は単一層の膜厚の合計
は、1〜3000μm、より好ましくは10〜2000
μm、さらに好ましくは50〜1000μmであること
が好ましい。The total thickness of these laminated films or single layers is 1 to 3000 μm, more preferably 10 to 2000.
μm, and more preferably 50 to 1000 μm.
【0088】以上の合成樹脂フィルムは1層の(高分
子)樹脂膜であってもよいし、2以上の積層(高分子)
樹脂膜であってもよい。The above synthetic resin film may be a single layer (polymer) resin film, or a laminate of two or more (polymer)
It may be a resin film.
【0089】本発明の条件に適う1層の高分子樹脂膜と
しては、例えば、(1)厚さ0.1mm以上のポリエチ
レンテレフタレート(PET)、(2)厚さ0.3mm
以上のアクリロニトリルブタジエン共重合体、(3)厚
さ0.1mm以上の塩酸ゴム等が挙げられ、中でもポリ
エチレンテレフタレートは耐アルカリ性、耐酸性の点で
も優れているため、本発明に好適に用い得る。Examples of the one-layer polymer resin film suitable for the conditions of the present invention include (1) polyethylene terephthalate (PET) having a thickness of 0.1 mm or more, and (2) a thickness of 0.3 mm.
The acrylonitrile butadiene copolymers described above and (3) hydrochloric acid rubber having a thickness of 0.1 mm or more can be mentioned. Among them, polyethylene terephthalate is excellent in alkali resistance and acid resistance, and thus can be suitably used in the present invention.
【0090】次に、本発明の条件に適う積層の高分子樹
脂膜としては、例えば、(4)PET/ポリビニルアル
コール・エチレン共重合体(エバール)/ポリエステル
(PE)、(5)延伸ポリプロピレン(OPP)/エバ
ール/PE、(6)未延伸ポリプロピレン(CPP)/
エバール/PE、(7)ナイロン(N)/アルミニウム
箔(Al)/PE、(8)PET/Al/PE、(9)
セロファン/PE/Al/PE、(10)Al/紙/P
E、(11)PET/PE/Al/PE、(12)N/
PE/Al/PE、(13)紙/PE/Al/PE、
(14)PET/Al/PET/ポリプロピレン(P
P)、(15)PET/Al/PET/高密度ポリエチ
レン(HDPE)、(16)PET/Al/PE/低密
度ポリエチレン(LDPE)、(17)エバール/P
P、(18)PET/Al/PP、(19)紙/Al/
PE、(20)PE/PVDCコートナイロン/PE/
エチルビニルアセテート・ポリエチレン縮合物(EV
A)、(21)PE/PVDCコートN/PE、(2
2)EVA/PE/アルミ蒸着ナイロン/PE/EV
A、(23)アルミ蒸着ナイロン/N/PE/EVA、
(24)OPP/PVDCコートN/PE、(25)P
E/PVDCコートN/PE、(26)OPP/エバー
ル/LDPE、(27)OPP/エバール/CPP、
(28)PET/エバール/LDPE、(29)ON
(延伸ナイロン)/エバール/LDPE、(30)CN
(未延伸ナイロン)/エバール/LDPE等があり、中
でも上記(20〜(30)が好ましく用いられる。Next, as the laminated polymer resin film which meets the conditions of the present invention, for example, (4) PET / polyvinyl alcohol / ethylene copolymer (Eval) / polyester (PE), (5) stretched polypropylene ( OPP) / Eval / PE, (6) unstretched polypropylene (CPP) /
EVAL / PE, (7) Nylon (N) / Aluminum foil (Al) / PE, (8) PET / Al / PE, (9)
Cellophane / PE / Al / PE, (10) Al / Paper / P
E, (11) PET / PE / Al / PE, (12) N /
PE / Al / PE, (13) Paper / PE / Al / PE,
(14) PET / Al / PET / polypropylene (P
P), (15) PET / Al / PET / high density polyethylene (HDPE), (16) PET / Al / PE / low density polyethylene (LDPE), (17) Eval / P
P, (18) PET / Al / PP, (19) paper / Al /
PE, (20) PE / PVDC coated nylon / PE /
Ethyl vinyl acetate / polyethylene condensate (EV
A), (21) PE / PVDC coated N / PE, (2
2) EVA / PE / Aluminum deposition nylon / PE / EV
A, (23) Aluminum vapor deposition nylon / N / PE / EVA,
(24) OPP / PVDC coat N / PE, (25) P
E / PVDC coated N / PE, (26) OPP / Eval / LDPE, (27) OPP / Eval / CPP,
(28) PET / EVAL / LDPE, (29) ON
(Stretched nylon) / Eval / LDPE, (30) CN
(Unstretched nylon) / Eval / LDPE and the like, among which (20 to (30)) is preferably used.
【0091】さらに具体的な包装材料の構成としては処
理剤に接する側を内面とすれば、内面から順に、PE/
主体となる板紙/PE/Al/エポキシ−リン酸系樹脂
層/ポリエステル系樹脂層/PE
PE/K−ナイロン/PEまたは接着剤/Al/PE/
板紙/PE、PE/ビンロン/PEまたは接着剤/Al
/PE/板紙/PE、PE/塩化ビニリデン/PEまた
は接着剤/Al/PE/板紙/PE、PE/ポリエステ
ル/PEまたは接着剤/Al/PE/板紙/PE、ポリ
プロピレン/K−ナイロン/ポリプロピレン/Al/ポ
リプロピレン/板紙/ポリプロピレンなどがある。As a more specific constitution of the packaging material, if the side in contact with the treating agent is the inner surface, PE /
Main board / PE / Al / epoxy-phosphoric acid resin layer / polyester resin layer / PE PE / K-nylon / PE or adhesive / Al / PE /
Paperboard / PE, PE / Vinlon / PE or adhesive / Al
/ PE / paperboard / PE, PE / vinylidene chloride / PE or adhesive / Al / PE / paperboard / PE, PE / polyester / PE or adhesive / Al / PE / paperboard / PE, polypropylene / K-nylon / polypropylene / Examples include Al / polypropylene / paperboard / polypropylene.
【0092】錠剤や顆粒を防湿包装する方法としては、
4方シール、3方シール、スティック(ピロー包装、ガ
ゼット包装)、PTP、カートリッジがある。As a method for moisture-proof packaging of tablets and granules,
There are four-sided seals, three-sided seals, sticks (pillow packaging, gusset packaging), PTP, and cartridges.
【0093】4方シール、3方シール、スティック(ピ
ロー、ガゼット)包装は形態の違いであり前記材料が用
いられる。ただしピールオープン方式に利用するときは
シーラント剤をラミネートしピールオープン適性を持た
せる。The four-sided seal, the three-sided seal, and the stick (pillow, gusset) packaging have different forms, and the above materials are used. However, when using the peel open method, a sealant agent is laminated to give the peel open aptitude.
【0094】このピールオープンの方式には、通常、凝
集破壊方式、界面剥離方式、層間剥離方式がある。The peel-open method generally includes a cohesive failure method, an interfacial peeling method, and an interlayer peeling method.
【0095】凝集破壊方式はホットメルトと言われる接
着剤で、ヒートシールラッカーでシール剤として用いる
方式であり、開封時にシーラント層の内部凝集破壊によ
り剥離するものである。The cohesive failure method is an adhesive called hot melt, which is used as a sealant in a heat seal lacquer, and peels off due to internal cohesive failure of the sealant layer at the time of opening.
【0096】界面活性剥離方式はフィルム間の界面で剥
離する方式であり、シール用フィルム(シーラント)と
被着体が完全に融着しておらず適度の強度で剥がせるも
のである。シーラントとしては粘着性の樹脂を混合した
フィルムであり、被着体の材質によるポリエチレン、ポ
リプロピレン又はその共重合体、ポリエステル系等を選
択することができる。The surface-active peeling method is a method of peeling at the interface between films, in which the sealing film (sealant) and the adherend are not completely fused and can be peeled off with appropriate strength. The sealant is a film in which an adhesive resin is mixed, and polyethylene, polypropylene or a copolymer thereof, a polyester type or the like can be selected depending on the material of the adherend.
【0097】さらにシーラントをラミネートフィルムの
ような多層共押出しフィルムを使い、ラミネートフィル
ムの層間で剥離するのが層間剥離方式である。Further, the delamination method is one in which the sealant is peeled between the layers of the laminate film by using a multilayer coextrusion film such as a laminate film.
【0098】本発明のフィルムを用いたピールオープン
方式では層間剥離方式又は界面剥離方式が好ましい。In the peel open method using the film of the present invention, the interlaminar peeling method or the interfacial peeling method is preferable.
【0099】また、このようなシーラントは薄いため、
通常他のフィルムたとえばポリエチレン、ポリプロピレ
ン、ポリスチレン、ポリカーボネート、ポリエステル
(ポリエチレンテレフタレート)、ポリ塩化ビニル、ナ
イロン、エバール、アルミニウム等をラミネートして使
用するが、防湿性、環境対応及び内容物とのマッチング
を考えるポリエチレン、ポリプロピレン、ポリエステ
ル、エバール等が好ましい。また印刷性を考慮すると最
外面は無延伸ポリプロピレン、ポリエステル、紙などが
好ましい。Since such a sealant is thin,
Usually, other films such as polyethylene, polypropylene, polystyrene, polycarbonate, polyester (polyethylene terephthalate), polyvinyl chloride, nylon, eval, aluminum are laminated and used, but considering moisture resistance, environmental friendliness and matching with contents. Polyethylene, polypropylene, polyester, EVAL and the like are preferable. In consideration of printability, the outermost surface is preferably unstretched polypropylene, polyester, paper or the like.
【0100】シーラントフィルムとしては、たとえばト
ーセロ製CMPSフィルム、大日本インキ製ディフラン
PP−100、PS−300又は凸版印刷製のLTSフ
ィルム、サンエー化学製サンシールFR、サンシールM
S等があり、すでにポリエステルとラミネートされてい
るタイプとしてはディクランC−1600T、C−16
02Tなどがある。As the sealant film, for example, CMPS film manufactured by Tohcello, Diffran PP-100, PS-300 manufactured by Dainippon Ink and LTS film manufactured by Toppan Printing, Sunseal FR, Sunseal M manufactured by San-A Chemical Co., Ltd.
There are S etc., and as a type already laminated with polyester, Declan C-1600T, C-16
02T and so on.
【0101】PTPはブリスター包装の一種で成形され
たPVC、CPP等のシートに固体処理剤を入れアルミ
シール材でヒートシールした包装形態である。PTP is a packaging form in which a solid processing agent is put into a sheet of PVC, CPP or the like which is molded as a kind of blister packaging and heat sealed with an aluminum sealing material.
【0102】形成材として環境上PVCは使用しない方
向にあり、最近はA−PETや高防湿PP(例えばTA
S−1130、TAS−2230、TAS−3230:
大成化工(株))が好ましく用いられる。Environmentally, PVC is not used as a forming material, and recently, A-PET and highly moisture-proof PP (for example, TA
S-1130, TAS-2230, TAS-3230:
Taisei Kako Co., Ltd. is preferably used.
【0103】処理剤を水溶性フィルムないし結着剤で包
装または結着ないし被覆する場合、水溶性フィルムない
し結着剤は、ポリビニルアルコール系、メチルセルロー
ス系、ポリエチレンオキサイド系、デンプン系、ポリビ
ニルピロリドン系、ヒドロキシプロピルセルロース系、
プルラン系、デキストラン系及びアラビアガム系、ポリ
酢酸ビニル系、ヒドロキシエチルセルロース系、カルボ
キシエチルセルロース系、カルボキシメチルヒドロキシ
エチルセルロースナトリウム塩系、ポリ(アルキル)オ
キサゾリン系、ポリエチレングリコール系の基材からな
るフィルムないし結着剤が好ましく用いられ、これらの
中でも、特にポリビニルアルコール系及びプルラン系の
ものが被覆ないしは結着の効果の点からより好ましく用
いられる。When the treating agent is packaged or bound or coated with a water-soluble film or binder, the water-soluble film or binder may be polyvinyl alcohol, methyl cellulose, polyethylene oxide, starch, polyvinyl pyrrolidone, Hydroxypropyl cellulose system,
Film or binder consisting of pullulan-based, dextran-based, gum arabic-based, polyvinyl acetate-based, hydroxyethyl cellulose-based, carboxyethyl cellulose-based, carboxymethyl hydroxyethyl cellulose sodium salt-based, poly (alkyl) oxazoline-based, polyethylene glycol-based substrates Agents are preferably used, and among these, polyvinyl alcohol-based and pullulan-based agents are more preferably used from the viewpoint of the effect of coating or binding.
【0104】好ましいポリビニルアルコールは極めて良
好なフィルム形成材料であり、ほとんどの条件下で良好
な強度及び柔軟性を有する。フィルムとして注型する市
販のポリビニルアルコール組成物は分子量及び加水分解
の程度が様々であるが、分子量が約10000ないし約
100000であることが好ましい。加水分解の程度と
は、ポリビニルアルコールの酢酸エステル基が水酸基に
置換される割合である。フィルムに適用するには、加水
分解の範囲は通常約70%〜100%までである。この
ように、ポリビニルアルコールという言葉は通常ポリ酢
酸ビニル化合物を含む。The preferred polyvinyl alcohol is a very good film-forming material and has good strength and flexibility under most conditions. Commercially available polyvinyl alcohol compositions cast as films vary in molecular weight and degree of hydrolysis, but preferably have a molecular weight of about 10,000 to about 100,000. The degree of hydrolysis is the rate at which the acetic acid ester group of polyvinyl alcohol is replaced with a hydroxyl group. For film applications, the hydrolysis range is usually up to about 70% to 100%. Thus, the term polyvinyl alcohol usually includes polyvinyl acetate compounds.
【0105】これら水溶性フィルムの製造法は、例え
ば、特開平2−124945号、特開昭61−9734
8号、同60−158245号、特開平2−86638
号、特開昭57−117867号、特開平2−7565
0号、特開昭59−226018号、同63−2187
41号及び同54−13565号等に記載されるが如き
方法で製造される。The method for producing these water-soluble films is described in, for example, JP-A-2-124945 and JP-A-61-1934.
No. 8, 60-158245, and JP-A-2-86638.
JP-A-57-117867 and JP-A-2-7565.
No. 0, JP-A-59-226018, 63-2187.
No. 41 and No. 54-13565, and the like.
【0106】更にこれら水溶性フィルムはソルブロン
(アイセロ化学社製)、ハイセロン(日合フィルム社
製)、あるいはプルラン(林原社製)の名称で市販され
ているものを用いることができる。また、クリス・クラ
フト・インダストリーズ(Chris Craft I
ndustries)Inc.のMONO−SOL部門
から入手できる7−000シリーズのポリビニルアルコ
ールフィルムは、約34度Fないし約200度Fの水温
において溶解し、無害で、高度の化学的抵抗性を示すも
のであり、特に好ましく用いられる。Further, as these water-soluble films, those commercially available under the names of Solbron (manufactured by Aicello Chemical Co., Ltd.), Hi-Selon (manufactured by Nigo Film Co., Ltd.) or Pullulan (manufactured by Hayashibara Co., Ltd.) can be used. Also, Chris Craft Industries (Chris Craft I)
ndustries) Inc. The 7-000 series polyvinyl alcohol films available from the MONO-SOL Division of the Company dissolve in water temperatures of about 34 ° F. to about 200 ° F., are harmless and exhibit a high degree of chemical resistance, and are particularly preferred. Used.
【0107】上記水溶性フィルムの膜厚は固体処理剤の
保存安定性、水溶性フィルムの溶解時間及び自動現像機
内での結晶析出の点で10〜120μmのものが好まし
く用いられ、特に15〜80μmのものが好ましく、と
りわけ特に20〜60μmのものが好ましく用いられ
る。The thickness of the water-soluble film is preferably 10 to 120 μm, particularly 15 to 80 μm, from the viewpoints of storage stability of the solid processing agent, dissolution time of the water-soluble film and crystal precipitation in an automatic processor. Those having a thickness of 20 to 60 μm are particularly preferably used.
【0108】また、水溶性フィルムは熱可塑性であるこ
とが好ましい。これは、ヒートシール加工や超音波溶着
加工が容易となるだけでなく、被覆効果もより良好に奏
するためである。The water-soluble film is preferably thermoplastic. This is because not only the heat sealing process and the ultrasonic welding process are facilitated, but also the covering effect is more excellently achieved.
【0109】更に、水溶性フィルムの引張り強度は0.
5×106〜50×106kg/m2が好ましく、特に
1×106〜25×106kg/m2が好ましく、とり
わけ特に1.5×106〜10×106kg/m2が好
ましい。これら引張り強度はJIS Z−1521に記
載される方法で計測される。Further, the tensile strength of the water-soluble film is 0.
5 × 10 6 to 50 × 10 6 kg / m 2 is preferable, 1 × 10 6 to 25 × 10 6 kg / m 2 is particularly preferable, and 1.5 × 10 6 to 10 × 10 6 kg / m 2 is particularly preferable. These tensile strengths are measured by the method described in JIS Z-1521.
【0110】また、水溶性フィルムないし結着剤で包装
又は結着ないし被覆した写真処理剤は、貯蔵、輸送、及
び取扱中において、高湿度、雨、及び霧のような大気中
の湿気、及び水はね又は濡れた手による水との突発的な
接触の損害から防ぐため防湿包装材で包装されているこ
とが好ましく、該防湿包装材としては、膜厚が10〜1
50μmのフィルムが好ましく、防湿包装材がポリエチ
レンテレフタレート、ポリエチレン、ポリプロピレンの
ようなポリオレフィンフィルム、ポリエチレンで耐湿効
果を持ち得るクラフト紙、ロウ紙、耐湿性セロファン、
グラシン、ポリエステル、ポリスチレン、ポリ塩化ビニ
ル、ポリ塩化ビニリデン、ポリアミド、ポリカーボネー
ト、アクリロニトリル系及びアルミニウムの如き金属
箔、金属化ポリマーフィルムから選ばれる少なくとも一
つであることが好ましく、また、これらを用いた複合材
料であってもよい。Further, the photographic processing agent packaged or bound or coated with a water-soluble film or a binding agent is used in storage, transportation, and handling during storage, transportation, and handling, and humidity in the atmosphere such as high humidity, rain, and fog, and In order to prevent water from splashing or accidental contact with water due to wet hands, it is preferable to be packaged in a moisture-proof packaging material, and the moisture-proof packaging material has a film thickness of 10 to 1
A film having a thickness of 50 μm is preferable, and a moisture-proof packaging material is a polyolefin film such as polyethylene terephthalate, polyethylene or polypropylene, kraft paper, wax paper, moisture-resistant cellophane, which can have a moisture resistance effect with polyethylene.
At least one selected from glassine, polyester, polystyrene, polyvinyl chloride, polyvinylidene chloride, polyamide, polycarbonate, acrylonitrile-based metal foil such as aluminium, and metallized polymer film is preferable, and a composite using these is also used. It may be a material.
【0111】また、本発明の実施においては、防湿包装
材が、分解性プラスチック、特に生分解又は光分解性プ
ラスチックのものを用いることが好ましい。In the practice of the present invention, the moisture-proof packaging material is preferably a degradable plastic, particularly a biodegradable or photodegradable plastic.
【0112】前記生分解性プラスチックは、天然高分
子からなるもの、微生物産出ポリマー、生分解性の
よい合成ポリマー、プラスチックへの生分解性天然高
分子の配合等が挙げられ、光分解性プラスチックは、
紫外線で励起され、切断に結びつく基が主鎖に存在する
もの等が挙げられる。更に上記に掲げた高分子以外にも
光分解性と生分解性との二つの機能を同時に有したもの
も良好に使用できる。Examples of the biodegradable plastic include those made of natural polymers, polymers produced by microorganisms, synthetic polymers having good biodegradability, blending of biodegradable natural polymers with plastics, and photodegradable plastics are ,
Examples thereof include a group that is excited by ultraviolet rays and has a group that is linked to cleavage in the main chain. Further, other than the above-mentioned polymers, those having two functions of photodegradability and biodegradability at the same time can be favorably used.
【0113】これらの具体的代表例をそれぞれ挙げる
と、以下のようになる。The specific representative examples are as follows.
【0114】生分解性プラスチックとしては、
天然高分子
多糖類、セルロース、ポリ乳酸、キチン、キトサン、ポ
リアミノ酸、あるいはその修飾体等
微生物産出ポリマー
PHB−PHV(3−ヒドロキシブチレートと3−ヒド
ロキシバレレートとの共重合物)を成分とする「Bio
pol」、微生物産出セルロース等
生分解性のよい合成ポリマー
ポリビニルアルコール、ポリカプロラクトン等、あるい
はそれらの共重合物ないし混合物
プラスチックへの生分解性天然高分子の配合
生分解性のよい天然高分子としては、デンプンやセルロ
ースがあり、プラスチックに加え形状崩壊性を付与した
ものである。Examples of biodegradable plastics include natural high molecular polysaccharides, cellulose, polylactic acid, chitin, chitosan, polyamino acids, and modified products thereof such as PHB-PHV (3-hydroxybutyrate and 3-hydroxyvalerate), which are polymers produced by microorganisms. (Copolymer with rate) as a component
pol ", microbial-produced cellulose and other biodegradable synthetic polymers such as polyvinyl alcohol, polycaprolactone, etc., or their copolymers or mixtures of the biodegradable natural polymer into plastics. , Starch, and cellulose, which have shape-disintegrating properties in addition to plastic.
【0115】また、この光分解性の例としては、光崩壊
性のためのカルボニル基の導入等があり、更に崩壊促進
のために紫外線吸収剤が添加されることもある。Further, examples of the photodegradability include introduction of a carbonyl group for photodisintegration, and an ultraviolet absorber may be added to accelerate the disintegration.
【0116】このような分解性プラスチックについて
は、「科学と工業」第64巻第10号第478〜484
頁(1990年)、「機能材料」1990年7月号第2
3〜34頁等に一般的に記載されるものが使用できる。
また、Biopol(バイオポール)(ICI社製)、
Eco(エコ)(Union Carbide社製)、
Ecolite(エコライト)(Eco Plasti
c社製)、Ecostar(エコスター)(St.La
wrence Starch社製)、ナックルP(日本
ユニカー社製)等の市販されている分解性プラスチック
を使用することができる。Regarding such degradable plastics, "Science and Industry", Vol. 64, No. 10, No. 478-484.
Page (1990), "Functional Materials," July 1990, Issue 2
What is generally described on pages 3 to 34 can be used.
Also, Biopol (manufactured by ICI),
Eco (made by Union Carbide),
Ecolite (Eco Plasti)
c company), Ecostar (Ecostar) (St. La
Commercially available degradable plastics such as Wrence Starch) and Knuckle P (Nippon Unicar) can be used.
【0117】上記防湿包装材は、好ましくは水分透過係
数が10g・mm/m224hr以下のものであり、よ
り好ましくは5g・mm/m224hr以下のものであ
る。The moisture-proof packaging material preferably has a moisture permeability coefficient of 10 g · mm / m 2 24 hr or less, more preferably 5 g · mm / m 2 24 hr or less.
【0118】本発明において固体処理剤を処理槽に供給
する供給手段としては、例えば、固体処理剤が錠剤であ
る場合、実開昭63−137783号、同63−975
22号、実開平1−85732号等公知の方法がある
が、要は錠剤を処理槽に供給せしめる機能が最低限付与
されていればいかなる方法でも良い。また固体処理剤が
顆粒又は粉末である場合には実開昭62−81964
号、同63−84151号、特開平1−292375号
等記載の重力落下方式や実開昭63−105159号、
同63−195345号等記載のスクリュー又はネジに
よる方式が公知の方法としてあるが、これらに限定され
るものではない。In the present invention, as a means for supplying the solid processing agent to the processing tank, for example, when the solid processing agent is a tablet, JP-B-63-137783 and 63-975.
Although there are known methods such as No. 22, No. 22 and Jitsukaihei 1-85732, any method may be used as long as it has at least the function of supplying tablets to the processing tank. Further, when the solid processing agent is granules or powders, it is used in the practical method of Sho 62-81964.
No. 63-84151, the gravity drop method described in JP-A-1-292375 and the like, Japanese Utility Model Publication No. 63-105159,
Although a method using a screw or a screw described in JP-A-63-195345 and the like is a known method, the method is not limited thereto.
【0119】しかしながら好ましい方法は、固体処理剤
を処理槽に供給する供給手段としては、例えば予め秤量
し分割包装された所定量の固体処理剤を感光材料の処理
量に応じて包装体を開封、取出す方法が考えられる。具
体的には、固体処理剤が所定量ずつ好ましくは一回分の
補充量ずつ、少なくとも二つの包装材料から構成される
包装体に挟持収納されており、包装体を2方向に分離も
しくは包装体の一部を開封することにより取出し可能状
態にする。取出し可能状態の固体処理剤は自然落下によ
り容易に濾過手段を有する処理槽に供給することができ
る。所定量の固体処理剤は外気及び隣の固体処理剤との
通気性が遮断されるよう各々が分割密封された包装体に
収納されているため開封しなければ防湿が保証されてい
る。However, a preferable method is, as a supply means for supplying the solid processing agent to the processing tank, for example, a predetermined amount of the solid processing agent which has been previously weighed and divided and packaged is opened according to the processing amount of the light-sensitive material, and the package is opened. A method of taking it out is possible. Specifically, the solid processing agent is sandwiched and housed in a package composed of at least two packaging materials by a predetermined amount, preferably one replenishment amount, and the package is separated in two directions or the package A part of it is opened so that it can be taken out. The solid processing agent that can be taken out can be easily supplied to the processing tank having the filtering means by spontaneous fall. A predetermined amount of the solid processing agent is housed in a package that is divided and hermetically sealed so that the air permeability between the solid processing agent and the adjacent solid processing agent is blocked. Therefore, moisture resistance is guaranteed unless the package is opened.
【0120】実施態様として、固体処理剤を挟むように
少なくとも二つの包装材料からなる包装体が固体処理剤
の周囲を分離可能なようにお互いの接面で密着もしくは
接着されている構成が考えられる。固体処理剤を挟んだ
各々の包装材料を異なった方向に引っ張ることにより密
着もしくは接着された接面が分離し、固体処理剤が取出
し可能状態となる。As an embodiment, it is conceivable that a package composed of at least two packaging materials sandwiching the solid processing agent is closely adhered or adhered to each other so that the periphery of the solid processing agent can be separated. . By pulling each packaging material sandwiching the solid processing agent in different directions, the closely contacted or adhered contact surfaces are separated, and the solid processing agent can be taken out.
【0121】別の実施態様として、固体処理剤を挟むよ
うに少なくとも二つの包装材料からなる包装体の少なく
とも一方が外力により開封可能となる構成が考えられ
る。ここでいう開封とは包装材料の一部を残した切り込
みもしくは破断である。開封方法としては、開封しない
側の包装体から固体処理剤を介して開封可能な包装体の
方向へ圧縮力を加えることにより強制的に固体処理剤を
押し出す、または開封可能な側の包装体に鋭利な部材で
切り込みを入れることにより固体処理剤を取り出し可能
状態にすることが考えられる。As another embodiment, it is conceivable that at least one of the packages made of at least two packaging materials can be opened by an external force so as to sandwich the solid processing agent. The term "opening" as used herein means a cut or break that leaves a part of the packaging material. As the unsealing method, the solid processing agent is forcibly pushed out by applying a compressive force from the packaging body on the non-opening side through the solid processing agent in the direction of the packaging body that can be opened, or on the packaging body on the openable side. It is considered that the solid processing agent can be taken out by making a cut with a sharp member.
【0122】供給開始信号は処理量の情報を検出するこ
とにより得る。また供給停止信号は所定量の供給が完了
した情報を検出することにより得る。また、処理剤が分
包されていて開封が必要な場合には得た供給開始信号に
基づき分離又は開封するための駆動手段が動作し、供給
停止信号に基づき分離又は開封するための駆動手段が停
止するよう制御できる。The supply start signal is obtained by detecting the processing amount information. The supply stop signal is obtained by detecting the information that the supply of the predetermined amount is completed. Further, when the treatment agent is packaged and needs to be opened, the driving means for separating or opening based on the obtained supply start signal operates, and the driving means for separating or opening based on the supply stop signal is It can be controlled to stop.
【0123】上記固体処理剤の供給手段は感光材料の処
理量情報に応じて一定量の固体処理剤を投入する制御手
段を有することが好ましい。すなわち、本発明の自動現
像機においては各処理槽の成分濃度を一定に保ち、写真
性能を安定化させるために必要である。ハロゲン化銀写
真感光材料の処理量情報とは、処理液で処理されるハロ
ゲン化銀写真感光材料の処理量、あるいは処理されたハ
ロゲン化銀写真感光材料の処理量あるいは処理中のハロ
ゲン化銀写真感光材料の処理量に比例した値であり、処
理液中の処理剤の減少量を間接的あるいは直接的に示
す。感光材料が処理液中に搬入される前、後、あるいは
処理液に浸漬中、いずれのタイミングで検出されても良
い。さらに、処理液中の組成の濃度あるいは濃度変化や
pHや比重等の物理的パラメーターであっても良い。ま
た処理液の乾燥後、外部に出た量でも良い。It is preferable that the means for supplying the solid processing agent has a control means for supplying a fixed amount of the solid processing agent according to information on the processing amount of the photosensitive material. That is, in the automatic processor of the present invention, it is necessary to keep the concentration of components in each processing tank constant and to stabilize the photographic performance. The processing amount information of the silver halide photographic light-sensitive material is the processing amount of the silver halide photographic light-sensitive material processed by the processing liquid, or the processing amount of the processed silver halide photographic light-sensitive material or the silver halide photograph during the processing. It is a value proportional to the processing amount of the light-sensitive material, and indirectly or directly indicates the reduction amount of the processing agent in the processing liquid. It may be detected at any timing before or after the photosensitive material is carried into the processing liquid, or during the immersion in the processing liquid. Further, it may be a physical parameter such as the concentration of the composition in the treatment liquid or a change in the concentration, pH and specific gravity. Further, it may be the amount that has been discharged to the outside after the treatment liquid is dried.
【0124】本発明の固体処理剤を投入する場所は処理
槽中であればよいが、好ましいのは、感光材料を処理す
る処理部と連通し、該処理部との間を処理液が流通して
いる場所であり、更に処理部との間に一定の処理液循環
量があり溶解した成分が処理部に移動する構造が好まし
い。固体処理剤は温調されている処理液中に投入される
ことが好ましい。The solid processing agent of the present invention may be put in a processing tank, but preferably, it is connected to a processing section for processing a light-sensitive material, and a processing solution flows between the processing section and the processing section. It is preferable that the structure is such that the dissolved components move to the processing section because there is a certain amount of processing liquid circulation between the processing section and the processing section. The solid processing agent is preferably added to the temperature-controlled processing liquid.
【0125】一般に自動現像機は温調のため、電気ヒー
ターにより処理液を温調している。一般的方法としては
処理槽と連結した補助タンクに熱交換部を設け、ヒータ
ーを設置しこの補充タンクには処理タンクから液を一定
循環量で送り込み、温度を一定ならしめるようポンプが
配置されている。Generally, since the temperature of the automatic processor is adjusted, the temperature of the processing liquid is adjusted by an electric heater. As a general method, a heat exchange section is provided in an auxiliary tank connected to the processing tank, a heater is installed, and a pump is arranged in this replenishment tank to pump the liquid from the processing tank in a constant circulation amount and to keep the temperature constant. There is.
【0126】そして通常は処理液中に混入したり、結晶
化で生じる結晶異物を取り除く目的でフィルターが配置
され、異物を除去する役割を担っている。[0126] Usually, a filter is arranged for the purpose of removing the crystalline foreign matter that is mixed into the processing liquid or is generated by crystallization, and plays a role of removing the foreign matter.
【0127】この補助タンクの如き、処理部と連通した
場所であって、温調が施された場所に固体処理剤が投入
されるのが最も好ましい方法である。何故なら投入され
た処理剤のうちの不溶成分はフィルター部によって処理
部とは遮断され、固形分が処理部に流れ込み感光材料な
どに付着することは防止でき、固体処理剤の溶解性も非
常に良好となる。The most preferable method is to add the solid processing agent to a place where the temperature is adjusted, such as a place communicating with the processing section such as this auxiliary tank. This is because the insoluble component in the processing agent that has been added is blocked from the processing section by the filter section, and it is possible to prevent solids from flowing into the processing section and adhering to photosensitive materials, etc., and the solubility of the solid processing agent is also very high. It will be good.
【0128】また、処理タンク内に処理部と共に処理剤
投入部を設ける場合には、不溶成部分がフィルム等に直
接接触しないよう遮閉物等の工夫をすることが好まし
い。Further, when the treatment agent input portion is provided in the treatment tank together with the treatment portion, it is preferable to devise a shield or the like so that the insoluble portion does not come into direct contact with the film or the like.
【0129】フィルターや濾過装置などの材質は一般的
な自動現像機に使用されるものは全て本発明では使用で
き、特殊な構造や材料が本発明の効果を左右するもので
はない。As for the material of the filter, the filtering device, etc., all the materials used for general automatic processors can be used in the present invention, and the special structure and material do not influence the effect of the present invention.
【0130】本発明における循環手段により循環される
処理液の巡環回数は、0.5〜2.0回/minが好ま
しく、特に0.8〜2.0回/min、さらに1.0〜
2.0回/minが好ましい。これにより、固体処理剤
の溶解が促進され、また、高濃度液のかたまりの発生を
防止でき、処理された感光材料の濃度ムラの発生を防止
でき、また、処理不十分な感光材料の発生を防止でき
る。ここで循環回数とは循環される液流量を示し、処理
槽中の総液量に相当する液量が流れたときを一回とす
る。The number of cycles of the processing solution circulated by the circulation means in the present invention is preferably 0.5 to 2.0 times / min, particularly 0.8 to 2.0 times / min, and further 1.0 to
2.0 times / min is preferable. As a result, the dissolution of the solid processing agent is promoted, the occurrence of agglomeration of the high-concentration liquid can be prevented, the unevenness of the density of the processed photosensitive material can be prevented, and the generation of an insufficiently processed photosensitive material can be prevented. It can be prevented. Here, the number of circulations indicates the flow rate of the liquid to be circulated, and it is defined as once when the liquid amount corresponding to the total liquid amount in the processing tank flows.
【0131】本発明に用いられる固体処理剤は、補充水
とは別に各々処理槽に添加されるが、該補充水は補水タ
ンクにより供給される。The solid processing agent used in the present invention is added to the processing tank separately from the replenishing water, and the replenishing water is supplied by the replenishing water tank.
【0132】この場合の補水タンクの防黴手段について
説明する。補水タンク中の交換率が落ち、水の滞留時間
が長くなると、水あかが発生し、2〜3週間もすると水
が腐敗して悪臭が生じるという問題がある。また、発生
した水あかがそのまま補充されると写真感光材料や固体
処理剤の表面に付着し、現像槽の場合には、現像ムラ、
定着槽の場合には定着不良を生じ、商品価値を著しく落
としてしまうという大きな問題がある。従って、この水
あかを除去するために定期的に洗浄しなくてはならず非
常に手間がかかってしまう。そこで、本発明に用いられ
る水供給タンクには防黴手段を有する。この防黴手段は
下記群の中から選ばれる少なくとも1つの手段によって
達成できる。
(一群)
1)キレート剤添加手段
2)防黴剤添加手段
3)脱イオン処理手段
4)紫外線照射手段
5)磁気処理手段
6)超音波処理手段
7)電解殺菌手段
8)銀イオン放出手段
9)空気発泡手段
10)活性酸素放出手段
11)多孔質物質との接触による手段
無害な他の菌類を添加し、有害な菌の増殖を防止する手
段
これらの手段を具体的に説明する。この発明で防黴手段
として用いられるキレート剤及び殺菌剤は、公知のもの
を任意に使用できる。The antifungal means of the refill water tank in this case will be described. When the replacement rate in the replenishment tank decreases and the residence time of water becomes long, water stains occur, and the water rots for 2-3 weeks, causing a bad odor. Further, when the generated water scale is replenished as it is, it adheres to the surface of the photographic light-sensitive material or the solid processing agent, and in the case of a developing tank, uneven development,
In the case of a fixing tank, there is a big problem that fixing failure occurs and the commercial value is significantly reduced. Therefore, in order to remove this water stain, it has to be washed regularly, which is very troublesome. Therefore, the water supply tank used in the present invention has an antifungal means. This antifungal means can be achieved by at least one means selected from the following group. (Group) 1) Chelating agent addition means 2) Antifungal agent addition means 3) Deionization treatment means 4) Ultraviolet irradiation means 5) Magnetic treatment means 6) Ultrasonic treatment means 7) Electrolytic sterilization means 8) Silver ion release means 9 ) Air-foaming means 10) Active oxygen releasing means 11) Means by contact with porous material Means for preventing harmful bacteria from growing by adding harmless other fungi. These means will be specifically described. As the chelating agent and bactericidal agent used as the antifungal means in the present invention, known ones can be arbitrarily used.
【0133】キレート剤としては、エチレンジアミンテ
トラ酢酸、ジエチレントリアミンペンタ酢酸、1−ヒド
ロキシエチリデン−1,1−ジホスホン酸、エチレンジ
アミンテトラ(メチレンホスホン酸)、2−ヒドロキシ
−4−スルホフェノール、2−ヒドロキシ−3,5−ジ
スルホフェノールが好ましく、殺菌剤としてはフェノー
ル系化合物、チアゾール系化合物及びベンツトリアゾー
ル系化合物が好ましい。具体的には、1,2−ベンツイ
ソチアゾリン−3−オン、2−メチル−4−イソチアゾ
リン−3−オン、2−オクチル−4−イソチアゾリン−
3−オン、5−クロロ−2−メチル−4−イソチアゾリ
ン−3−オン、o−フェニルフェノールナトリウム、ベ
ンツトリアゾールが好ましい化合物として挙げられる。
これらの化合物は、一括包装してあるのなら、錠剤の形
態をしていることが好ましく、予め分割秤量してある場
合は一回に投入する量を個包装していることが好まし
い。Examples of the chelating agent include ethylenediaminetetraacetic acid, diethylenetriaminepentaacetic acid, 1-hydroxyethylidene-1,1-diphosphonic acid, ethylenediaminetetra (methylenephosphonic acid), 2-hydroxy-4-sulfophenol and 2-hydroxy-3. , 5-disulfophenol is preferable, and as the bactericide, phenol compounds, thiazole compounds and benztriazole compounds are preferable. Specifically, 1,2-benzisothiazolin-3-one, 2-methyl-4-isothiazolin-3-one, 2-octyl-4-isothiazolin-one
3-one, 5-chloro-2-methyl-4-isothiazolin-3-one, sodium o-phenylphenol, and benztriazole are mentioned as preferable compounds.
It is preferable that these compounds are in the form of tablets if they are packaged in a package, and if they are divided and weighed in advance, they are individually packaged in an amount to be added at one time.
【0134】これらを添加する手段は、調薬者が手動で
添加しても良いが、好ましくは固体処理剤供給装置が設
置され、これにより添加すること、さらに好ましくは補
水タンクに検出器が付いていてタンクのある一定量まで
水が補充されると自動で添加することがメンテナンスフ
リーの観点より好ましい。Means for adding these may be added manually by the pharmacist, but it is preferable to install a solid processing agent supply device, and to add by this, and more preferably to add a detector to the rehydration tank. However, it is preferable from the viewpoint of maintenance-free that water is automatically added when water is replenished up to a certain amount in the tank.
【0135】イオン交換樹脂で水を改質する手段は、特
開昭61−131632号公報に記載の手段に基づいて
実施できる。The means for modifying water with an ion exchange resin can be carried out based on the means described in JP-A-61-131632.
【0136】イオン交換樹脂としては公開技報、公技番
号90−473等に記載の公知の各種カチオン交換樹脂
(強酸性カチオン交換樹脂、弱酸性カチオン交換樹脂)
と各種アニオン交換樹脂(強塩基性アニオン交換樹脂)
とがあり、これらを単独または組み合わせて用いること
ができる。通常は強酸性H型カチオン交換樹脂と弱塩基
性OH型アニオン交換樹脂を用いるが好ましい。水補充
タンクにつけても良いし他の場所で水を改良しても良
い。As the ion exchange resin, various publicly known cation exchange resins described in, for example, Kokai Giho, Kogi No. 90-473 (strongly acidic cation exchange resin, weakly acidic cation exchange resin).
And various anion exchange resins (strongly basic anion exchange resins)
And these can be used alone or in combination. Usually, it is preferable to use a strongly acidic H type cation exchange resin and a weakly basic OH type anion exchange resin. It may be attached to the water replenishment tank or the water may be improved elsewhere.
【0137】好ましい強酸性用イオン交換樹脂としては
DIAION SK1B SK102、SE104、S
K106、SK110、SK112、SK116(三菱
化成(株))があり、好ましいOH型強塩基性アニオン
交換樹脂としてはDIAION PA406、PA40
8、PA412、PA416、PA418(三菱化成
(株))がある。Preferred ion exchange resins for strong acid are DIAION SK1B SK102, SE104, S.
K106, SK110, SK112, and SK116 (Mitsubishi Kasei Co., Ltd.), and preferred OH type strongly basic anion exchange resins are DIAION PA406 and PA40.
8, PA412, PA416, PA418 (Mitsubishi Kasei Co., Ltd.).
【0138】紫外線を照射する手段は、特開昭60−2
63939号公報に記載の手段で実施できる。紫外線照
射装置としては、キンダイ・バイオ研究所(本社神戸
市)製が小型で好ましく利用できる。この発明の磁場を
与える手段は特開昭60−263939号公報記載の手
段で実施することができる。また、超音波を与える手段
は特開昭60−263940号公報記載の手段で実施す
ることができる。また、電解を与える手段は特開平3−
22468号公報記載の手段で実施することができる。
更に、銀イオンを放出する手段とは水補充タンクの中に
銀箔を入れるとか銀板を入れておくとか内壁を銀でコー
ティングする手段及び銀イオン放出化合物を入れる手段
がある。The means for irradiating with ultraviolet rays is disclosed in JP-A-60-2.
It can be carried out by the means described in Japanese Patent No. 63939. As the ultraviolet irradiation device, a product manufactured by Kindai Bio Research Institute (headquarters Kobe City) is small and can be preferably used. The means for applying the magnetic field of the present invention can be implemented by the means described in JP-A-60-263939. The means for applying ultrasonic waves can be implemented by the means described in JP-A-60-263940. Further, means for applying electrolysis is disclosed in JP-A-3-
It can be carried out by the means described in Japanese Patent No. 22468.
Further, means for releasing silver ions include means for putting a silver foil or a silver plate in a water replenishing tank, means for coating the inner wall with silver, and means for putting a silver ion releasing compound.
【0139】一方、空気発泡手段は補水タンク中に気泡
を吹き込む非常に簡単な手段でよく、補水タンクの大き
さに合わせて適宜選択される。これらの水あか及び防黴
物の発生を防止する手段はコンパクト化と経済性の点か
ら上記1)、2)、3)、7)、8)がよく、更に好ま
しくは1)、3)、8)が選択される。On the other hand, the air bubbling means may be a very simple means for blowing bubbles into the replenishment tank, and is appropriately selected according to the size of the replenishment tank. From the viewpoints of compactness and economy, the means for preventing the formation of water stains and mildew-proofing materials is preferably the above 1), 2), 3), 7), 8), and more preferably 1), 3), 8 ) Is selected.
【0140】8)の手段の銀イオン放出化合物とは、塩
化銀、臭化銀、沃化銀、酸化銀、硫酸銀、硝酸銀や酢酸
銀、シュウ酸銀、ベヘン酸銀、マレイン酸銀等の有機酸
銀等が具体例として挙げられる。The silver ion-releasing compound of the means 8) is, for example, silver chloride, silver bromide, silver iodide, silver oxide, silver sulfate, silver nitrate or silver acetate, silver oxalate, silver behenate or silver maleate. Specific examples thereof include organic acid silver.
【0141】これら銀化合物は、化学構造として網目構
造を有するSiO2−Na2O系のガラス体を基体構造
成分とするものや、メタン型構造のSiO4四面体とA
lO4四面体が互いに1個ずつの酸素原子を共有した形
の三次元骨格構造を有するゼオライト体に、前記銀化合
物を含有させたものが、本発明においては、好ましく用
いられる。These silver compounds have SiO 2 —Na 2 O type glass bodies having a network structure as a chemical structure as a base structure component, or SiO 4 tetrahedra having a methane type structure and A.
zeolite having a three-dimensional skeleton structure in the form of lO 4 tetrahedra shared oxygen atoms one by one to each other, those obtained by containing the silver compound, in the present invention, is preferably used.
【0142】これら銀化合物や、該化合物を含有するゼ
オライト体やガラス体としては、市販品として入手する
ことができ、例えば、近畿パイプ技研(株)製のバイオ
シュアSG(Bio−Sure SG)、オポファルマ
社製(スイス)のオパージェント錠(Opargent
錠)や(株)シナネンゼオミック製のゼオミック(Ze
omic)等を挙げることができる。These silver compounds and the zeolite bodies and glass bodies containing the compounds can be obtained as commercially available products. For example, bio-sure SG (Bio-Sure SG) manufactured by Kinki Pipe Giken Co., Ltd., Opa Pharma (Switzerland) Opagent Tablets (Opargent
Tablets and Zeomic (Ze manufactured by Sinanen Zeomic Co., Ltd.)
mic) and the like.
【0143】さらに、銀化合物や該化合物を含有するゼ
オライト体やガラス体は、各種形状で用いることができ
る。例えば、粉末状、球状、ペレット状、センイ状やフ
ィルター状とすることができ、あるいはこれらのものを
木綿、羊毛、ポリエステル等の繊維にねり込んで用いる
こともできる。これらの具体例としては、(株)クラレ
製のサニター30(SANITER30)等が挙げられ
る。これらの中でも、フィルター状や、球状のものが本
発明において好ましい態様の1つである。Further, the silver compound and the zeolite body or glass body containing the compound can be used in various shapes. For example, it may be in the form of powder, spheres, pellets, fibers, or filters, or these may be kneaded into fibers such as cotton, wool, polyester, etc. before use. Specific examples thereof include Saniter 30 manufactured by Kuraray Co., Ltd. and the like. Among these, the filter-like and spherical ones are one of the preferable embodiments in the present invention.
【0144】さらにまた、これら銀化合物又は該化合物
を含有するゼオライト体やガラス体は、プラスチックケ
ースやティーバッグ状の水透過性容器に入れて用いるこ
とも、本発明の好ましい態様の1つである。そのほかに
も日板研究所(株)製クリンカ205やパシフィック化
学のラッキングなども好ましく用いることができる。Furthermore, it is also one of the preferred embodiments of the present invention to use the silver compound or the zeolite or glass body containing the silver compound in a water permeable container such as a plastic case or a tea bag. . In addition, Clinker 205 manufactured by Nichiban Kenkyusho Co., Ltd. or racking manufactured by Pacific Chemical Co., Ltd. can be preferably used.
【0145】一方、本発明に用いられる固体処理剤は、
少なくとも1種の糖類及び/又は下記一般式(B)及び
(C)で表される化合物を含有する。固体処理剤中の糖
類の含有量としては総重量の0.5%以上30%未満が
好ましく、特に3%以上20%未満が好ましい。On the other hand, the solid processing agent used in the present invention is
It contains at least one saccharide and / or a compound represented by the following general formulas (B) and (C). The content of saccharides in the solid processing agent is preferably 0.5% or more and less than 30% of the total weight, and particularly preferably 3% or more and less than 20%.
【0146】本発明でいう糖類とは、単糖類とこれが複
数個互いにグリコシド結合した多糖類及びこれらの分解
物とをいう。The saccharides in the present invention refer to monosaccharides, polysaccharides in which a plurality of these are glycosidic-bonded to each other, and degradation products thereof.
【0147】単糖類とは、単一のポリヒドロキシアルデ
ヒド、ポリヒドロキシケトン及びこれらの還元誘導体、
酸化誘導体、デオキシ誘導体、アミノ誘導体、チオ誘導
体など広い範囲の誘導体の総称である。多くの糖は、一
般式CnH2nOnで表されるが、この一般式で表され
る糖骨格から誘導される化合物も含めて、本発明では単
糖類と定義する。これらの単糖類のうちで好ましいもの
は、糖のアルデヒド基及びケトン基を還元して各々第
1、第2アルコール基とした糖アルコールである。The monosaccharide means a single polyhydroxyaldehyde, polyhydroxyketone and their reduced derivatives,
It is a general term for a wide range of derivatives such as oxidized derivatives, deoxy derivatives, amino derivatives, and thio derivatives. Although many sugars are represented by the general formula CnH 2 nOn, they are defined as monosaccharides in the present invention, including compounds derived from the sugar skeleton represented by this general formula. Among these monosaccharides, preferred are sugar alcohols obtained by reducing the aldehyde group and the ketone group of sugar to form primary and secondary alcohol groups, respectively.
【0148】多糖類には、セルロース類、デンプン類、
グリコーゲン類等が含まれ、セルロース類には、水酸基
の一部又は全部がエーテル化されたセルロースエーテル
等の誘導体を含み、デンプン類には加水分解して麦芽糖
に至るまでの種々の分解生成物であるデキストリン糖類
を含む。セルロース類は溶解性の観点からアルカリ金属
塩の形でもかまわない。これら多糖類で好ましく用いら
れるものは、セルロース類とデキストリン類であり、よ
り好ましくはデキストリン類である。The polysaccharides include celluloses, starches,
Glycogen, etc. are included, and celluloses include derivatives such as cellulose ethers in which some or all of the hydroxyl groups are etherified, and starches are various decomposition products until they are hydrolyzed to maltose. Contains certain dextrin sugars. Cellulose may be in the form of an alkali metal salt from the viewpoint of solubility. Of these polysaccharides, those preferably used are celluloses and dextrins, more preferably dextrins.
【0149】単糖類で好ましい化合物としては、
・エリトリット(商品名、三菱化成食品エリスリトー
ル)
・D−ソルビット
・L−ソルビット
・D−マンニット
・L−マンニット
・D−イジット
・L−イジット
・D−タリット
・L−タリット
・ズルシット
・アロズルシット
である。Preferred compounds as monosaccharides are: -Elitrit (trade name, Mitsubishi Kasei Foods erythritol) -D-sorbit-L-sorbit-D-mannite-L-mannite-D-idit-L-idit-D -Talit, L-Talit, Zulsit, Allozulsit.
【0150】多糖類及び糖分解物の具体例として好まし
い化合物を以下に示す。Preferred compounds are shown below as specific examples of the polysaccharides and sugar-decomposed products.
【0151】・α−シクロデキストリン ・β−シクロデキストリン ・γ−シクロデキストリン ・ヒドロキシプロピル−α−シクロデキストリン ・ヒドロキシプロピル−β−シクロデキストリン ・ヒドロキシプロピル−γ−シクロデキストリン ・マルトデキストリン である。Α-cyclodextrin ・ Β-Cyclodextrin ・ Γ-Cyclodextrin ・ Hydroxypropyl-α-cyclodextrin ・ Hydroxypropyl-β-cyclodextrin ・ Hydroxypropyl-γ-cyclodextrin ·Maltodextrin Is.
【0152】また、本発明に用いられるデキストリンの
重量平均分子量は何であっても良いが、好ましくは10
〜1000である。The dextrin used in the present invention may have any weight average molecular weight, but is preferably 10
~ 1000.
【0153】糖類は、広く天然に存在しており、市販品
を簡単に入手できる。又、種々の誘導体についても還
元、酸化あるいは脱水反応などを行うことによって容易
に合成できる。[0153] Saccharides exist widely in nature, and commercial products are easily available. Also, various derivatives can be easily synthesized by performing reduction, oxidation or dehydration reaction.
【0154】市販品として、デンプンの分解物としては
松谷化学工業(株)社製のパインフロー、パインデック
スシリーズ、フードテックス、マックス100、グリス
ターP、TK−16、MPD、H−PDX、スタコデッ
クス、日本油脂(株)社製オイルQシリーズが挙げられ
る。As a commercially available product, a decomposed product of starch is Pine Flow, Paindex series, Foodtex, Max 100, Glister P, TK-16, MPD, H-PDX, Stacodex manufactured by Matsutani Chemical Industry Co., Ltd. , Oil Q series manufactured by Nippon Oil & Fats Co., Ltd.
【0155】次に本発明における一般式(B)で示され
る化合物について具体的に説明をする。Next, the compound represented by formula (B) in the present invention will be specifically described.
【0156】一般式(B)
HO−(A1−O)l1−(A2−O)l2−(A3−
O)l3−H
式中、A1、A2、A3はそれぞれ置換、無置換の直鎖
又は分岐のアルキレン基を表し、これらは同一であって
も異なっていてもよい。General formula (B) HO- (A 1 -O) l 1- (A 2 -O) l 2- (A 3-
O) l in 3 -H formula, A 1, A 2, A 3 is substituted independently represent an unsubstituted straight-chain or branched alkylene group, which may optionally be the same or different.
【0157】また、置換基としては、ヒドロキシ基、カ
ルボキシ基、スルホニル基、アルコキシ基、カルバモイ
ル基、スルファモイル基が挙げられる。好ましく用いら
れるものは、A1、A2、A3がそれぞれ無置換である
ものである。また最も好ましいものとしては、A1、A
2、A3が−CH2CH2−、−CH(CH3)−CH
2−である。Examples of the substituent include a hydroxy group, a carboxy group, a sulfonyl group, an alkoxy group, a carbamoyl group and a sulfamoyl group. Those preferably used are those in which A 1 , A 2 and A 3 are each unsubstituted. Most preferred are A 1 , A
2, A 3 is -CH 2 CH 2 -, - CH (CH 3) -CH
2- .
【0158】l1、l2、l3は、それぞれ0または0
〜500の整数を表す。ただし、l1+l2+l3≧5
である。L 1 , l 2 , and l 3 are 0 or 0, respectively.
Represents an integer of ˜500. However, l 1 + l 2 + l 3 ≧ 5
Is.
【0159】これらのうちで、好ましく用いられるのは
l1、l2、l3のうち少なくとも1つが15以上のも
のであり、さらに好ましく用いられるのは20以上のも
のである。Of these, at least one of l 1 , l 2 and l 3 is preferably used 15 or more, and more preferably 20 or more.
【0160】また、本発明における一般式(B)で示さ
れる化合物が例えば2種類のモノマーA、Bを混ぜて共
重合させた共重合体となる場合は、以下に示される配列
のものも包含される。When the compound represented by the general formula (B) in the present invention is, for example, a copolymer obtained by mixing two kinds of monomers A and B and copolymerizing them, those having the sequences shown below are also included. To be done.
【0161】
−A−B−A−B−A−B−A−B−A−B
−A−A−B−A−B−B−A−A−A−B−A−A−B−B−A−
−A−A−A−A−A−A−B−B−B−B−B−B−A−A−A−A−A−
これらの共重合体となるもののうち、特に好ましい化合
物としては、下記一般式(B−1)で示される。エチレ
ングリコールとプロピレングリコールのブロックポリマ
ー(プルロニック型非イオン)である。-A-B-A-B-A-B-A-B-A-B-A-A-B-A-B-B-B-A-A-B-A-A-B- B-A--A-A-A-A-A-A-B-B-B-B-B-B-A-A-A-A-A- Among these copolymers, especially Preferred compounds are represented by the following general formula (B-1). It is a block polymer of ethylene glycol and propylene glycol (Pluronic type nonionic).
【0162】一般式(B−1)
HO−(CH2CH2−O)l4〔CH(CH3)CH
2−O〕l5−(CH2CH2−O)l6−H
式中、l4、l5、l6は前記一般式(B)中のl1、
l2、l3と同義である。[0162] Formula (B-1) HO- (CH 2 CH 2 -O) l 4 [CH (CH 3) CH
2 -O] l 5 - in (CH 2 CH 2 -O) l 6 -H formula, l 4, l 5, l 6 is l 1 in the foregoing formula (B),
It is synonymous with l 2 and l 3 .
【0163】本発明における一般式(B−1)で示され
る化合物において、総分子量中のエチレンオキシドの含
有率(重量%)は70重量%以上であることが好まし
く、特に好ましくは80重量%以上のものである。In the compound represented by the general formula (B-1) in the present invention, the content (% by weight) of ethylene oxide in the total molecular weight is preferably 70% by weight or more, particularly preferably 80% by weight or more. It is a thing.
【0164】以下に更に一般式(B)及び一般式(B−
1)で表される具体的化合物を以下に示す。The general formula (B) and the general formula (B-
Specific compounds represented by 1) are shown below.
【0165】
HO−(CH2−CH2−O)n′−H 平均分子量
B−1 300
B−2 600
B−3 1000
B−4 1500
B−5 2000
B−6 3000
B−7 4000
B−8 6000
B−9 10000
B−10 15000
B−11 20000
B−12 30000
HO−(CH2CH2−O)a′−〔CH(CH3)−CH2−O〕b′
−(CH2CH2−O)c′−H
総分子中のエチレンオキサイド 平均分子量
の含有率(重量%)
B−1−1 80 8350
B−1−2 80 10800
B−1−3 50 4600
B−1−4 70 6500
B−1−5 80 5000
B−1−6 50 3500
B−1−7 70 7850
B−1−8 50 4150
上記式中、n′は5以上の整数を表し、a′、b′、
c′はl1、l2、l3と同義である。[0165] HO- (CH 2 -CH 2 -O) n'-H -average molecular weight B-1 300 B-2 600 B-3 1000 B-4 1500 B-5 2000 B-6 3000 B-7 4000 B- 8 6000 B-9 10000 B- 10 15000 B-11 20000 B-12 30000 HO- (CH 2 CH 2 -O) a '- [CH (CH 3) -CH 2 -O] b' - (CH 2 CH 2- O) c'-H Content of ethylene oxide average molecular weight in total molecule (% by weight) B-1-1 80 8350 B-1-2 80 10800 B-1-3 50 4600 B-1-4 70 6500 B-1-5 80 5000 B-1-6 50 3500 B-1-7 70 7850 B-1-8 50 4150 In the above formula, n'represents an integer of 5 or more, a ', b',
c'is synonymous with l 1 , l 2 , and l 3 .
【0166】本発明における一般式(B)及び一般式
(B−1)で示される化合物において、最も好ましいも
のはポリエチレングリコール(PEGと称することもあ
る)である。Among the compounds represented by the general formula (B) and the general formula (B-1) in the present invention, the most preferable one is polyethylene glycol (sometimes referred to as PEG).
【0167】また、ポリエチレングリコールの場合は、
平均分子量が2000〜20000の範囲にあるものが
好ましく、特に好ましくは3000〜15000の範囲
のものである。In the case of polyethylene glycol,
Those having an average molecular weight of 2,000 to 20,000 are preferable, and those of 3,000 to 15,000 are particularly preferable.
【0168】ここで本発明における平均分子量とは水酸
基価により算出した分子量である。一般式(B)で表さ
れる化合物は、1種で用いても、2種以上を併用しても
良い。The average molecular weight in the present invention is the molecular weight calculated from the hydroxyl value. The compound represented by the general formula (B) may be used alone or in combination of two or more kinds.
【0169】一般式(C)
R−SxOyM
[式中、Rは脂肪族基、芳香族基又はヘテロ環基、xは
1又は2、yは2〜8の整数、Mはカチオンを示す。]
次に一般式(C)で表される有機硫黄酸化物について説
明する。General formula (C) R-SxOyM [In the formula, R is an aliphatic group, an aromatic group or a heterocyclic group, x is 1 or 2, y is an integer of 2 to 8, and M is a cation. Next, the organic sulfur oxide represented by the general formula (C) will be described.
【0170】本発明に係る固体処理剤は前記一般式
(C)で表される有機酸化物を総重量の0.01%以上
3.0%以下含有する。好ましくは0.1%以上、2.
5%以下、更に好ましくは0.5%以上2.0%以下で
ある。The solid processing composition according to the present invention contains the organic oxide represented by the general formula (C) in an amount of 0.01% to 3.0% of the total weight. Preferably 0.1% or more, 2.
It is 5% or less, more preferably 0.5% or more and 2.0% or less.
【0171】一般式(C)において、Rで表される脂肪
族基としては、アルキル基、アルケニル基、アルキニル
基などがあり、アルキル基としては、例えばメチル、エ
チル、i−プロピル、ブチル、t−ブチル、ペンチル、
シクロペンチル、ヘキシル、シクロヘキシル、オクチ
ル、ドデシル等の各基が挙げられる。これらのアルキル
基は、更にハロゲン原子(例えば塩素、臭素、フッ素
等)、アルコキシ基(例えばメトキシ、エトキシ、1,
1−ジメチルエトキシ、ヘキシルオキシ、ドデシルオキ
シ等)、アリールオキシ基(例えばフェノキシ、ナフチ
ルオキシ)、アリール基(例えばフェニル、ナフチル
等)、アルコキシカルボニル基(例えばメトキシカルボ
ニル、エトキシカルボニル、ブトキシカルボニル、2−
エチルヘキシルカルボニル等)、アリールオキシカルボ
ニル基(例えばフェノキシカルボニル、ナフチルオキシ
カルボニル等)、アルケニル基(例えばビニル、アリル
等)、複素環基(例えば2−ピリジル、3−ピリジル、
4−ピリジル、モルホリル、ピペリジン、ピペラジル、
ピリミジン、ピラゾリン、フリル等)、アルキニル基
(例えばプロパルギル)、アミノ基(例えばアミノ、
N,N−ジメチルアミノ、アニリノ)、シアノ基、スル
ホアミド基(例えばメチルスルホニルアミノ、エチルス
ルホニルアミノ、ブチルスルホニルアミノ、オクチルス
ルホニルアミノ、フェニルスルホニルアミノ等)によっ
て置換されてもよい。In the general formula (C), the aliphatic group represented by R includes an alkyl group, an alkenyl group and an alkynyl group, and examples of the alkyl group include methyl, ethyl, i-propyl, butyl and t. -Butyl, pentyl,
Each group such as cyclopentyl, hexyl, cyclohexyl, octyl, dodecyl and the like can be mentioned. These alkyl groups further include a halogen atom (eg chlorine, bromine, fluorine, etc.), an alkoxy group (eg methoxy, ethoxy, 1,
1-dimethylethoxy, hexyloxy, dodecyloxy, etc.), aryloxy groups (eg, phenoxy, naphthyloxy), aryl groups (eg, phenyl, naphthyl, etc.), alkoxycarbonyl groups (eg, methoxycarbonyl, ethoxycarbonyl, butoxycarbonyl, 2-
Ethylhexylcarbonyl etc.), aryloxycarbonyl group (eg phenoxycarbonyl, naphthyloxycarbonyl etc.), alkenyl group (eg vinyl, allyl etc.), heterocyclic group (eg 2-pyridyl, 3-pyridyl,
4-pyridyl, morpholyl, piperidine, piperazil,
Pyrimidine, pyrazoline, furyl, etc.), alkynyl group (eg propargyl), amino group (eg amino,
It may be substituted with N, N-dimethylamino, anilino), a cyano group, a sulfonamide group (eg, methylsulfonylamino, ethylsulfonylamino, butylsulfonylamino, octylsulfonylamino, phenylsulfonylamino, etc.).
【0172】アルケニル基としては、例えばビニル、ア
リル等が挙げられ、アルキニル基としては例えばプロパ
ルギルが挙げられる。Examples of the alkenyl group include vinyl and allyl, and examples of the alkynyl group include propargyl.
【0173】Rで表される芳香族基としては、例えばフ
ェニル、ナフチル等が挙げられる。Examples of the aromatic group represented by R include phenyl and naphthyl.
【0174】Rで表される複素環基としては、例えばピ
リジル基(2−ピリジル、3−ピリジル、4−ピリジル
等)、チアゾリル基、オキサゾリル基、イミダゾリル
基、フリル基、チェニル基、ピロリル基、ピラジニル
基、ピリミジニル基、ピリダジニル基、セレナゾリル
基、スルホラニル基、ピペジリニル基、ピラゾリル基、
テトラゾリル基等が挙げられる。Examples of the heterocyclic group represented by R include a pyridyl group (2-pyridyl, 3-pyridyl, 4-pyridyl, etc.), a thiazolyl group, an oxazolyl group, an imidazolyl group, a furyl group, a cenyl group, a pyrrolyl group, Pyrazinyl group, pyrimidinyl group, pyridazinyl group, selenazolyl group, sulforanyl group, piperidinyl group, pyrazolyl group,
Examples thereof include a tetrazolyl group.
【0175】上記、アルケニル基、アルキニル基、芳香
族基、複素環基は、いずれもRで表されるアルキル基及
びアルキル基の置換基として示した基と同様な基によっ
て置換することができる。The above alkenyl group, alkynyl group, aromatic group and heterocyclic group can be substituted with the same groups as the alkyl group represented by R and the groups shown as the substituents of the alkyl group.
【0176】Mで表される基は、好ましくは金属イオン
又は有機カチオンである。金属イオンとしては、例えば
リチウムイオン、ナトリウムイオン、カリウムイオン等
が挙げられ、有機カチオンとしては、例えばアンモニウ
ムイオン(アンモニウム、テトラメチルアンモニウム、
テトラブチルアンモニウム等)、ホスホニウムイオン
(テトラフェニルホスホニウム)、グアニジル等が挙げ
られる。The group represented by M is preferably a metal ion or an organic cation. Examples of the metal ion include lithium ion, sodium ion, potassium ion and the like, and examples of the organic cation include ammonium ion (ammonium, tetramethylammonium,
Tetrabutylammonium, etc.), phosphonium ion (tetraphenylphosphonium), guanidyl and the like.
【0177】一般式(C)で表される化合物は、本発明
の糖類及び/又は一般式(B)で表される化合物を含有
する固体処理剤を圧縮成形により、錠剤状にする際に含
有させることで滑沢性及び錠剤の硬度、摩損度を飛躍的
に改良することがわかった。The compound represented by the general formula (C) is contained when the solid processing agent containing the saccharide of the present invention and / or the compound represented by the general formula (B) is formed into tablets by compression molding. It was found that by doing so, lubricity, tablet hardness, and friability were dramatically improved.
【0178】以下に一般式(C)で表される化合物の具
体例を挙げるが、本発明はこれらに限定されるものでは
ない。Specific examples of the compound represented by formula (C) are shown below, but the invention is not limited thereto.
【0179】C−1 C2H5SO3Na C−2 CH3(CH2)6SO3Na C−3 CH3(CH2)7SO3Na C−4 CH3(CH2)5OSO3Na C−5 CH3(CH2)6OSO3Na C−6 CH3(CH2)7OSO3Na C−7 CH3O(CH2)2SO3Na[0179] C-1 C 2 H 5 SO 3 Na C-2 CH 3 (CH 2) 6 SO 3 Na C-3 CH 3 (CH 2) 7 SO 3 Na C-4 CH 3 (CH 2) 5 OSO 3 Na C-5 CH 3 ( CH 2) 6 OSO 3 Na C-6 CH 3 (CH 2) 7 OSO 3 Na C-7 CH 3 O (CH 2) 2 SO 3 Na
【0180】[0180]
【化16】 [Chemical 16]
【0181】[0181]
実施例1
<塗布試料の作成>
《感光材料の調製》下記のようにして種乳剤−1を調製
した。
A1
オセインゼラチン 24.2g
水 9657ml
S−3(10%エタノール水溶液) 6.78ml
臭化カリウム 10.8g
10%硝酸 114ml
B1
2.5N 硝酸銀水溶液 2825ml
C1
臭化カリウム 841g
水で 2825ml
D1
1.75N 臭化カリウム水溶液 下記銀電位制御量Example 1 <Preparation of coated sample><< Preparation of photosensitive material >> Seed emulsion-1 was prepared as follows. A1 ossein gelatin 24.2 g water 9657 ml S-3 (10% ethanol aqueous solution) 6.78 ml potassium bromide 10.8 g 10% nitric acid 114 ml B1 2.5N silver nitrate aqueous solution 2825 ml C1 potassium bromide 841 g water 2825 ml D1 1.75N Potassium bromide aqueous solution Silver potential control amount below
【0182】42℃で特公昭58−58288号、同5
8−58289号に示される混合攪拌機を用いて溶液A
1に溶液B1及び溶液C1の各々464.3mlを同時
混合法により1.5分を要して添加し、核形成を行っ
た。No. 58-58288 and 5 at 42 ° C.
Solution A using the mixing stirrer shown in No. 8-58289.
464.3 ml of each of solution B1 and solution C1 was added to 1 by the simultaneous mixing method over 1.5 minutes to perform nucleation.
【0183】溶液B1及び溶液C1の添加を停止した
後、60分の時間を要して溶液A1の温度を60℃に上
昇させ、3%KOHでpHを5.0に合わせた後、再び
溶液B1と溶液C1を同時混合法により、各々55.4
ml/minの流量で42分間添加した。この42℃か
ら60℃への昇温及び溶液B1、C1による再同時混合
の間の銀電位(飽和銀−塩化銀電極を比較電極として銀
イオン選択電極で測定)を溶液D1を用いてそれぞれ+
8mv及び+16mvになるように制御した。After stopping the addition of solution B1 and solution C1, it took 60 minutes to raise the temperature of solution A1 to 60 ° C., adjust the pH to 5.0 with 3% KOH, and then re-solution. B1 and solution C1 were each mixed by the simultaneous mixing method at 55.4.
It was added at a flow rate of ml / min for 42 minutes. The silver potential (measured with a silver ion selective electrode using a saturated silver-silver chloride electrode as a reference electrode) during the temperature increase from 42 ° C. to 60 ° C. and the re-simultaneous mixing with the solutions B1 and C1 was made + using the solution D1.
It was controlled to be 8 mv and +16 mv.
【0184】添加終了後3%KOHによってpHを6に
合わせ直ちに脱塩、水洗を行った。この種乳剤はハロゲ
ン化銀粒子の全投影面積の90%以上が最大隣接辺比が
1.0〜2.0の六角平板粒子よりなり、六角平板粒子
の平均厚さは0.064μm、平均直径(円直径換算)
は0.595μmであることを電子顕微鏡にて確認し
た。又、厚さの変動係数は40%、双晶面間距離の変動
係数は42%であった。After completion of the addition, the pH was adjusted to 6 with 3% KOH, and desalting and washing with water were immediately performed. In this seed emulsion, 90% or more of the total projected area of silver halide grains is composed of hexagonal tabular grains having a maximum adjacent side ratio of 1.0 to 2.0. The hexagonal tabular grains have an average thickness of 0.064 μm and an average diameter. (Circle diameter conversion)
Was confirmed to be 0.595 μm with an electron microscope. The variation coefficient of thickness was 40%, and the variation coefficient of distance between twin planes was 42%.
【0185】〈Em−1〜Em−4の調製〉種乳剤−1
と以下に示す4種の溶液を用い、平板状ハロゲン化銀乳
剤Em−1を調製した。
A2
オセインゼラチン 34.03g
S−3(10%エタノール水溶液) 2.25ml
種乳剤−1 1.218モル相当
水で 3150mlに仕上げる。
B2
臭化カリウム 1734g
水で 3644mlに仕上げる。
C2
硝酸銀 2478g
水で 4165mlに仕上げる。
D2
3重量%のゼラチンと、沃化銀粒子(平均粒径0.05μm)から成る微粒子
乳剤(*) 0.080モル相当
* 0.06モルの沃化カリウムを含む5.0重量%のゼラチン水溶液6.6
4リットルに、7.06モルの硝酸銀と、7.06モルの沃化カリウムを含む水
溶液それぞれ2リットルを、10分間かけて添加した。微粒子形成中のpHは硝
酸を用いて2.0に、温度は40℃の制御した。粒子形成後に、炭酸ナトリウム
水溶液を用いてpHを6.0に調製した。<Preparation of Em-1 to Em-4> Seed emulsion-1
A tabular silver halide emulsion Em-1 was prepared using the following four solutions. A2 ossein gelatin 34.03 g S-3 (10% ethanol aqueous solution) 2.25 ml seed emulsion-1 1.218 mol equivalent Water is made up to 3150 ml. B2 Potassium bromide 1734 g Make up to 3644 ml with water. C2 Silver nitrate 2478 g Water to make 4165 ml. D2 Fine grain emulsion composed of 3% by weight of gelatin and silver iodide grains (average particle size: 0.05 μm) (equivalent to 0.080 mol) * 5.0% by weight of gelatin containing 0.06 mol of potassium iodide To 66.4 liters of the aqueous solution, 2 liters each of an aqueous solution containing 7.06 mol of silver nitrate and 7.06 mol of potassium iodide were added over 10 minutes. The pH during fine particle formation was controlled to 2.0 using nitric acid, and the temperature was controlled to 40 ° C. After forming the particles, the pH was adjusted to 6.0 using an aqueous sodium carbonate solution.
【0186】反応容器内で溶液A2を60℃に保ちなが
ら激しく攪拌し、そこに溶液B2の一部と溶液C2の一
部及び溶液D2の半量を5分かけて同時混合法にて添加
し、その後引き続き溶液B2と溶液C2の残量の半分量
を37分かけて添加し、また引き続き溶液B2の一部と
溶液C2の一部及び溶液D2の残りの全量を15分かけ
て添加し、最後に溶液B2と溶液C2の残り全量を33
分かけて添加した。この間pHは5.8に、pAgは
8.8に終始保った。ここで、溶液B2と溶液C2の添
加速度は臨界成長速度に見合った時間に対して関数様に
変化させた。Solution A2 was vigorously stirred in the reaction vessel while maintaining it at 60 ° C., and part of solution B2, part of solution C2 and half of solution D2 were added thereto by the simultaneous mixing method over 5 minutes, After that, half of the remaining amount of the solution B2 and the solution C2 was added over 37 minutes, and then a part of the solution B2, a part of the solution C2 and the remaining whole amount of the solution D2 were added over 15 minutes. Solution B2 and solution C2 with the remaining total amount of 33
Added over minutes. During this period, the pH was kept at 5.8 and the pAg was kept at 8.8 throughout. Here, the addition rates of the solution B2 and the solution C2 were changed in a function-like manner with respect to the time corresponding to the critical growth rate.
【0187】更に、上記溶液D2を全銀量に0.15モ
ル%相当添加してハロゲン置換を行った。Further, the above solution D2 was added in an amount corresponding to 0.15 mol% of the total amount of silver for halogen substitution.
【0188】添加終了後、この乳剤を40℃に冷却し、
凝集高分子としてフェニルカルバモイル基で変性された
(置換率90%)変性ゼラチン13.8%(重量)水溶
液1800mlを添加し、3分間撹拌した。その後、酢
酸56%(重量)水溶液を添加して、乳剤のpHを4.
6に調整し、3分間撹拌した後、20分間静置させ、デ
カンテーションにより上澄み液を排水した。その後、4
0℃の蒸留水9.0リットルを加え、撹拌静置後上澄み
液を排水し、更に蒸留水11.25リットルを加え、撹
拌静置後、上澄み液を排水した。続いて、ゼラチン水溶
液と炭酸ナトリウム10%(重量)水溶液を加え、pH
が5.80に成るように調整し、50℃で30分間撹拌
し、再分散した。再分散後40℃にてpHを5.8、p
Agを8.06に調整した。After the addition is complete, the emulsion is cooled to 40.degree.
1800 ml of a 13.8% (weight) modified gelatin aqueous solution modified with a phenylcarbamoyl group (substitution rate 90%) was added as an aggregating polymer, and the mixture was stirred for 3 minutes. Thereafter, a 56% (weight) aqueous acetic acid solution was added to adjust the pH of the emulsion to 4.
After adjusting to 6, the mixture was stirred for 3 minutes, allowed to stand for 20 minutes, and the supernatant was drained by decantation. Then 4
Distilled water (9.0 liters) at 0 ° C was added, and the mixture was left to stir, and the supernatant was drained. Further, 11.25 liters of distilled water was added, and the mixture was left standing to stir, and then the supernatant was drained. Subsequently, a gelatin aqueous solution and a 10% (weight) aqueous solution of sodium carbonate were added to adjust the pH.
Was adjusted to 5.80, stirred at 50 ° C. for 30 minutes and redispersed. After redispersion, the pH was adjusted to 5.8 at 40 ° C, p
Ag was adjusted to 8.06.
【0189】得られたハロゲン化銀乳剤を電子顕微鏡観
察したところ、平均粒径1.11μm、平均厚さ0.2
5μm、平均アスペクト比約4.5、粒径分布の広さが
18.1%での平板状ハロゲン化銀粒子であった。又、
双晶面間距離の平均は0.020μmであり、双晶面間
距離と厚さの比が5以上の粒子が全平板状ハロゲン化銀
粒子の97%(個数)、10以上の粒子が49%、15
以上の粒子が17%を占めていた。又、AgNO3、K
Br量、沃化カリウム量、pH、pAgを変更し、Em
−1と同様に粒子調製を行い、表1記載の如く、アスペ
クト比、AgI含有量の異なるEm−2、Em−3、E
m−4のハロゲン化銀乳剤を調製した。When the obtained silver halide emulsion was observed with an electron microscope, the average grain size was 1.11 μm and the average thickness was 0.2.
The tabular silver halide grains had an average aspect ratio of about 4.5 and a width of grain size distribution of 18.1%. or,
The average distance between twin planes is 0.020 μm and 97% (number) of all tabular silver halide grains have a ratio of distance between twin planes to 5 or more and 49 or more are 49 or more. %, 15
The above particles accounted for 17%. Also, AgNO 3 , K
Br, potassium iodide, pH and pAg are changed to
The particles were prepared in the same manner as in -1, and as shown in Table 1, Em-2, Em-3, E having different aspect ratios and AgI contents were used.
An m-4 silver halide emulsion was prepared.
【0190】次に上記の乳剤Em−1〜Em−4各々を
60℃にした後に、分光増感色素の所定量を、固体微粒
子状の分散物として添加した10分後に、アデニン、チ
オシアン酸アンモニウム、塩化金酸及びチオ硫酸ナトリ
ウムの混合水溶液及びトリフェニルフォスフィンセレナ
イドの分散物液を加え、更に30分後に沃化銀微粒子乳
剤を加え、総計2時間の熟成を施した。熟成終了時に安
定剤として4−ヒドロキシ−6−メチル−1,3,3
a,7−テトラザインデン(TAI)の所定量を添加し
た。Next, after each of the above-mentioned emulsions Em-1 to Em-4 was heated to 60 ° C., 10 minutes after adding a predetermined amount of the spectral sensitizing dye as a solid fine particle dispersion, adenine and ammonium thiocyanate were added. , A mixed aqueous solution of chloroauric acid and sodium thiosulfate, and a dispersion liquid of triphenylphosphine selenide were added, and after 30 minutes, a silver iodide fine grain emulsion was added, and ripening was performed for a total of 2 hours. 4-hydroxy-6-methyl-1,3,3 as a stabilizer at the end of aging
A predetermined amount of a, 7-tetrazaindene (TAI) was added.
【0191】尚、上記の添加剤とその添加量(AgX1
モル当り)を下記に示す。
5,5´−ジクロロ−9−エチル−3,3´−ジ−(スルホプロピル)−オキ
サカルボシアニンナトリウム塩無水物 400mg
5,5´−ジ−(ブトキシカルボニル)−1,1´−ジエチル−3,3´−ジ
(4−スルホブチル)ベンゾイミダゾロカルボシアニン−ナトリウム塩無水物
4.0mg
アデニン 15mg
チオシアン酸カリウム 95mg
塩化金酸 2.5mg
チオ硫酸ナトリウム 2.0mg
トリフェニルフォスフィンセレナイド 0.2mg
沃化銀微粒子 280mg
4−ヒドロキシ−6−メチル−1,3,3a,7−テトラザインデン(TAI
) 500mgThe above additives and their addition amounts (AgX1
(Per mole) is shown below. 5,5'-Dichloro-9-ethyl-3,3'-di- (sulfopropyl) -oxacarbocyanine sodium salt anhydrous 400 mg 5,5'-di- (butoxycarbonyl) -1,1'-diethyl- 3,3'-di (4-sulfobutyl) benzimidazolocarbocyanine-sodium salt anhydride 4.0 mg adenine 15 mg potassium thiocyanate 95 mg chloroauric acid 2.5 mg sodium thiosulfate 2.0 mg triphenylphosphine selenide 0. 2 mg Silver iodide fine particles 280 mg 4-Hydroxy-6-methyl-1,3,3a, 7-tetrazaindene (TAI) 500 mg
【0192】分光増感色素の固体微粒子状分散物は特願
平4−99437号記載の方法に準じた方法によって調
製した。即ち上記分光増感色素の所定量を予め27℃に
調温した水に加え、高速攪拌(ディゾルバー)で3,5
00rpmにて30〜120分間にわたって攪拌するこ
とによって得た。A solid fine particle dispersion of a spectral sensitizing dye was prepared by a method according to the method described in Japanese Patent Application No. 4-99437. That is, a predetermined amount of the above-mentioned spectral sensitizing dye is added to water whose temperature has been adjusted to 27 ° C. in advance, and the mixture is stirred at a high speed (dissolver) for 3,5
Obtained by stirring at 00 rpm for 30-120 minutes.
【0193】上記セレン増感剤の分散液は次のように調
製した。即ち、トリフェニルフォスフィンセレナイド1
20gを50℃の酢酸エチル30kg中に添加し、撹拌
し完全に溶解した。他方で写真用ゼラチン3.8kgを
純水38kgに溶解し、これにドデシルベンゼンスルフ
ォン酸ナトリウム25wt%水溶液93gを添加した。
次いでこれらの2液を混合して直径10cmのディゾル
バーを有する高速攪拌型分散機により50℃下において
分散翼周速40m/秒で30分間分散を行った。その後
速やかに減圧下で、酢酸エチルの残留濃度が0.3wt
%以下になるまで撹拌を行いつつ、酢酸エチルを除去し
た。その後、この分散液を純水で希釈して80kgに仕
上げた。このようにして得られた分散液の一部を分取し
て上記実験に使用した。A dispersion liquid of the above selenium sensitizer was prepared as follows. That is, triphenylphosphine selenide 1
20 g was added to 30 kg of ethyl acetate at 50 ° C., and the mixture was stirred and completely dissolved. On the other hand, 3.8 kg of photographic gelatin was dissolved in 38 kg of pure water, and 93 g of a 25 wt% aqueous solution of sodium dodecylbenzene sulfonate was added thereto.
Next, these two liquids were mixed and dispersed at a peripheral speed of the dispersing blade of 40 m / sec for 30 minutes at 50 ° C. by a high-speed stirring type disperser having a dissolver having a diameter of 10 cm. Immediately after that, the residual concentration of ethyl acetate was 0.3 wt.
Ethyl acetate was removed while stirring until the amount became less than or equal to%. Then, this dispersion was diluted with pure water to obtain 80 kg. A part of the thus obtained dispersion was collected and used in the above experiment.
【0194】(乳剤層塗布液の調製)上記で得た乳剤に
下記の各種添加剤を加えた。(Preparation of Coating Solution for Emulsion Layer) The following various additives were added to the emulsion obtained above.
【0195】
化合物(G) 0.5mg/m2
2,6−ビス(ヒドロキシアミノ)−4−ジエチルアミノ−1,3,5−トリ
アジン 5mg/m2
1,1−ジメチロール−1−ブロム−1−ニトロメタン 70mg
t−ブチル−カテコール 130mg/m2
ポリビニルピロリドン(分子量10,000) 35mg/m2
スチレン−無水マレイン酸共重合体 80mg/m2
ポリスチレンスルホン酸ナトリウム 80mg/m2
トリメチロールプロパン 350mg/m2
ジエチレングリコール 50mg/m2
ニトロフェニル−トリフェニル−ホスホニウムクロリド 20mg/m2
1,3−ジヒドロキシベンゼン−4−スルホン酸アンモニウム
500mg/m2
2−メルカプトベンツイミダゾール−5−スルホン酸ナトリウム
5mg/m2
化合物(H) 0.5mg/m2
n−C4H9OCH2CH(OH)CH2N(CH2COOH)2
350mg/m2
一般式(1) 表1記載量
一般式(2) 表1記載量
コロイダルシリカ(ルドックスAM:デュポン社製粒径0.013μm)
0.5g/m2
但し、ゼラチンとしては乳剤を混合して1.5g/m2
になるように調整した。Compound (G) 0.5 mg / m 2 2,6-bis (hydroxyamino) -4-diethylamino-1,3,5-triazine 5 mg / m 2 1,1-dimethylol-1-bromo-1- Nitromethane 70 mg t-Butyl-catechol 130 mg / m 2 Polyvinylpyrrolidone (molecular weight 10,000) 35 mg / m 2 Styrene-maleic anhydride copolymer 80 mg / m 2 Sodium polystyrene sulfonate 80 mg / m 2 Trimethylolpropane 350 mg / m 2 Diethylene glycol 50 mg / m 2 Nitrophenyl-triphenyl-phosphonium chloride 20 mg / m 2 1,3-Dihydroxybenzene-4-sulfonate ammonium 500 mg / m 2 2-Mercaptobenzimidazole-5-sulfonate sodium 5 mg / m 2 compound (H) 0.5 mg / m 2 n-C 4 H 9 OCH 2 CH (OH) CH 2 N (CH 2 COOH) 2 350 mg / m 2 General formula (1) Table 1 amount described General formula (2) Amount shown in Table 1 Colloidal silica (Ludox AM: particle size 0.013 μm manufactured by DuPont) 0.5 g / m 2 However, as gelatin, 1.5 g / m 2 by mixing an emulsion.
I adjusted it to be.
【0196】
(保護層塗布液の調製)
ゼラチン 0.8g/m2
ポリメチルメタクリレートからなりマット剤(面積平均粒径7.0μm)
50mg/m2
硬膜剤(CH2=CHSO2CH2)2O 36mg/m2
2,4−ジクロロ−6−ヒドロキシ−1,3,5−トリアジンナトリウム塩
10mg/m2
ラテックス(L) 0.2g/m2
ポリアクリルアミド(平均分子量10000) 0.2g/m2
ポリアクリル酸ナトリウム 30mg/m2
ポリシロキサン(SI) 20mg/m2
化合物(I) 12mg/m2
化合物(J) 2mg/m2
化合物(S−1) 7mg/m2
化合物(K) 15mg/m2
化合物(O) 50mg/m2
化合物(S−2) 5mg/m2
化合物(F−1) 3mg/m2
化合物(F−2) 2mg/m2
化合物(F−3) 1mg/m2
一般式(1)、一般式(2)の化合物 表1記載量
なお、素材の付量は片面1m2当たりであり、塗布銀量
は片面分として1.6g/m2になるように調整した。(Preparation of Protective Layer Coating Liquid) Gelatin 0.8 g / m 2 Polymethylmethacrylate Matting Agent (Area Average Particle Diameter 7.0 μm) 50 mg / m 2 Hardener (CH 2 = CHSO 2 CH 2 ) 2 O 36 mg / m 2 2,4-dichloro-6-hydroxy-1,3,5-triazine sodium salt 10 mg / m 2 latex (L) 0.2 g / m 2 polyacrylamide (average molecular weight 10000) 0.2 g / m 2 sodium polyacrylate 30 mg / m 2 polysiloxane (SI) 20 mg / m 2 compound (I) 12 mg / m 2 compound (J) 2 mg / m 2 compound (S-1) 7 mg / m 2 compound (K) 15 mg / m 2 compound (O) 50 mg / m 2 compound (S-2) 5mg / m 2 compound (F-1) 3mg / m 2 compound (F-2) 2mg m 2 Compound (F-3) 1 mg / m 2 Formula (1), compounds shown in Table 1 of the general formula (2) In addition, the amount with the material is one-sided 1 m 2 per silver coverage as one side component It was adjusted to be 1.6 g / m 2 .
【0197】(クロスオーバーカット層の作成)グリシ
ジルメタクリレート50wt%、メトリアクリレート1
0wt%、ブチルメタクリレート40wt%、の3種の
モノマーからなる共重合体の濃度が10wt%になるよ
うに希釈して得た共重合体分散液を下引液として塗布し
た厚さ175μm青色着色したポリエチレンテレフタレ
ート支持体の両面に、片面1m2当たりの塗布量が下記
組成になるようにクロスオーバーカット層を塗布した支
持体試料を作成した。(Creation of Crossover Cut Layer) Glycidyl Methacrylate 50 wt%, Metriacrylate 1
Copolymer dispersion obtained by diluting the copolymer consisting of three monomers of 0 wt% and 40 wt% of butyl methacrylate so as to have a concentration of 10 wt% was applied as an undercoat liquid to give a blue color with a thickness of 175 μm. A support sample was prepared by coating a crossover cut layer on both sides of a polyethylene terephthalate support such that the coating amount per 1 m 2 on one side was the following composition.
【0198】 固体微粒子分散体染料(AH) 50mg ゼラチン 0.2g ドデシルベンゼンスルホン酸ナトリウム 5mg 化合物(I) 5mg 2,4−ジクロロ−6−ヒドロキシ−1,3,5−トリアジンナトリウム塩 5mg コロイダルシリカ(平均粒径0.014μm) 10mg ポリスチレンスルホン酸カリウム 50mg[0198] Solid fine particle dispersion dye (AH) 50 mg Gelatin 0.2g Sodium dodecylbenzene sulfonate 5mg Compound (I) 5 mg 2,4-Dichloro-6-hydroxy-1,3,5-triazine sodium salt 5 mg Colloidal silica (average particle size 0.014 μm) 10 mg Polystyrene potassium sulfonate 50mg
【0199】[0199]
【化17】 [Chemical 17]
【0200】[0200]
【化18】 [Chemical 18]
【0201】[0201]
【化19】 [Chemical 19]
【0202】(塗布)これらの塗布液を用いて、塗布量
が片面当たり銀量が1.6g/m2、ゼラチン付量は
2.5g/m2となるように2台のスライドホッパー型
コーターを用い、毎分120Mのスピードで上記支持体
試料上に以下の層構成で両面同時塗布を行い2分20秒
で乾燥し、塗布試料を作成した。(Coating) Using these coating solutions, two slide hopper type coaters were used so that the coating amount was 1.6 g / m 2 on one side and the coating amount on gelatin was 2.5 g / m 2. Was simultaneously coated on both surfaces of the above-mentioned support sample at the speed of 120 M per minute with the following layer structure and dried for 2 minutes and 20 seconds to prepare a coated sample.
【0203】 層の位置 層の種類 片面当たりのゼラチン量(g/m2) 上層 保護層 0.8 中間層 乳剤層 1.5 下層 フィルター層 0.2Layer position Layer type Gelatin amount per one side (g / m 2 ) Upper layer Protective layer 0.8 Intermediate layer Emulsion layer 1.5 Lower layer Filter layer 0.2
【0204】 〈単分散立方晶種乳剤Em−Bの調製〉 <溶液A> オセインゼラチン 30g KBr 1.25g 硝酸(0.1N) 150ml 蒸留水で7700mlとする[0204] <Preparation of monodisperse cubic seed emulsion Em-B> <Solution A> Ocein gelatin 30g KBr 1.25g Nitric acid (0.1N) 150 ml Make up to 7700 ml with distilled water
【0205】 <溶液B> KBr 6g KI 0.16g 蒸留水で740mlとする[0205] <Solution B> KBr 6g KI 0.16g Make up to 740 ml with distilled water
【0206】 <溶液C> KBr 680g KI 20g 蒸留水で2480mlとする[0206] <Solution C> KBr 680g KI 20g Make up to 2480 ml with distilled water
【0207】 <溶液D> 硝酸銀 8.4g 硝酸(0.1N) 32ml 蒸留水で740mlとする[0207] <Solution D> Silver nitrate 8.4g Nitric acid (0.1N) 32 ml Make up to 740 ml with distilled water
【0208】 <溶液E> 硝酸銀 991.6g 硝酸(0.1N) 80ml 蒸留水で2480mlとする[0208] <Solution E> Silver nitrate 991.6g Nitric acid (0.1N) 80 ml Make up to 2480 ml with distilled water
【0209】60℃で激しく攪拌した溶液Aに、溶液B
と溶液Dをダブルジェット法により10分間かけて添加
した。そして、溶液Cと溶液Eをダブルジェット法によ
り140分間かけて添加した。このとき初期添加流量は
最終添加流量の1/8で、時間とともに直線的に増感せ
しめた。これら液を添加せしめている間は、pH=2、
pAg=8に一定に調製した。添加終了後に炭酸ナトリ
ウムでpHを6まで上げ、KBr 150gを加えた後
に、直ちに脱塩、水洗を行って、平均粒径0.3μmの
沃化銀2モル%を含む沃臭化銀の単分散立方晶種乳剤E
m−Bを得た。電子顕微鏡によれば、双晶の発生率は個
数で1%以下であった。Solution A stirred vigorously at 60 ° C. was added to solution B.
And Solution D were added by the double jet method over 10 minutes. Then, the solution C and the solution E were added by the double jet method over 140 minutes. At this time, the initial addition flow rate was 1/8 of the final addition flow rate, and linear sensitization was performed with time. While adding these solutions, pH = 2,
It was constantly adjusted to pAg = 8. After the addition was completed, the pH was raised to 6 with sodium carbonate, 150 g of KBr was added, and then desalting and washing with water were carried out immediately to obtain a monodispersion of silver iodobromide containing 2 mol% of silver iodide having an average particle size of 0.3 μm. Cubic seed emulsion E
m-B was obtained. According to an electron microscope, the generation rate of twins was 1% or less in number.
【0210】(正常晶コア/シェル乳剤Em−5の調
製)以下の5種類の溶液を用いて2.0モル%AgIを
含有する正常晶乳剤Em−5を作成した。
<溶液A>
オセインゼラチン 75.5g
HO−(CH2CH2O)n−〔CH(CH3)CH2O〕
−(CH2CH2O)mH (n+m=5.7)
10%メタノール水溶液 15ml
種乳剤Em−B 0.40モル相当
蒸留水で4000mlとする(Preparation of Normal Crystal Core / Shell Emulsion Em-5) A normal crystal emulsion Em-5 containing 2.0 mol% AgI was prepared using the following 5 kinds of solutions. <Solution A> ossein gelatin 75.5g HO- (CH 2 CH 2 O ) n- [CH (CH 3) CH 2 O] - (CH 2 CH 2 O) mH (n + m = 5.7) 10% methanol Aqueous solution 15 ml Seed emulsion Em-B equivalent to 0.40 mol Distilled water to 4000 ml
【0211】 <溶液B> AgNO3 46.2g AgNO3と等モル量のアンモニア溶液と蒸留水を加えて259mlとする<Solution B> AgNO 3 46.2 g AgNO 3 and an equimolar amount of ammonia solution and distilled water are added to make 259 ml.
【0212】 <溶液C> AgNO3 647.6g AgNO3と等モル量のアンモニア溶液と蒸留水を加えて1088mlとする<Solution C> AgNO 3 647.6 g AgNO 3 and an equimolar amount of ammonia solution and distilled water were added to make 1088 ml.
【0213】 <溶液D> KBr 22.6g KI 13.5g 蒸留水で259mlとする[0213] <Solution D> KBr 22.6g KI 13.5g Make up to 259 ml with distilled water
【0214】 <溶液E> KBr 453.3g 蒸留水で1088mlとする[0214] <Solution E> KBr 453.3g Make up to 1088 ml with distilled water
【0215】反応釜内に溶液Aを40℃に保ち、さらに
アンモニア水と酢酸を加えpHを9.5に調製した。ア
ンモニア性銀イオン液にてpAgを7.3に調製後、p
HとpAgを一定に保ちつつ溶液Bと溶液Dをダブルジ
ェット法で添加し、沃化銀30モル%を含む沃臭化銀層
を形成しめした。酢酸とKBrを用いてpHを9.0、
pAgを9.0に調製した後に溶液Cと溶液Eを同時に
添加し成長後、粒径の90%にあたるまで成長させた。
このときのpHは、9.0から8.20まで徐々に下げ
た。KBr液を加え、pAgを11にした後にさらに溶
液Cと溶液Eを加えてpHを徐々に8まで下げながら成
長せしめ、沃下銀2モル%の沃臭化銀乳剤を得た。添加
終了後、過剰な塩類を除去するため下記の方法で沈澱脱
塩を行った。The solution A was kept at 40 ° C. in the reaction vessel, and ammonia water and acetic acid were further added to adjust the pH to 9.5. After adjusting pAg to 7.3 with ammoniacal silver ion solution, p
Solution B and solution D were added by the double jet method while H and pAg were kept constant to form a silver iodobromide layer containing 30 mol% of silver iodide. The pH was adjusted to 9.0 using acetic acid and KBr,
After the pAg was adjusted to 9.0, the solution C and the solution E were added at the same time and grown, and then grown until the particle diameter reached 90%.
At this time, the pH was gradually lowered from 9.0 to 8.20. A KBr solution was added to adjust the pAg to 11, and solutions C and E were further added to grow while gradually lowering the pH to 8 to obtain a silver iodobromide emulsion containing 2 mol% of silver under iodine. After the addition was completed, precipitation desalting was carried out by the following method in order to remove excess salts.
【0216】1.混合終了した反応液を40℃にして、
凝集ゼラチン剤を20g/AgX1モル加え、56wt
%酢酸を加えてpHをおとし、静置し、デカンテーショ
ンを行う。
2.40℃の純水1.8リットル/AgXlモルを加
え、10分間攪拌させた後、静置、デカンテーションを
行う。
3.上記2の工程をもう1回繰り返す。
4.オセインゼラチン92.2gを含むゼラチン水溶液
を加え2500mlとして攪拌再分散しEm−5とし
た。1. The reaction mixture after mixing is brought to 40 ° C.,
Add 20g / AgX1mol of coagulated gelatin agent, 56wt
% Acetic acid is added to adjust the pH, and the mixture is left standing and decanted. After adding 1.8 liter / AgX1 mol of pure water at 2.40 ° C. and stirring for 10 minutes, the mixture is left standing and decanted. 3. Repeat step 2 above once more. 4. An aqueous gelatin solution containing 92.2 g of ossein gelatin was added to 2500 ml with stirring and redispersion to give Em-5.
【0217】Em−5の粒子約1000個を電子顕微鏡
により観察・測定し形状を分析したところ、平均粒子直
径0.51μm、分布の広さが12%の単分散球状粒子
であった。Approximately 1000 particles of Em-5 were observed and measured by an electron microscope and the shape was analyzed. As a result, the particles were monodisperse spherical particles having an average particle diameter of 0.51 μm and a distribution width of 12%.
【0218】次に、得られた乳剤を以下の方法で分光増
感及び化学増感を施した。乳剤を50℃にした後、増感
色素(A)が銀1モル当たり40mgになるように、上
記固体微粒子分散物を加えた後に、下記セレン増感剤
7.0×10−6モル添加し、チオシアン酸アンモニウ
ム塩を銀1モル当たり4.0×10−4モル、及び塩化
金酸3.2×10−6モルとチオ硫酸ナトリウム3.4
×10−5モル添加し、その40分後、上記沃臭化銀微
粒子乳剤を1.7×10−3モル/Ag1モル添加後、
4−ヒドロキシ−6−メチル−1,3,3a,7−テト
ラザインデン(TAI)1.2×10−2モルで安定化
した。Next, the obtained emulsion was spectrally and chemically sensitized by the following methods. After the emulsion was heated to 50 ° C., the solid fine particle dispersion described above was added so that the sensitizing dye (A) was 40 mg per mol of silver, and then 7.0 × 10 −6 mol of the following selenium sensitizer was added. Ammonium thiocyanate salt of 4.0 × 10 −4 mol per mol of silver, 3.2 × 10 −6 mol of chloroauric acid and 3.4 of sodium thiosulfate.
X 10 -5 mol was added, and 40 minutes after that, the above silver iodobromide fine grain emulsion was added with 1.7 x 10 -3 mol / Ag 1 mol, and then
4-Hydroxy-6-methyl-1,3,3a, 7-tetrazaindene (TAI) was stabilized with 1.2 × 10 −2 mol.
【0219】[0219]
【化20】 [Chemical 20]
【0220】(試料の作成)得られたそれぞれの乳剤
に、下記の各種添加剤を加えて乳剤液(感光性ハロゲン
化銀塗布液)とした。添加量はハロゲン化銀1モル当た
りの量で示す。(Preparation of Sample) To each of the obtained emulsions, the following various additives were added to prepare emulsion solutions (photosensitive silver halide coating solutions). The addition amount is indicated by the amount per mol of silver halide.
【0221】 t−ブチル−カテコール 400mg ポリビニルピロリドン(分子量10,000) 1.0g スチレン無水マレイン酸共重合体 2.5g トリメチロールプロパン 10g ジエチレングリコール 5g ニトロフェニル−トリフェニルホスホニウムクロリド 50mg 1,3−ジヒドロキシベンゼン−4−スルホン酸アンモニウム 4g 2−メルカプトベンズインダゾール−5−スルホン酸ナトリウム 1.5mg n−C4H9OCH2CH(OH)CH2N(CH2COOH)2 1gT-butyl-catechol 400 mg polyvinylpyrrolidone (molecular weight 10,000) 1.0 g styrene maleic anhydride copolymer 2.5 g trimethylolpropane 10 g diethylene glycol 5 g nitrophenyl-triphenylphosphonium chloride 50 mg 1,3-dihydroxybenzene sodium-4-sulfonic acid ammonium 4g 2-mercaptobenzimidazole indazole-5-sulfonic acid 1.5mg n-C 4 H 9 OCH 2 CH (OH) CH 2 n (CH 2 COOH) 2 1g
【0222】[0222]
【化21】 [Chemical 21]
【0223】
一般式(1)の化合物 表1記載量
一般式(2)の化合物 表1記載量
また保護層に用いた添加剤は次の通りである。添加量は
ゼラチン1g当たりの量で示す。
保護層用塗布液
面積平均粒径7μmのポリメチルメタクリレートからなるマット剤
7mg
コロイドシリカ(平均粒径0.013μm) 70mg
2,4−ジクロロ−6−ヒドロキシ−1,3,5−トリアジンナトリウム塩
30mgCompound of General Formula (1) Amount Described in Table 1 Compound of General Formula (2) Amount Described in Table 1 The additives used in the protective layer are as follows. The added amount is shown as an amount per 1 g of gelatin. Coating liquid for protective layer Matting agent composed of polymethylmethacrylate having an area average particle size of 7 μm 7 mg Colloidal silica (average particle size 0.013 μm) 70 mg 2,4-Dichloro-6-hydroxy-1,3,5-triazine sodium salt 30 mg
【0224】[0224]
【化22】 [Chemical formula 22]
【0225】
(CH2=CHSO2CH2)2O(硬膜剤) 36mg
一般式(1)の化合物 表1記載量
一般式(2)の化合物 表1記載量
以上の塗布液を、厚さ175μmの下引き処理済のブル
ーに着色したポリエチレンテレフタレートフィルムベー
ス上に乳剤層と保護層1層を両面に均一に塗布、乾燥し
て試料を作成した。尚、ハロゲン化銀乳剤層の銀付量は
片面当たり2.20g/m2とした。(CH 2 = CHSO 2 CH 2 ) 2 O (hardener) 36 mg Compound of general formula (1) Table 1 amount of compound of general formula (2) Compound of table 1 A sample was prepared by uniformly coating an emulsion layer and a protective layer on both sides on a blue-colored polyethylene terephthalate film base having an undercoating treatment of 175 μm and drying the layer. The silver coverage of the silver halide emulsion layer was 2.20 g / m 2 per side.
【0226】以下に本発明に係る現像剤の固形剤及び液
剤を作成した。
<ハイドロキノン現像主薬とする固形現像剤α> 現像
液として100リットル量の調製。The solid agent and liquid agent of the developer according to the present invention are prepared below. <Solid developer α used as hydroquinone developing agent> Preparation of 100 liter amount as a developing solution.
【0227】[造粒物(A)]現像主薬のハイドロキノ
ン3000g、フェニドン400g、ホウ酸1000
g、N−アセチル−D,L−ペニシラミン10g、グル
タルアルデヒド重亜硫酸Na塩500gをそれぞれ市販
のバンダムミル中で、平均10μmになるまで粉砕す
る。この微粉に表1記載のレダクトン類を表1記載量、
亜硫酸ナトリウム700g、結合剤D−ソルビットを2
00gを加えミル中で30分混合して市販の攪拌造粒機
中で室温にて約5分間、30mlの水を添加することに
より造粒した後、造粒物を流動層乾燥機で40℃にて2
時間乾燥して造粒物の水分をほぼ完全に除去する。[Granulated product (A)] 3000 g of hydroquinone as a developing agent, 400 g of phenidone, 1000 of boric acid.
g, N-acetyl-D, L-penicillamine 10 g, and glutaraldehyde sodium bisulfite 500 g are ground in a commercially available bandam mill to an average of 10 μm. The amount of reductones listed in Table 1 in this fine powder,
700 g of sodium sulfite, 2 parts of binder D-sorbit
After adding 00 g and mixing for 30 minutes in a mill and granulating by adding 30 ml of water for about 5 minutes at room temperature in a commercial stirring granulator, the granulated product was dried at 40 ° C. in a fluid bed dryer. At 2
The granules are dried for an hour to almost completely remove water.
【0228】[固形現像剤Aの作成]このようにして得
られた造粒物(A)を1−オクタンスルホン酸ナトリウ
ム100gと25℃、40%RH以下に調湿された部屋
で混合機を用いて10分間均一に混合した後、得られた
混合物を菊水製作所(株)製タフプレストコレクト15
27HUを改造した打錠機により1錠当たり充填量を1
0gにして圧縮打錠を行い、直径30mmの円筒形にな
るようにしてハイドロキノン系現像錠剤を作成した。[Preparation of Solid Developer A] The granulated product (A) thus obtained was mixed with 100 g of sodium 1-octanesulfonate in a room conditioned at 25 ° C. and 40% RH or less. After uniformly mixing for 10 minutes, the resulting mixture is toughly pressed collect 15 manufactured by Kikusui Seisakusho KK
The filling amount per tablet is 1 by the tablet machine modified from 27HU.
The tablets were compressed to 0 g and compressed to give a hydroquinone-based developing tablet having a cylindrical shape with a diameter of 30 mm.
【0229】[造粒物(B)]炭酸カリウム10000
g、重炭酸ナトリウム1000g、KBr200gをそ
れぞれ市販のバンダムミル中で平均10μmになるまで
粉砕する。各々の微粉にLIOH・H20 200g、
DTPA・5H 250g、1−フェニル−5−メルカ
プトテトラゾール5g、亜硫酸ナトリウム4000g、
一般式(1)表1記載量、一般式(2)表2記載量、結
合剤マンニトール1000gを加えミル中で30分混合
して市販の攪拌造粒機中で室温にて約15分間、30m
lの水を添加することにより造粒した後、造粒物を流動
乾燥機で40℃にて2時間乾燥して造粒物の水分をほぼ
完全に除去する。[Granulated product (B)] 10000 potassium carbonate
g, 1000 g of sodium bicarbonate, and 200 g of KBr are ground in a commercially available bandam mill to an average of 10 μm. LIOH to each fine · H 2 0 200g,
DTPA · 5H 250 g, 1-phenyl-5-mercaptotetrazole 5 g, sodium sulfite 4000 g,
General formula (1) The amount described in Table 1 of general formula (2), the amount described in Table 2 of general formula (2), and 1000 g of a binder mannitol were added and mixed in a mill for 30 minutes, and then in a commercially available stirring granulator at room temperature for about 15 minutes at 30 m.
After granulating by adding 1 liter of water, the granulated product is dried at 40 ° C. for 2 hours in a fluid dryer to almost completely remove the water content of the granulated product.
【0230】[固形現像剤Bの作成]このようにして得
られた造粒物(B)を1−オクタンスルホン酸ナトリウ
ム200gと25℃、40%RH以下に調湿された部屋
で混合機を用いて10分間均一に混合した後、得られた
混合物を菊水製作所(株)製タフプレストコレクト15
27HUを改造した打錠機により1錠当たり充填量を1
0gにして圧縮打錠を行いアルカリ現像錠剤を作成し
た。[Preparation of Solid Developer B] The granulated product (B) thus obtained was mixed with 200 g of sodium 1-octanesulfonate in a room conditioned at 25 ° C. and 40% RH or less. After uniformly mixing for 10 minutes, the resulting mixture is toughly pressed collect 15 manufactured by Kikusui Seisakusho KK
The filling amount per tablet is 1 by the tablet machine modified from 27HU.
Alkali developed tablets were prepared by compression compression to 0 g.
【0231】<本発明のレダクトン類を主薬とする固形
現像剤β> 現像液として100l量の調製。
[造粒物(A)]1−フェニル−3−ピラゾリドンを3
00g、N−アセチル−D,L−ペニシラミン10g、
グルタルアルデヒド重亜硫酸ナトリウム500gをそれ
ぞれ市販のバンダムミル中で平均10μmになるまで粉
砕する。この微粉にメタ重亜硫酸ナトリウム1500
g、本発明レダクトン類表1記載量、結合剤D−ソルビ
ット亜600gを加えミル中で30分混合して市販の攪
拌造粒機中で室温にて約10分間、30mlの水を添加
することにより造粒した後、造粒物を流動層乾燥機で4
0℃にて2時間乾燥して造粒物の水分をほぼ完全に除去
する。<Solid developer β containing the reductone of the present invention as a main component> Preparation of 100 l of a developer. [Granulate (A)] 1-phenyl-3-pyrazolidone 3
00 g, N-acetyl-D, L-penicillamine 10 g,
500 g of glutaraldehyde sodium bisulfite is ground in a commercial Van Dam mill to an average of 10 μm. 1500 g of sodium metabisulfite was added to this fine powder.
g, the amount of the reductone of the present invention shown in Table 1 and 600 g of the binder D-sorbitite were added and mixed in a mill for 30 minutes, and 30 ml of water was added in a commercially available stirring granulator at room temperature for about 10 minutes. After granulating with the
The granulated product is dried at 0 ° C. for 2 hours to almost completely remove water.
【0232】[固形現像剤Aの作成]このようにして得
られた造粒物(A)を1−オクタンスルホン酸ナトリウ
ム80gと25℃、40%RH以下に調湿された部屋で
混合機を用いて10分間均一に混合した後、得られた混
合物を菊水製作所(株)製タフプレストコレクト152
7HUを改造した打錠機により1錠当たり充填量を10
gにして圧縮打錠を行いレダクトン類主薬系現像錠剤を
作成した。[Preparation of Solid Developer A] The granulated product (A) thus obtained was mixed with 80 g of sodium 1-octanesulfonate in a room conditioned at 25 ° C. and 40% RH or less. After uniformly mixing for 10 minutes, the obtained mixture is toughly pressed collect 152 manufactured by Kikusui Seisakusho KK
Filling amount per tablet is 10 with a tablet machine modified from 7HU.
Then, the tablet was compressed to g to prepare a reductone-based developing tablet.
【0233】[造粒物(B)]炭酸カリウム9000
g、重炭酸ナトリウム100gをそれぞれ市販のバンダ
ムミル中で平均10μmになるまで粉砕する。各々の微
粉にDTPA・5H 250g、一般式(1)表1記載
量、一般式(2)表1記載量、KI表1記載量、メチル
−β−シクロデキストリン200g、結合剤マンニトー
ル2000g、D−ソルビット700gを加えミル中で
30分混合して市販の攪拌造粒機中で室温にて約15分
間、30mlの水を添加することにより造粒した後、造
粒物を流動乾燥機で40℃にて2時間乾燥して造粒物の
水分をほぼ完全に除去する。[Granulated product (B)] Potassium carbonate 9,000
g and 100 g of sodium bicarbonate are ground in a commercially available bandam mill to an average of 10 μm. 250 g of DTPA · 5H in each fine powder, the amount described in General Formula (1) Table 1, the amount described in General Formula (2) Table 1, KI Table 1, 200 g of methyl-β-cyclodextrin, 2000 g of binder mannitol, D- After 700 g of sorbit was added and mixed in a mill for 30 minutes, and granulated by adding 30 ml of water in a commercially available stirring granulator at room temperature for about 15 minutes, the granulated product was dried at 40 ° C. in a fluidized dryer. And dried for 2 hours to almost completely remove the water content of the granulated product.
【0234】[固形現像剤Bの作成]このようにして得
られた造粒物(B)を1−オクタンスルホン酸ナトリウ
ム150gと25℃、40%RH以下に調湿された部屋
で混合機を用いて10分間均一に混合した後、得られた
混合物を菊水製作所(株)製タフプレストコレクト15
27HUを改造した打錠機により1錠当たり充填量を1
0gにして圧縮打錠を行いアルカリ現像錠剤を作成し
た。[Preparation of Solid Developer B] The granulated product (B) thus obtained was mixed with 150 g of sodium 1-octanesulfonate in a room conditioned at 25 ° C. and 40% RH or less. After uniformly mixing for 10 minutes, the resulting mixture is toughly pressed collect 15 manufactured by Kikusui Seisakusho KK
The filling amount per tablet is 1 by the tablet machine modified from 27HU.
Alkali developed tablets were prepared by compression compression to 0 g.
【0235】ハイドロキノン主薬の現像剤及びレダクト
ン主薬現像剤は現像剤A、B両方とも防湿のためアルミ
を含有させたピロー袋に4.0リットル量ずつ封入包装
した。The developer of hydroquinone base and the developer of reductone base were both packaged in a pillow bag containing aluminum for the purpose of preventing moisture in both developers A and B in an amount of 4.0 liters.
【0236】以下の操作で定着液として100リットル
量になる固形定着剤を作成した。A solid fixing agent having a volume of 100 liters was prepared as a fixing solution by the following operation.
【0237】[造粒物(C)]チオ硫酸アンモニウム/
チオ硫酸ナトリウム(90/10重量比)15000g
を市販のバンダミル中で平均10μmになるまで粉砕す
る。この微粉に亜硫酸ナトリウム500g、Na2S2
05 750g、結合剤パインフロー1300gを加え
水添加量を50mlにして攪拌造粒を行い、造粒物を流
動層乾燥機で40℃で乾燥して水分をほぼ完全に除去す
る。[Granulate (C)] Ammonium thiosulfate /
Sodium thiosulfate (90/10 weight ratio) 15000g
Are ground in a commercial bander mill to an average of 10 μm. To this fine powder, 500 g of sodium sulfite, Na 2 S 2
0 5 750 g and binder pine flow 1300 g are added and the amount of water added is set to 50 ml to carry out stirring granulation, and the granulated product is dried at 40 ° C. in a fluid bed dryer to remove water almost completely.
【0238】[造粒物(D)]ホウ酸400g、硫酸ア
ルミ・8水塩1200g、琥珀酸1200g、酒石酸3
00gを市販のバンダムミル中で平均10μmになるま
で粉砕する。この微粉にD−マソニット250g、D−
ソルビット120g、PEG#4000を160g加
え、水添加量30mlにして攪拌造粒を行い、造粒物を
流動層乾燥機で40℃で乾燥して水分を完全に除去す
る。[Granulate (D)] Boric acid 400 g, aluminum sulfate octadecahydrate 1200 g, succinic acid 1200 g, tartaric acid 3
00 g is ground in a commercial Van Dam mill to an average of 10 μm. 250g of D-Masonite, D-
Sorbit (120 g) and PEG # 4000 (160 g) were added, and water was added in an amount of 30 ml to carry out stirring granulation, and the granulated product was dried at 40 ° C. in a fluid bed dryer to completely remove water.
【0239】[固形定着剤]このようにして得られた造
粒物(C)にβ−アラニン3000g、酢酸ナトリウム
4330g、更に1−オクタンスルホン酸ナトリウムを
総重量の1.5%になるように添加し、更に造粒物
(D)にはメタ重亜硫酸ナトリウム750gと1−オク
タンスルホン酸ナトリウムを総重量の1.0%となるよ
うに添加し、それぞれ25℃、40%RH以下に調湿さ
れた部屋で混合機を用いて10分間均一に混合した後、
得られた混合物を菊水製作所(株)製タフプレストコレ
クト1527HUを改造した打錠機により1錠当たり充
填量を(C)は10.2g、(D)は11.2gにして
圧縮打錠を行い、直径30mmの円筒形の定着錠剤を作
成した。これを、各々固形剤を防湿のためにアルミを含
有させたピロー袋に4.0リットル量分ずつ封入包装し
た。[Solid-fixing agent] To the granulated product (C) thus obtained, 3,000 g of β-alanine, 4330 g of sodium acetate, and 1-octanesulfonic acid sodium were added so as to be 1.5% of the total weight. In addition, 750 g of sodium metabisulfite and sodium 1-octanesulfonate are added to the granulated product (D) so as to be 1.0% of the total weight, and the humidity is adjusted to 25 ° C and 40% RH or less, respectively. After uniformly mixing for 10 minutes using a mixer in the designated room,
The obtained mixture was compressed into tablets with a tableting machine modified from Tough Pressed Collect 1527HU manufactured by Kikusui Seisakusho Co., Ltd., so that the filling amount per tablet was (C) 10.2 g and (D) 11.2 g. A cylindrical fixed tablet having a diameter of 30 mm was prepared. Each of the solid agents was sealed and packed in a pillow bag containing aluminum for moisture prevention in an amount of 4.0 liters.
【0240】<処理方法>自現機はSRX−201(コ
ニカ(株)製)を改造し使用した。現像温度35℃、定
着温度35℃、乾燥温度55℃で処理時間dry to
dry表1記載の条件で処理を行った。補充は表1に
記載して量で行った。<Treatment Method> As the automatic developing machine, SRX-201 (manufactured by Konica Corporation) was modified and used. Development temperature 35 ° C., fixing temperature 35 ° C., drying temperature 55 ° C., processing time dry to
dry The treatment was carried out under the conditions shown in Table 1. Replenishment was done in the amounts listed in Table 1.
【0241】スタート時の現像タンク内の現像液はハイ
ドロキノン主薬固形現像剤α、レダクトン主薬固形現像
剤βともに各々の固形現像剤A、BをMIXして後記載
の改造ケミカルミキサーで希釈水で希釈溶解して調整す
る。尚、錠剤は完全に溶解し、析出物は見られなかっ
た。この現像液7.8リットルをSRX−201(コニ
カ(株)製)に入れ、後記載のスターターを加えてスタ
ート液として現像槽を満たして処理を開始した。スター
ター添加量は35ml/1リットルであった。定着剤は
固形定着剤(C)、(D)を後記載の改造ケミカルミキ
サーで希釈水で希釈して調整する。尚、錠剤は完全に溶
解し、析出物は見られなかった。この調整した定着液
5.6リットルをSRX−201の定着処理タンクに入
れてスタート液とした。At the start, the developer in the developing tank was mixed with hydroquinone-based solid developer α and reductone-based solid developer β of respective solid developers A and B, and diluted with diluted water with a modified chemical mixer described later. Dissolve and adjust. The tablets were completely dissolved and no precipitate was observed. 7.8 liters of this developing solution was put into SRX-201 (manufactured by Konica Corporation), and a starter described later was added to fill a developing tank as a starting solution to start the processing. The amount of starter added was 35 ml / 1 liter. The fixing agent is prepared by diluting the solid fixing agents (C) and (D) with diluted water with a modified chemical mixer described later. The tablets were completely dissolved and no precipitate was observed. 5.6 liters of this adjusted fixing solution was put into the fixing processing tank of SRX-201 to be used as a starting solution.
【0242】
スターター処方
KBr 5.5g
HO(CH2)2S(CH2)2S(CH)2OH 0.05g
N−アセチル−D,L−ペニシラミン 0.10g
メタ重亜硫酸ナトリウム 下記開始液pHになる量
水仕上げ 35ml
尚、SRX−201を現像、定着ともに各々の固形剤が
投入できるように改造ケミカルミキサー投入口を設けて
固形剤溶解用に内蔵ケミカルミキサーを改造した。[0242] Starter formulation KBr 5.5g HO (CH 2) 2 S (CH 2) 2 S (CH) 2 OH 0.05g N- acetyl -D, L-penicillamine 0.10g sodium metabisulfite following starting solution pH The amount of water to be finished 35 ml Incidentally, the built-in chemical mixer for dissolving the solid agent was modified by providing a modified chemical mixer inlet so that each solid agent could be charged during development and fixing of SRX-201.
【0243】現像、定着ともに各々の固形剤の投入口に
それぞれの包装袋を手で開封したものをセットし内蔵ケ
ミカルミキサーに錠剤を落とすと同時に温水(25〜3
0℃)を注水し攪拌溶解しながら溶解時間25分で4.
0リットルに調液する。これを現像・定着補充液として
用いた。この調整された補充液を現像槽、定着槽に供給
して前記記載の量を満たす。For development and fixing, each packaging bag was manually opened in each solid agent charging port, and the tablets were dropped into the built-in chemical mixer and at the same time warm water (25 to 3
(0 ° C) is poured and dissolved with stirring with a dissolution time of 25 minutes.
Adjust to 0 liter. This was used as a developing / fixing replenisher. The adjusted replenisher is supplied to the developing tank and the fixing tank to satisfy the above-mentioned amount.
【0244】現像を溶解した時のpHはハイドロキノン
系現像が10.55、レダクトン主薬系の場合pH1
0.15になるように酢酸、KOHで微調整した。定着
液の溶解補充液pHは4.80であった。The pH when the development is dissolved is 10.55 for the hydroquinone type development, and pH 1 for the reductone base type.
Fine adjustment was carried out with acetic acid and KOH so as to be 0.15. The solution replenisher pH of the fixer was 4.80.
【0245】内蔵ケミカルミキサーは調液槽と予備タン
ク槽に分かれており調液槽容量は3.0リットル、予備
タンク容量も3.0リットルであり、フィルムをランニ
ング処理中に調液槽で作成された補充液がなくなって
も、また攪拌溶解時間(約25分)中に無補充状態にな
らないように補充液が供給されるように予備タンクを設
けた。The built-in chemical mixer is divided into a preparation tank and a reserve tank tank, and the preparation tank capacity is 3.0 liters and the reserve tank capacity is 3.0 liters. The film is prepared in the preparation tank during the running process. A spare tank was provided so that the replenisher was supplied so that the replenisher was not consumed and the replenisher was not replenished during the stirring and dissolving time (about 25 minutes).
【0246】スターターを添加した時の現像液のpHは
αが10.45、βが9.90であった。The pH of the developer when the starter was added was α of 10.45 and β of 9.90.
【0247】上記固形剤でなく下記3パート構成の濃縮
液キットから内蔵CMを3パート構成で調液できるよう
に改造したSRX−201で調液した補充現像液γにも
同様にスターターを添加し開始液(開始pH9.90)
とし処理を行った。定着液は上記で調整されたと同じ液
を使用した。A starter is also added to the replenishment developer γ prepared by SRX-201 modified from the concentrated solution kit of the following three-part composition to prepare the built-in CM in the three-part composition instead of the above solid agent. Starting liquid (starting pH 9.90)
And processed. As the fixing solution, the same solution as prepared above was used.
【0248】
現像液γの調整
[濃縮液現像キットの組成] 現像液1リットル仕上げ量
(Aパート)
レダクトン類 表1記載量
4−ヒドロキシメチル−4−メチル−1−フェニル−3−ピラゾリドン
4g
亜硫酸カリウム50% 70g
重炭酸カリウム 3g
炭酸カリウム 100g
一般式(1) 表1記載量
一般式(2) 表1記載量
ジエチレングリコール 70g
50%水酸化カリウム pH調整用
純水で550mlに仕上げpHは10.80に調製し
た。Adjustment of Developer γ [Composition of Concentrated Solution Development Kit] Developer 1 liter Finishing amount (A part) Reductones Amount described in Table 1 4-hydroxymethyl-4-methyl-1-phenyl-3-pyrazolidone 4 g Sulfurous acid Potassium 50% 70 g Potassium bicarbonate 3 g Potassium carbonate 100 g General formula (1) Amount described in Table 1 General formula (2) Amount described in Table 1 Diethylene glycol 70 g 50% Potassium hydroxide pH adjusted to 550 ml with pure water for pH adjustment 10.80 Was prepared.
【0249】 (Bパート) 酢酸(90%) 22g トリエチレングリコール 10g N−アセチル−D,L−ペニシラミン 0.2g 1−フェニル−3−ピラゾリドン 2.0g 4−ヒドロキシメチル−4−メチル−1−フェニル−3−ピラゾリドン 4g 5−ニトロインダゾール 0.02g[0249] (Part B) Acetic acid (90%) 22 g Triethylene glycol 10g N-acetyl-D, L-penicillamine 0.2 g 1-phenyl-3-pyrazolidone 2.0 g 4-hydroxymethyl-4-methyl-1-phenyl-3-pyrazolidone 4 g 5-nitroindazole 0.02g
【0250】
(Cパート)
50%グルタルアルデヒド液 5.0g
尚、上記現像剤1リットル調液した時のpHは10.1
0であった。(Part C) 50% glutaraldehyde solution 5.0 g Incidentally, when 1 liter of the developer is prepared, the pH is 10.1.
It was 0.
【0251】前記、得られた塗布試料、処理剤、自現機
を用い下記の評価を行った。The following evaluations were carried out using the obtained coated sample, treating agent and automatic developing machine.
【0252】<長期安定性>表1に水補充有無を示す
が、長期ランニングによる濃縮化の影響を抑制するため
に、SRX−201自動現像機を改造し現像槽及び/又
は定着槽に水を補充する機構を設けた。<Long-term stability> Table 1 shows the presence or absence of water replenishment. In order to suppress the effect of concentration due to long-term running, the SRX-201 automatic developing machine was modified to add water to the developing tank and / or fixing tank. A mechanism for replenishment was provided.
【0253】各々の処理槽に液面センサーを設け、処理
開始前に液面センサーがONになるように液面低下を補
う水を補充し、自現機稼働中は1時間もしくは2時間ご
とに液面チェックをし低下分を水補充し補うようにし
た。但し、定着への補充は現−定のワタリラックの洗浄
水をその補充分に含めるようにした。A liquid level sensor is provided in each processing tank, and water is added to make up the liquid level sensor so that the liquid level sensor is turned on before the start of processing, and every 1 or 2 hours during operation of the automatic processing machine. The liquid level was checked and the decreased amount was replenished with water. However, for replenishment to fixing, the current-constant Watarilac wash water was included in the replenishment.
【0254】又、現像補充液、定着補充液を処理開始前
に四つ切り4枚処理相当量を稼働時に1時間当たり四つ
切り2枚分相当量を添加し液面低下、濃縮を抑制する方
法も行った。Further, the developer replenisher and the fixer replenisher are cut into four pieces before the start of processing, and a quantity equivalent to the processing of four pieces is cut into four pieces per hour during operation to suppress a decrease in the liquid level and concentration. The method also went.
【0255】[センシトメトリー変動の評価]先に調製
した感光材料を大角サイズに裁断し、現像処理後の光学
濃度が1.0となるように全面均一な露光を施し、ラン
ニングを行った。ランニング中は感光材料四つ切りサイ
ズ1枚(0.077m2)当たり現像、定着の補充量表
1記載量であった。ランニングは1日当たり50枚処理
を行い、初日(スタート液の状態)と500枚(20
日)、1000枚(40日)、1500枚(60日)の
センシトメトリーを求め表1に示した。[Evaluation of Sensitometric Variation] The photosensitive material prepared above was cut into a large-angle size, uniformly exposed to light so that the optical density after development was 1.0, and running was performed. During running, the amount of replenishment for developing and fixing per one sheet (0.077 m 2 ) of four-cut photosensitive material was as shown in Table 1. For running, 50 sheets are processed per day, and the first day (start liquid state) and 500 sheets (20 sheets)
The sensitometry of 1000 sheets (40 days), 1500 sheets (60 days) was obtained and shown in Table 1.
【0256】センシトメトリーは次のようにして求め
た。得られたフィルムを蛍光増感紙KO−250(コニ
カ(株)製)で挟み、管電圧90KVP、電流20m
A、時間0.05秒の条件でX線照射を行い、距離方法
にてセンシトメトリーカーブを作成し感度を求めた。感
度の値はFog+1.0を得るのに必要なX線量の逆数
として求めた。γ値としてFog+0.25〜Fog+
2.0の濃度範囲において濃度差を濃度を得るのに必要
な露光量の対数値差で割った値である傾きとして表し
た。又、露光量を増やし得られる最高濃度をDmとして
表1に示した。Sensitometry was determined as follows. The obtained film was sandwiched between fluorescent intensifying screens KO-250 (manufactured by Konica Corp.), tube voltage 90 KVP, current 20 m.
X-ray irradiation was performed under the conditions of A and time of 0.05 seconds, and a sensitometric curve was created by the distance method to determine the sensitivity. The sensitivity value was obtained as the reciprocal of the X-ray dose required to obtain Fog + 1.0. Fog + 0.25-Fog + as γ value
The density difference in the density range of 2.0 was expressed as the slope which is the value obtained by dividing the logarithmic difference in the exposure amount required to obtain the density. The maximum density that can be obtained by increasing the exposure dose is shown in Table 1 as Dm.
【0257】[残色性の評価]得られた塗布試料を3
0.5×25.4cmのサイズに裁断し、未露光のまま
上記処理方法で現像処理した。残色の度合いは目視にて
下記の基準で評価した。[Evaluation of Remaining Coloring Property]
It was cut into a size of 0.5 × 25.4 cm, and developed by the above-mentioned processing method while being unexposed. The degree of residual color was visually evaluated according to the following criteria.
【0258】 A:ほとんど残色しない B:わずかに残色しているが気にならない C:残色しているが実用的に許容される D:残色が多く不可[0258] A: Almost no residual color B: The color remains slightly, but it does not bother me C: Remaining color, but practically acceptable D: Many residual colors are not possible
【0259】[銀色調の評価]得られたフィルムの大角
サイズを蛍光増感紙KO−250(コニカ(株)製)で
挟み、管電圧90KVP、電流200mA、時間0.0
5秒の条件でファントームを被写体としてX線照射を行
った。これを上記ランニングの中で処理した。得られた
画像を下記ランクに従い目視評価した。[Evaluation of Silver Tone] The large size of the obtained film was sandwiched between fluorescent intensifying screens KO-250 (manufactured by Konica Corp.), tube voltage 90 KVP, current 200 mA, time 0.0.
X-ray irradiation was performed with the phantom as a subject under the condition of 5 seconds. This was processed in the above run. The obtained image was visually evaluated according to the following ranks.
【0260】
ランク5 : 色調が黒調である
ランク4 : 色調が温黒調である
ランク3 : 色調がわずかに黄色味を帯びている
ランク2 : 色調がやや黄色味を帯びておりNGレベ
ル
ランク1 : 明らかに黄色味を帯びるRank 5: Color tone is black tone Rank 4: Color tone is warm black tone Rank 3: Color tone is slightly yellowish Rank 2: Color tone is slightly yellowish, NG level rank 1: Clearly yellowish
【0261】[銀スラッジの評価]処理後の濃度が1.
0±0.1となるように均一ベタ露光された塗布試料の
四つ切りサイズ200枚を処理した後、現像槽内及び搬
送ローラーの汚れを目視で評価した。[Evaluation of Silver Sludge] The density after the treatment was 1.
After processing 200 sheets of quadrants of the coated sample uniformly exposed to a solid of 0 ± 0.1, stains in the developing tank and the transport roller were visually evaluated.
【0262】 ランク3 : 全く問題無いレベル ランク2 : 許容レベル ランク1 : 問題となるレベル[0262] Rank 3: No problem Rank 2: Acceptable level Rank 1: Problematic level
【0263】[0263]
【発明の効果】表1の記載・評価からわかるように本発
明の構成をとることによりランニング(経時を含めた長
期ランニング)による感度、γ、Dm変動が大きく改善
されることがわかる。特にγ、Dmの変動改善は顕著で
ある。又、銀色調、銀スラッジも本発明の改善が大き
い。As can be seen from the description and evaluation in Table 1, the composition of the present invention significantly improves the sensitivity (γ, Dm variation) due to running (long-term running including aging). In particular, the improvement in fluctuations in γ and Dm is remarkable. Further, silver tone and silver sludge are also greatly improved by the present invention.
【0264】さらに本発明の現像剤、定着剤は固形化が
達成でき70%近くスペースを削減したコンパクト化が
はかれると同時に濃縮液キットより固形化により長期安
定性(センシトメトリー、銀色調)は向上していること
がわかる。Further, the developer and the fixing agent of the present invention can be solidified and can be compacted by reducing the space by nearly 70%, and at the same time, the solidification from the concentrate kit results in long-term stability (sensitometry, silver tone). You can see that it is improving.
【0265】特にレダクトン類を主薬とする現像液を使
用した場合に本発明構成をとることにより水補充するこ
とにより本発明の改善効果が大きく発揮される。特に残
色で発揮されたのは驚くべき発明である。In particular, when a developing solution containing a reductone as a main component is used, the improvement effect of the present invention is greatly exerted by replenishing water by adopting the constitution of the present invention. It was a surprising invention that was especially exhibited in residual color.
【0266】[0266]
【表1】 [Table 1]
【0267】[0267]
【表2】 [Table 2]
【0268】[0268]
【表3】 [Table 3]
───────────────────────────────────────────────────── フロントページの続き (58)調査した分野(Int.Cl.7,DB名) G03C 1/34 G03C 5/26 520 G03C 5/29 G03C 5/30 G03C 5/305 ─────────────────────────────────────────────────── ─── Continuation of front page (58) Fields surveyed (Int.Cl. 7 , DB name) G03C 1/34 G03C 5/26 520 G03C 5/29 G03C 5/30 G03C 5/305
Claims (10)
乳剤層を含む親水性コロイド層を設けたハロゲン化銀写
真感光材料において、前記親水性コロイド層は下記一般
式(1)で表される化合物及び一般式(2)で表される
化合物を含有することを特徴とするハロゲン化銀写真感
光材料。 【化1】 式中Y、ZはNまたはCR2(R2は水素原子及び置
換、無置換のアルキル基又はアリール基を表す。) R1は少なくとも1個以上のスルホ基、カルボキシ基、
アミノ基、ヒドロキシ基又はその塩又はボロン残基で置
換されたアリール基を表す。またそれらの置換基が2個
以上ある時は同じであっても異なっても良い。Mは水素
原子、アルカリ金属原子、4級アンモニウム及びアルカ
リ条件下でMが水素原子又はアルカリ金属となりうる基
を表す。 【化2】 式中P、QはNまたはCR4(R4は水素原子及び置
換、無置換のアルキル基又はアリール基を表す。) R3は少なくとも1個以上のスルホ基、カルボキシ基、
アミノ基、ヒドロキシ基又はその塩又はボロン残基で置
換されたアルキル基を表す。それらの置換基が2個以上
ある時は同じであっても異なっても良い。M1は水素原
子、アルカリ金属原子、4級アンモニウム及びアルカリ
条件下でMが水素原子又はアルカリ金属となりうる基を
表す。1. A silver halide photographic light-sensitive material comprising a support and a hydrophilic colloid layer containing at least one silver halide emulsion layer, wherein the hydrophilic colloid layer is represented by the following general formula (1). And a compound represented by the general formula (2). [Chemical 1] In the formula, Y and Z are N or CR 2 (R 2 represents a hydrogen atom and a substituted or unsubstituted alkyl group or aryl group.) R 1 is at least one or more sulfo group, carboxy group,
It represents an amino group, a hydroxy group or a salt thereof, or an aryl group substituted with a boron residue. When two or more of these substituents are present, they may be the same or different. M represents a hydrogen atom, an alkali metal atom, quaternary ammonium, and a group in which M can be a hydrogen atom or an alkali metal under alkaline conditions. [Chemical 2] In the formula, P and Q are N or CR 4 (R 4 represents a hydrogen atom and a substituted or unsubstituted alkyl group or aryl group.) R 3 is at least one or more sulfo group, carboxy group,
It represents an alkyl group substituted with an amino group, a hydroxy group or a salt thereof, or a boron residue. When there are two or more such substituents, they may be the same or different. M 1 represents a hydrogen atom, an alkali metal atom, a quaternary ammonium, or a group in which M can be a hydrogen atom or an alkali metal under alkaline conditions.
記一般式(2)で表される化合物を含有するハロゲン化
銀写真感光材料用現像液。2. A developer for a silver halide photographic light-sensitive material, containing a compound represented by the general formula (1) and a compound represented by the general formula (2).
性コロイド層を設けたハロゲン化銀写真感光材料を前記
一般式(1)で表される化合物及び前記一般式(2)で
表される化合物の存在下、現像処理することを特徴とす
るハロゲン化銀写真感光材料の処理方法。3. A silver halide photographic light-sensitive material having a hydrophilic colloid layer containing a silver halide emulsion layer provided on a support is represented by the compound represented by the general formula (1) and the general formula (2). The method for processing a silver halide photographic light-sensitive material, which comprises performing development processing in the presence of the compound described above.
徴とする請求項2記載のハロゲン化銀写真感光材料用現
像液。4. The developer for a silver halide photographic light-sensitive material according to claim 2, wherein the developer contains reductones.
徴とする請求項3記載のハロゲン化銀写真感光材料の処
理方法。5. The method of processing a silver halide photographic light-sensitive material according to claim 3, wherein the developer contains reductones.
を含まないことを特徴とする請求項2又は4記載のハロ
ゲン化銀写真感光材料用現像液。6. The developing solution for silver halide photographic light-sensitive materials according to claim 2, wherein the developing solution contains substantially no dihydroxybenzenes.
を含まないことを特徴とする請求項3又は5記載のハロ
ゲン化銀写真感光材料の処理方法。7. The method of processing a silver halide photographic light-sensitive material according to claim 3, wherein the developing solution contains substantially no dihydroxybenzenes.
記一般式(2)で表される化合物を含有するハロゲン化
銀写真感光材料用固体状現像剤。8. A solid developer for a silver halide photographic light-sensitive material, containing a compound represented by the general formula (1) and a compound represented by the general formula (2).
解して調整されることを特徴とする請求項2、4又は6
記載のハロゲン化銀写真感光材料用現像液。9. The developer is prepared by dissolving the solid developer according to claim 8.
The developer for a silver halide photographic light-sensitive material as described above.
溶解して調整されることを特徴とする請求項3、5又は
7記載のハロゲン化銀写真感光材料の処理方法。10. The method for processing a silver halide photographic light-sensitive material according to claim 3, 5 or 7, wherein a developing solution is prepared by dissolving the solid developer according to claim 8.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP29716996A JP3481802B2 (en) | 1996-07-11 | 1996-10-18 | Silver halide photographic material, developer for silver halide photographic material and processing method thereof |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20119196 | 1996-07-11 | ||
| JP8-201191 | 1996-07-11 | ||
| JP29716996A JP3481802B2 (en) | 1996-07-11 | 1996-10-18 | Silver halide photographic material, developer for silver halide photographic material and processing method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH1078628A JPH1078628A (en) | 1998-03-24 |
| JP3481802B2 true JP3481802B2 (en) | 2003-12-22 |
Family
ID=26512639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP29716996A Expired - Fee Related JP3481802B2 (en) | 1996-07-11 | 1996-10-18 | Silver halide photographic material, developer for silver halide photographic material and processing method thereof |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3481802B2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1695091A (en) * | 2002-11-15 | 2005-11-09 | 柯尼卡美能达影像株式会社 | Silver halide photosensitive material for color photography |
| WO2004046821A1 (en) * | 2002-11-15 | 2004-06-03 | Konica Minolta Photo Imaging, Inc. | Silver halide color photosensitive material |
-
1996
- 1996-10-18 JP JP29716996A patent/JP3481802B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH1078628A (en) | 1998-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3574986B2 (en) | Solid processing agent for silver halide photographic light-sensitive material and method of processing silver halide photographic light-sensitive material | |
| JP3481802B2 (en) | Silver halide photographic material, developer for silver halide photographic material and processing method thereof | |
| JP3622165B2 (en) | Photographic processing method for silver halide photographic material | |
| US5869225A (en) | Processing method of silver halide photographic light sensitive material | |
| JPH10171075A (en) | Method for processing silver halide black-and-white photographic sensitive material | |
| JPH0895206A (en) | Processing method of silver halide photographic light-sensitive material using solid processing agent | |
| JP3312189B2 (en) | Processing method of silver halide photographic material | |
| JPH10123676A (en) | Processing method of silver halide photographic material | |
| JPH08106149A (en) | Processing method of silver halide photographic light-sensitive material | |
| JPH11242314A (en) | Treatment of silver halide photographic sensitive material | |
| US6077652A (en) | Photographic developer and method for developing silver halide photographic light sensitive material by use thereof | |
| JPH08110618A (en) | Method for processing silver halide photographic sensitive material | |
| JP3531020B2 (en) | Silver halide photographic material and processing method thereof | |
| JP3769953B2 (en) | Solid processing agent for fixing, its package and processing method using the same | |
| JPH08110617A (en) | Solid fixing agent for silver halide photographic light-sensitive material and processing method | |
| JPH08211570A (en) | Method for continuously processing silver halide photographic sensitive material | |
| JPH11167184A (en) | Fixing agent for silver halide photographic sensitive material and its processing method | |
| JPH09244172A (en) | Silver halide photographic sensitive material and processing method therefor | |
| JPH0876323A (en) | Method for forming silver image for silver halide photographic sensitive material | |
| JP2000171948A (en) | Developer and processing method for black-and-white silver halide photographic sensitive material | |
| JPH08146565A (en) | Processing method for silver halide photosensitive material | |
| JP2001264940A (en) | Solid developer for silver halide photographic sensitive material | |
| JPH1090845A (en) | Development processing method for silver halide photographic sensitive material | |
| JPH11242312A (en) | Treatment of silver halide photographic sensitive material | |
| JP2001033917A (en) | Thick fixing solution, solid fixing agent and its packaged body and processing method using same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |